data_2kxv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kxv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.595 ' N ' HD21 ' A' ' 4' ' ' ASN . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 39' ' ' ASP . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.481 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.481 ' ND2' ' OD1' ' A' ' 46' ' ' ASN . 85.6 m-20 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.636 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.636 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.416 ' O ' ' OG ' ' A' ' 72' ' ' SER . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.417 ' CD1' ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 5.1 t60 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.285 0.564 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' LEU . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 39' ' ' ASP . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.475 ' H ' ' HD1' ' A' ' 57' ' ' HIS . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 72' ' ' SER . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 134' ' ' GLU . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' SER . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' N ' ' HH ' ' A' ' 158' ' ' TYR . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.652 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.652 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.534 ' HH ' ' N ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.523 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.673 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 39' ' ' ASP . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.531 ' C ' ' H ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 9.7 t-20 -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.468 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 53' ' ' GLY . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.411 ' HD1' ' H ' ' A' ' 58' ' ' THR . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.414 ' HG1' ' CB ' ' A' ' 72' ' ' SER . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HG1' ' A' ' 58' ' ' THR . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' OH ' ' A' ' 125' ' ' TYR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 40.0 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.464 ' HH ' ' HH ' ' A' ' 169' ' ' TYR . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.583 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.464 ' HH ' ' HH ' ' A' ' 158' ' ' TYR . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 115' ' ' ASN . 27.2 mtt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.564 ' C ' ' H ' ' A' ' 38' ' ' GLY . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 39' ' ' ASP . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.521 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' GLY . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.471 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.471 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 58' ' ' THR . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 75.8 m-20 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.426 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 75' ' ' ILE . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' CB ' ' HG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.668 ' NE2' HE21 ' A' ' 105' ' ' GLN . 2.9 mm100 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.668 HE21 ' NE2' ' A' ' 101' ' ' GLN . 4.0 tp-100 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 117' ' ' ASP . 34.9 m120 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.531 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.671 ' HG ' ' H ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.671 ' H ' ' HG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.407 ' C ' ' H ' ' A' ' 4' ' ' ASN . 13.2 ptp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 2' ' ' MET . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 39' ' ' ASP . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.508 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.465 ' CG2' ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.502 ' HZ3' ' CB ' ' A' ' 143' ' ' TYR . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 117' ' ' ASP . 10.1 m120 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.54 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' A' ' 135' ' ' THR . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.502 ' CB ' ' HZ3' ' A' ' 86' ' ' LYS . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' GLN . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.468 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 164' ' ' SER . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.479 HD21 ' CB ' ' A' ' 117' ' ' ASP . 13.5 m-80 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' ASP . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.654 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HD1' ' N ' ' A' ' 58' ' ' THR . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.543 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.558 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 104' ' ' GLY . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 8' ' ' GLY . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' LEU . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.526 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.428 ' HD1' ' N ' ' A' ' 58' ' ' THR . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.428 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 21' ' ' PHE . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.469 ' CG ' ' HG ' ' A' ' 72' ' ' SER . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.469 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 79' ' ' ALA . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.4 t60 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 104' ' ' GLY . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 117' ' ' ASP . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.446 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.68 ' ND1' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.68 ' H ' ' ND1' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 160' ' ' GLY . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.34 0.59 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 39' ' ' ASP . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 43' ' ' ILE . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 50' ' ' SER . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.4 ' H ' ' CG1' ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.69 HD21 ' H ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.69 ' H ' HD21 ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.689 ' H ' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 128' ' ' THR . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 126' ' ' ASP . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' OG1' ' A' ' 133' ' ' THR . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.481 ' HH ' HH12 ' A' ' 152' ' ' ARG . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.532 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 69.6 m-80 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 8.6 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.302 0.572 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.5 m120 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 39' ' ' ASP . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 43' ' ' ILE . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 53' ' ' GLY . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.593 ' HD1' ' N ' ' A' ' 58' ' ' THR . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.593 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 72' ' ' SER . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 79' ' ' ALA . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.474 ' CD2' ' HZ1' ' A' ' 150' ' ' LYS . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.474 ' HZ1' ' CD2' ' A' ' 145' ' ' HIS . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.374 0.607 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.639 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 39' ' ' ASP . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 43' ' ' ILE . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.661 ' HD1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.661 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.498 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.567 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.498 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.596 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 6.5 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.1 m120 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.649 ' NH2' ' HG ' ' A' ' 107' ' ' SER . 95.8 mtt180 . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.2 m120 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' ASP . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.519 ' H ' ' C ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.586 ' HG ' ' H ' ' A' ' 55' ' ' VAL . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.49 ' C ' ' HG ' ' A' ' 50' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' A' ' 50' ' ' SER . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.528 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 88' ' ' ILE . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.649 ' HG ' ' NH2' ' A' ' 14' ' ' ARG . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 115' ' ' ASN . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.595 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 39' ' ' ASP . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.6 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 64' ' ' GLY . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.407 ' H ' ' HG1' ' A' ' 63' ' ' THR . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.4 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.65 HD22 ' HG1' ' A' ' 120' ' ' THR . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.65 ' HG1' HD22 ' A' ' 115' ' ' ASN . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 135' ' ' THR . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.434 ' C ' ' H ' ' A' ' 170' ' ' GLY . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 168' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 39' ' ' ASP . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.464 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.464 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 117' ' ' ASP . 3.4 m120 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.682 ' ND1' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.682 ' H ' ' ND1' ' A' ' 145' ' ' HIS . 0.1 OUTLIER -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.225 0.536 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 39' ' ' ASP . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.405 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 70.7 m-20 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' A' ' 65' ' ' GLU . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.412 ' H ' ' HG1' ' A' ' 63' ' ' THR . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 8.9 t-160 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.4 0.619 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 104' ' ' GLY . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 104' ' ' GLY . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.614 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.614 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' A' ' 58' ' ' THR . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.427 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 88' ' ' ILE . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.435 ' CG2' ' HZ1' ' A' ' 86' ' ' LYS . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 63.3 t60 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 104' ' ' GLY . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.451 ' H ' ' HG ' ' A' ' 102' ' ' SER . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 117' ' ' ASP . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' OG1' ' A' ' 133' ' ' THR . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-160 -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.494 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 145' ' ' HIS . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.433 ' CD2' ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.315 0.579 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.612 ' N ' HD21 ' A' ' 4' ' ' ASN . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.301 0.572 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.62 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.688 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 59' ' ' GLY . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.723 HD21 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.723 ' H ' HD21 ' A' ' 61' ' ' ASN . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' TRP . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 72' ' ' SER . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.482 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 87' ' ' ILE . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 13.6 t60 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 104' ' ' GLY . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 108' ' ' GLY . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 107' ' ' SER . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.4 ' CG2' ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 117' ' ' ASP . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.574 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.403 ' HD1' ' N ' ' A' ' 146' ' ' ASN . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' N ' ' HD1' ' A' ' 145' ' ' HIS . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.496 ' CG1' HE21 ' A' ' 156' ' ' GLN . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.496 HE21 ' CG1' ' A' ' 154' ' ' VAL . 60.7 mm-40 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 39' ' ' ASP . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CD1' ' HG ' ' A' ' 50' ' ' SER . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' A' ' 47' ' ' ASN . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.525 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.519 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.414 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.426 ' CG2' ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.6 p80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 119' ' ' GLN . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.492 ' CB ' HD21 ' A' ' 4' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.2 t30 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 86' ' ' LYS . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . 0.432 ' C ' ' H ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.2 t30 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.493 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' GLN . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' SER . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 39' ' ' ASP . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.513 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HZ2' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 94' ' ' HIS . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 93' ' ' ILE . 6.2 t-80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 117' ' ' ASP . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.0 OUTLIER -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' ASN . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.508 ' CD ' ' HZ2' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.49 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.562 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.556 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.427 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 79' ' ' ALA . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 88' ' ' ILE . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' ILE . 7.4 t-160 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.543 ' H ' ' HG1' ' A' ' 128' ' ' THR . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 117' ' ' ASP . 10.6 m120 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.543 ' HG1' ' H ' ' A' ' 109' ' ' ALA . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 132' ' ' SER . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.327 0.584 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 39' ' ' ASP . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 47' ' ' ASN . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HD21 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.413 ' CA ' ' OD1' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.44 ' H ' ' H ' ' A' ' 2' ' ' MET . 15.4 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.44 ' H ' ' H ' ' A' ' 1' ' ' SER . 58.7 mtt -52.0 114.81 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.595 ' N ' HD21 ' A' ' 4' ' ' ASN . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -132.81 106.78 7.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 t -93.68 105.59 17.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -84.41 -52.05 6.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.71 16.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.72 -27.76 2.32 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -83.74 150.96 25.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -1.117 . . . . 0.0 109.7 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -157.88 172.3 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -0.82 . . . . 0.0 109.314 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.596 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.596 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.529 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 39' ' ' ASP . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.481 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.481 ' ND2' ' OD1' ' A' ' 46' ' ' ASN . 85.6 m-20 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.636 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.636 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.416 ' O ' ' OG ' ' A' ' 72' ' ' SER . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' CD1' ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.666 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 5.1 t60 -61.88 -138.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.666 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 25.4 m-20 -71.15 -18.2 62.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.18 -19.27 1.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 109.144 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -62.9 -42.72 99.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -61.0 -47.48 86.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.12 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 11.4 mpt_? -71.14 11.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.516 ' H ' ' C ' ' A' ' 98' ' ' ALA . 18.7 mmt180 58.98 79.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.439 -0.788 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -150.95 64.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.531 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.52 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.99 -18.0 66.14 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -138.36 133.69 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -1.083 . . . . 0.0 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -77.57 147.24 35.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.533 ' N ' HD21 ' A' ' 172' ' ' ASN . . . -80.48 175.76 10.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.473 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.434 ' H ' ' HG ' ' A' ' 1' ' ' SER . 20.1 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt -73.72 53.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -86.43 106.86 17.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -96.13 128.98 43.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 t -158.18 -35.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.314 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -158.1 40.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.196 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.32 -19.32 23.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -61.53 151.1 33.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -162.67 150.73 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.616 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 39' ' ' ASP . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.475 ' H ' ' HD1' ' A' ' 57' ' ' HIS . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.522 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' O ' ' OG ' ' A' ' 72' ' ' SER . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -97.63 -56.88 2.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -49.63 -18.14 0.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -64.15 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -50.55 -38.26 44.04 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.665 -1.272 . . . . 0.0 109.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.501 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -91.2 -53.18 4.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.204 -0.935 . . . . 0.0 111.284 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.53 -11.31 20.22 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.938 -1.101 . . . . 0.0 111.271 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' ALA . 37.5 ttt180 59.2 89.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.984 -1.072 . . . . 0.0 109.345 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 -139.8 146.11 39.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 108.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 134' ' ' GLU . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.401 ' N ' ' HG ' ' A' ' 102' ' ' SER . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.502 ' C ' ' H ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' O ' ' OG ' ' A' ' 102' ' ' SER . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' N ' ' HH ' ' A' ' 158' ' ' TYR . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.608 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.652 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.652 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.534 ' HH ' ' N ' ' A' ' 138' ' ' LEU . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.523 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.06 -43.99 7.86 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.3 tt -72.94 145.88 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.097 -1.237 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.483 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 1.6 p30 -65.98 113.7 4.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.513 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 110.88 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.479 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.621 ' N ' ' ND2' ' A' ' 118' ' ' ASN . 42.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -174.08 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.382 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -132.79 106.93 8.03 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 m -120.65 105.78 11.11 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.63 -90.35 0.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.892 . . . . 0.0 109.285 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.46 -20.68 39.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.01 -21.87 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -56.56 176.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -1.142 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -175.92 -166.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.536 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.673 HD21 ' H ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.582 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 39' ' ' ASP . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.531 ' C ' ' H ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 9.7 t-20 -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 0.5 OUTLIER -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.468 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' A' ' 53' ' ' GLY . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.411 ' HD1' ' H ' ' A' ' 58' ' ' THR . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.414 ' HG1' ' CB ' ' A' ' 72' ' ' SER . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.414 ' CB ' ' HG1' ' A' ' 58' ' ' THR . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.656 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 11.8 t-160 -81.96 -134.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.656 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 19.6 p-10 -56.67 -27.79 59.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.091 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.52 -19.27 2.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 108.784 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.65 -45.27 65.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -64.27 -48.03 77.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.447 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 11.2 mpt_? -73.55 15.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.9 . . . . 0.0 108.98 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 98' ' ' ALA . 17.3 tpt180 53.5 78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -150.0 74.09 1.19 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 1' ' ' SER . 61.0 m-80 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.408 ' OD2' ' OH ' ' A' ' 125' ' ' TYR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.546 ' H ' ' C ' ' A' ' 131' ' ' ALA . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.419 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 40.0 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.464 ' HH ' ' HH ' ' A' ' 169' ' ' TYR . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.583 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.464 ' HH ' ' HH ' ' A' ' 158' ' ' TYR . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.67 -31.08 13.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.1 pt -138.36 145.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.385 -1.068 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -80.45 147.57 30.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 158.56 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.489 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.284 0.564 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.433 ' CE ' HD22 ' A' ' 115' ' ' ASN . 27.2 mtt -77.26 113.09 14.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -132.76 106.72 7.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.5 p -112.83 105.64 13.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.683 . . . . 0.0 109.483 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -96.71 -57.22 2.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.935 . . . . 0.0 109.111 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -158.65 18.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.08 -18.3 0.93 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -81.59 127.05 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.147 . . . . 0.0 109.624 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.67 141.13 11.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.564 ' C ' ' H ' ' A' ' 38' ' ' GLY . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.564 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.538 ' H ' ' C ' ' A' ' 39' ' ' ASP . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.536 ' HG ' ' N ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' N ' ' HG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.521 ' HG ' ' CB ' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 53' ' ' GLY . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.471 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 58' ' ' THR . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 75.8 m-20 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.426 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.428 ' CD1' ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.409 HG22 HD12 ' A' ' 75' ' ' ILE . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' CB ' ' HG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.558 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 96' ' ' ALA . 22.7 t-80 -87.08 -62.75 1.43 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.25 -18.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.654 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.87 -38.86 87.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -52.81 -33.34 48.67 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.734 -1.229 . . . . 0.0 109.417 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.96 -53.1 4.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.25 -0.906 . . . . 0.0 111.242 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -107.9 -6.38 16.69 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.212 -0.93 . . . . 0.0 111.069 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.8 ttt180 57.63 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.951 -1.093 . . . . 0.0 109.427 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.668 ' NE2' HE21 ' A' ' 105' ' ' GLN . 2.9 mm100 -143.67 142.52 31.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.255 -0.903 . . . . 0.0 109.212 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.668 HE21 ' NE2' ' A' ' 101' ' ' GLN . 4.0 tp-100 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 117' ' ' ASP . 34.9 m120 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.478 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.478 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.531 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.531 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.671 ' HG ' ' H ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.671 ' H ' ' HG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -155.36 40.5 0.61 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 167' ' ' ALA . 15.3 tt -76.39 154.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.402 ' C ' ' H ' ' A' ' 174' ' ' SER . 5.8 p-10 -79.21 124.46 28.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.55 36.2 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 172' ' ' ASN . 23.3 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.495 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 2' ' ' MET . 95.8 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.504 ' N ' ' OG ' ' A' ' 1' ' ' SER . 13.2 ptp -160.51 43.85 0.19 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.407 ' H ' ' C ' ' A' ' 2' ' ' MET . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -92.34 106.99 18.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -93.27 129.59 39.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.89 -38.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -158.03 44.58 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.22 -18.18 10.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -78.68 130.4 35.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.17 171.44 20.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.468 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.444 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.542 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 39' ' ' ASP . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.508 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.508 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.465 ' CG2' ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.564 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.502 ' HZ3' ' CB ' ' A' ' 143' ' ' TYR . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 96' ' ' ALA . 14.5 t-80 -95.93 -56.65 2.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -48.68 -18.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.631 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -49.51 -52.92 26.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.25 -25.67 48.68 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 109.651 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -53.95 4.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.101 -1.0 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.15 -3.67 14.62 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.121 -0.987 . . . . 0.0 110.719 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.0 ttt180 55.19 95.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 -158.84 152.53 23.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.518 ' C ' ' H ' ' A' ' 117' ' ' ASP . 10.1 m120 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 1' ' ' SER . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.558 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.54 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.425 ' CG ' ' H ' ' A' ' 135' ' ' THR . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.425 ' H ' ' CG ' ' A' ' 134' ' ' GLU . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.502 ' CB ' ' HZ3' ' A' ' 86' ' ' LYS . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.499 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 168' ' ' GLN . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.468 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.409 ' N ' ' O ' ' A' ' 164' ' ' SER . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.09 -40.93 7.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 88.7 mt -75.55 142.5 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.45 ' N ' HD21 ' A' ' 172' ' ' ASN . 1.4 m-80 -77.6 107.48 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.401 ' O ' ' OG ' ' A' ' 174' ' ' SER . . . -80.45 15.76 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 173' ' ' ALA . 21.4 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.305 0.574 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt -49.5 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.479 HD21 ' CB ' ' A' ' 117' ' ' ASP . 13.5 m-80 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -132.86 106.81 7.93 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -95.83 129.9 42.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.226 -0.921 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.5 p -152.82 -81.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.339 -0.851 . . . . 0.0 108.98 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -84.6 25.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.4 -3.59 86.95 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -82.96 168.71 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -176.22 157.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.57 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.608 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.608 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' ASP . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.654 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.654 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.543 ' HD1' ' N ' ' A' ' 58' ' ' THR . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.543 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.558 ' CD1' ' H ' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.514 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' ALA . 86.2 t60 -98.69 -66.29 0.91 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.67 -17.87 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.01 -18.17 22.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.434 -0.791 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -70.73 -61.98 1.56 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.937 -1.102 . . . . 0.0 109.659 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.82 -42.34 10.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 111.056 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -83.28 -19.12 36.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.052 -1.03 . . . . 0.0 110.782 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 99' ' ' ARG . 52.4 ttt180 54.8 98.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 0.0 109.374 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 -165.93 147.36 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 106' ' ' VAL . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.431 ' N ' ' C ' ' A' ' 104' ' ' GLY . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 8' ' ' GLY . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.476 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 127' ' ' LEU . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.542 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.488 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.13 7.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 91.0 mt -76.94 112.82 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.4 107.29 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.52 162.98 24.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.483 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt -55.17 141.13 36.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -132.99 106.79 7.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -98.04 105.89 18.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.279 -0.888 . . . . 0.0 109.451 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.621 ' HG1' ' H ' ' A' ' 17' ' ' ASP . 39.3 p -82.31 -59.83 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.4 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.621 ' H ' ' HG1' ' A' ' 16' ' ' THR . 20.0 p-10 -158.35 18.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.29 -23.85 0.52 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 4.4 mp0 -81.02 159.41 24.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -174.7 149.31 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' NZ ' ' N ' ' A' ' 172' ' ' ASN . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' C ' ' H ' ' A' ' 38' ' ' GLY . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.526 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.428 ' HD1' ' N ' ' A' ' 58' ' ' THR . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.428 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.576 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.418 ' O ' ' O ' ' A' ' 21' ' ' PHE . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' CG ' ' HG ' ' A' ' 72' ' ' SER . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.469 ' HG ' ' CG ' ' A' ' 69' ' ' ASP . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' C ' ' H ' ' A' ' 79' ' ' ALA . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.638 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.4 t60 -64.71 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.638 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.2 m-20 -72.7 -19.29 61.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.923 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.68 -19.32 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 108.921 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -70.22 -49.33 51.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -58.39 -48.14 81.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' N ' ' CD ' ' A' ' 99' ' ' ARG . 11.9 mpt_? -73.74 14.23 0.4 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.101 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' A' ' 98' ' ' ALA . 8.9 tpm_? 54.57 79.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.446 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -154.14 77.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.44 ' N ' ' O ' ' A' ' 104' ' ' GLY . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 117' ' ' ASP . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.58 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.58 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.446 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.573 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.68 ' ND1' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.68 ' H ' ' ND1' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.461 ' C ' ' H ' ' A' ' 160' ' ' GLY . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.461 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.73 -24.62 41.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.38 141.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -1.197 . . . . 0.0 109.355 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.486 ' N ' ' NZ ' ' A' ' 35' ' ' LYS . 41.3 t30 -74.29 116.15 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 166.59 21.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.483 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.44 ' SD ' ' N ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -84.73 95.48 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.585 ' NH1' HE21 ' A' ' 19' ' ' GLN . 83.8 mtt180 -131.32 161.18 32.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m -85.75 166.53 16.03 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 18' ' ' GLY . 12.8 t -47.68 -26.35 1.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.88 -0.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 16' ' ' THR . . . -157.51 151.93 23.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.585 HE21 ' NH1' ' A' ' 14' ' ' ARG . 5.1 pm0 -46.77 147.03 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -1.137 . . . . 0.0 109.716 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 -93.17 -176.2 4.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.615 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.558 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 39' ' ' ASP . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.418 HG22 HD13 ' A' ' 43' ' ' ILE . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.478 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.478 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 50' ' ' SER . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.532 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' ALA . 53.6 t-80 -99.55 -70.23 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD2' ' OE1' ' A' ' 101' ' ' GLN . 8.3 p-10 -47.57 -17.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 109.714 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -53.75 -18.36 3.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.727 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.63 -60.24 2.45 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.925 -1.11 . . . . 0.0 109.833 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.02 -43.17 10.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.248 -0.907 . . . . 0.0 111.302 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -85.62 -16.73 38.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.927 -1.108 . . . . 0.0 111.112 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.2 OUTLIER 55.49 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.732 -1.23 . . . . 0.0 108.977 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 77.2 mt-30 -152.25 140.96 20.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.4 ' H ' ' CG1' ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.69 HD21 ' H ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.69 ' H ' HD21 ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.689 ' H ' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.498 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.42 ' OD1' ' OG1' ' A' ' 128' ' ' THR . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.42 ' OG1' ' OD1' ' A' ' 126' ' ' ASP . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.45 ' O ' ' OG1' ' A' ' 133' ' ' THR . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 130' ' ' ASP . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.481 ' HH ' HH12 ' A' ' 152' ' ' ARG . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.532 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.532 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 69.6 m-80 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.523 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 8.6 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.29 -41.81 7.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -138.35 136.81 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.422 -1.046 . . . . 0.0 109.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.84 111.36 17.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 40.05 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? -79.66 142.66 35.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.359 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -132.94 107.09 8.07 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -91.92 129.33 37.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 m -154.19 -47.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 16.9 p-10 -146.1 34.68 1.0 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.63 -6.34 80.05 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.498 ' NE2' ' OD1' ' A' ' 17' ' ' ASP . 32.4 mt-30 -71.59 141.89 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -160.32 144.79 14.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.5 m120 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 39' ' ' ASP . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 43' ' ' ILE . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.439 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.403 ' H ' ' C ' ' A' ' 53' ' ' GLY . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.593 ' HD1' ' N ' ' A' ' 58' ' ' THR . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.593 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' A' ' 72' ' ' SER . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 71' ' ' GLU . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.442 ' C ' ' H ' ' A' ' 79' ' ' ALA . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -108.79 -61.47 1.6 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -47.41 -19.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -59.11 -18.56 36.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.878 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -62.72 -59.59 4.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.773 -1.204 . . . . 0.0 109.172 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -33.82 15.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.821 . . . . 0.0 111.075 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -95.29 -19.52 19.92 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.907 -1.12 . . . . 0.0 111.447 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.435 ' HG3' HH11 ' A' ' 100' ' ' ARG . 13.3 ttm-85 53.63 85.12 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.672 -1.268 . . . . 0.0 109.186 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -142.9 150.88 40.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 12' ' ' ASP . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.505 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.405 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.474 ' CD2' ' HZ1' ' A' ' 150' ' ' LYS . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.474 ' HZ1' ' CD2' ' A' ' 145' ' ' HIS . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.31 -26.36 52.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.408 HG22 HD13 ' A' ' 171' ' ' ILE . 96.6 mt -79.47 120.26 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.421 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.98 129.27 39.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.476 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.47 160.42 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -73.44 89.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' A' ' 19' ' ' GLN . 41.0 ttp180 -85.29 106.72 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 p -101.58 132.02 47.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.376 -0.828 . . . . 0.0 109.333 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' CG2' ' CD ' ' A' ' 19' ' ' GLN . 6.1 t -161.36 -34.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 17.8 t70 -157.19 42.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.66 -30.16 4.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 10.8 pt20 -54.66 163.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.446 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.15 -162.65 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.639 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.639 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 39' ' ' ASP . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 HG21 ' A' ' 43' ' ' ILE . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.661 ' HD1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.661 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.413 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.498 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.6 t60 -96.34 -65.48 0.97 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.45 -18.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -63.07 -40.96 99.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.847 . . . . 0.0 109.635 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.5 -32.44 50.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.21 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.98 -53.68 4.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 111.273 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -111.97 3.05 17.22 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.125 -0.984 . . . . 0.0 111.127 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.7 ttp180 56.96 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.952 -1.092 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -150.15 134.34 17.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.26 -0.9 . . . . 0.0 109.485 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.503 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.567 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.567 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.498 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.596 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 6.5 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.507 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -93.01 -35.07 6.48 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.9 tt -138.15 140.61 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -1.04 . . . . 0.0 109.137 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.55 143.17 57.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 -171.94 3.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.903 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.454 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt -79.66 42.35 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.1 m120 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.649 ' NH2' ' HG ' ' A' ' 107' ' ' SER . 95.8 mtt180 -133.09 111.89 11.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -75.7 117.33 17.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 18' ' ' GLY . 4.0 p -148.82 139.35 22.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.367 -0.833 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 49.99 16.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 16' ' ' THR . . . 87.72 -11.16 67.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 16' ' ' THR . 35.5 mt-30 -77.03 174.77 10.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.538 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -175.88 160.68 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.55 ' N ' HD21 ' A' ' 33' ' ' ASN . 1.2 m120 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.593 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' H ' ' C ' ' A' ' 39' ' ' ASP . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.519 ' C ' ' H ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.519 ' H ' ' C ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.586 ' HG ' ' H ' ' A' ' 55' ' ' VAL . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.49 ' C ' ' HG ' ' A' ' 50' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.586 ' H ' ' HG ' ' A' ' 50' ' ' SER . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.554 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.528 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 HG23 HD12 ' A' ' 88' ' ' ILE . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' C ' ' N ' ' A' ' 96' ' ' ALA . 14.1 t-160 -93.13 -63.57 1.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.63 -18.15 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.693 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -62.19 -41.46 98.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.713 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.45 -34.03 47.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.592 -1.318 . . . . 0.0 109.268 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -53.29 4.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.3 -1.39 20.12 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.092 -1.005 . . . . 0.0 111.128 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 96' ' ' ALA . 44.8 ttt180 57.27 102.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.919 -1.113 . . . . 0.0 109.354 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -150.17 135.22 17.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.36 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.649 ' HG ' ' NH2' ' A' ' 14' ' ' ARG . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 115' ' ' ASN . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.528 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.21 -55.28 3.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 pt -76.56 139.73 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -1.135 . . . . 0.0 109.394 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.19 114.06 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -159.5 0.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.489 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -175.21 -179.14 1.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -132.5 106.87 8.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.9 p -83.26 105.77 14.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.598 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.35 -57.19 3.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.113 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.96 15.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.42 -16.47 1.29 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.66 168.64 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -1.211 . . . . 0.0 109.618 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 8.9 p30 -176.55 150.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.362 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.554 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.417 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.595 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.595 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 39' ' ' ASP . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.6 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.6 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.523 ' HG1' ' N ' ' A' ' 64' ' ' GLY . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' N ' ' HG1' ' A' ' 63' ' ' THR . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.407 ' H ' ' HG1' ' A' ' 63' ' ' THR . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.508 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.7 t-80 -94.56 -63.72 1.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 20' ' ' ASP . 81.2 m-20 -48.68 -18.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.23 -51.28 64.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.721 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -54.68 -27.5 40.72 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.684 -1.26 . . . . 0.0 109.713 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.79 -53.56 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.162 -0.962 . . . . 0.0 111.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -111.83 -4.44 14.61 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.202 -0.936 . . . . 0.0 110.825 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.3 ttt180 58.96 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.064 -1.023 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -153.14 145.46 23.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.2 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.4 ' CD1' ' CE2' ' A' ' 151' ' ' PHE . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.65 HD22 ' HG1' ' A' ' 120' ' ' THR . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.65 ' HG1' HD22 ' A' ' 115' ' ' ASN . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.403 ' CG ' ' H ' ' A' ' 135' ' ' THR . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.448 ' C ' ' SD ' ' A' ' 137' ' ' MET . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.434 ' C ' ' H ' ' A' ' 170' ' ' GLY . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 168' ' ' GLN . . . -152.14 27.79 0.9 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.16 130.76 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -1.134 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.99 109.81 16.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.427 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.37 134.63 36.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.461 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt -74.08 88.9 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -87.69 106.77 18.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -99.68 133.02 44.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.306 -0.872 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -157.03 -79.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -92.36 24.15 3.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 108.948 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.38 -1.31 81.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -84.13 174.46 10.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -1.128 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -175.85 -163.86 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.388 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 39' ' ' ASP . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.464 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.464 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.408 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.68 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 33.5 t60 -69.07 -141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.68 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 43.5 p30 -57.03 -24.28 52.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.494 ' N ' ' OD1' ' A' ' 95' ' ' ASP . . . -49.42 -19.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.045 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 95' ' ' ASP . 14.9 tt0 -69.74 -45.24 68.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.507 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -62.2 -51.86 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.406 ' N ' ' CD ' ' A' ' 99' ' ' ARG . 11.9 mpt_? -71.52 12.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.507 ' H ' ' C ' ' A' ' 98' ' ' ALA . 16.5 mmm180 56.37 81.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -150.47 75.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.313 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 117' ' ' ASP . 3.4 m120 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.552 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.559 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.559 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.4 ' CG ' ' H ' ' A' ' 135' ' ' THR . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.682 ' ND1' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.682 ' H ' ' ND1' ' A' ' 145' ' ' HIS . 0.1 OUTLIER -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.583 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -94.67 -50.33 2.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -81.72 103.25 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -77.0 132.16 38.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 -56.47 4.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.474 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt -80.0 98.21 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.577 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -132.83 106.72 7.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -92.84 128.8 38.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.8 m -153.28 -78.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 108.99 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.73 22.29 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.11 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.76 -8.88 70.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -84.25 177.97 7.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -1.125 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.21 167.25 2.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' A' ' 39' ' ' ASP . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.581 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.405 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 70.7 m-20 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' A' ' 65' ' ' GLU . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.412 ' H ' ' HG1' ' A' ' 63' ' ' THR . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.533 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.626 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 8.9 t-160 -62.0 -130.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.626 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.7 m-20 -68.3 -18.73 64.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.93 -19.37 1.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.066 -1.021 . . . . 0.0 108.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -73.2 -38.19 66.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.34 78.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.08 10.46 4.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.92 88.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 109.43 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -154.68 76.02 1.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 104' ' ' GLY . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 ' H ' ' C ' ' A' ' 104' ' ' GLY . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.503 ' H ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.567 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.581 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.8 -50.74 8.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.15 116.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -1.18 . . . . 0.0 109.299 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -65.92 104.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.561 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 -178.48 6.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.471 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.51 ' HG ' ' N ' ' A' ' 2' ' ' MET . 10.9 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.51 ' N ' ' HG ' ' A' ' 1' ' ' SER . 42.5 mtt -73.45 102.87 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -82.43 106.77 14.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -107.25 127.3 53.41 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.45 -0.781 . . . . 0.0 109.259 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 p -145.56 -45.79 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -156.64 41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -25.27 28.9 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.95 133.12 44.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -1.148 . . . . 0.0 109.293 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -158.17 157.57 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.574 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.414 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 ' CD2' ' N ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.589 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.555 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.53 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.53 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.511 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.42 ' CD1' ' N ' ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.614 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.614 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.555 ' HD1' ' N ' ' A' ' 58' ' ' THR . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.427 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.505 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HZ1' ' CG2' ' A' ' 88' ' ' ILE . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.435 ' CG2' ' HZ1' ' A' ' 86' ' ' LYS . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.647 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 63.3 t60 -79.2 -133.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.647 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 45.3 p-10 -71.41 -18.5 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.814 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.6 -19.24 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.051 -1.03 . . . . 0.0 108.886 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.63 -36.39 84.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.351 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.17 -34.75 56.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.573 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.57 15.34 2.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.236 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 53.82 69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.892 . . . . 0.0 109.49 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -151.27 64.75 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.901 . . . . 0.0 109.255 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.451 ' HG ' ' H ' ' A' ' 104' ' ' GLY . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.451 ' H ' ' HG ' ' A' ' 102' ' ' SER . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 117' ' ' ASP . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.446 ' O ' ' OG1' ' A' ' 133' ' ' THR . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.55 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.494 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-160 -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.494 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 145' ' ' HIS . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.433 ' CD2' ' H ' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.94 -49.69 6.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.77 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -79.91 136.18 36.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.02 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.459 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt -74.92 94.47 2.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.612 HD21 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.612 ' N ' HD21 ' A' ' 4' ' ' ASN . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -78.09 107.02 10.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -92.3 129.23 38.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.301 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.5 m -154.55 -46.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 6.2 p30 -148.05 32.76 0.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -17.17 58.62 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' NE2' ' OD2' ' A' ' 17' ' ' ASP . 2.6 pt20 -69.94 150.7 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -1.166 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -158.4 -162.93 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.62 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.512 ' H ' ' C ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.688 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.688 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.42 ' CG2' ' N ' ' A' ' 59' ' ' GLY . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' N ' ' CG2' ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.723 HD21 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.723 ' H ' HD21 ' A' ' 61' ' ' ASN . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' TRP . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' A' ' 72' ' ' SER . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.482 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 87' ' ' ILE . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.68 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.6 t60 -61.34 -136.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.68 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 89.8 m-20 -61.43 -19.34 61.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.424 -0.797 . . . . 0.0 110.414 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.65 -19.26 3.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.898 -1.127 . . . . 0.0 108.743 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 159' ' ' ALA . 19.7 tt0 -78.58 -21.68 48.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.56 63.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.908 . . . . 0.0 109.079 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.06 10.62 15.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.93 . . . . 0.0 108.884 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.54 95.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.673 . . . . 0.0 109.712 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -154.16 78.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.237 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 104' ' ' GLY . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 108' ' ' GLY . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . 0.423 ' N ' ' HG ' ' A' ' 107' ' ' SER . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.4 ' CG2' ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 117' ' ' ASP . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.557 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.574 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.4 ' CD2' ' CG2' ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.467 ' CD2' ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.523 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.403 ' HD1' ' N ' ' A' ' 146' ' ' ASN . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' N ' ' HD1' ' A' ' 145' ' ' HIS . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.496 ' CG1' HE21 ' A' ' 156' ' ' GLN . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.496 HE21 ' CG1' ' A' ' 154' ' ' VAL . 60.7 mm-40 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.492 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' A' ' 97' ' ' GLN . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.56 -40.46 8.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 86.6 mt -72.04 148.38 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.148 . . . . 0.0 109.475 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -79.78 106.75 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -156.91 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.514 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.23 100.54 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.492 HD21 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -132.95 128.24 36.01 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -81.74 122.45 27.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.4 m -153.61 133.06 12.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.43 13.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.363 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 79.72 62.54 2.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -150.73 170.54 18.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -1.171 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.83 152.83 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.432 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.585 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 39' ' ' ASP . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 ' CD1' ' HG ' ' A' ' 50' ' ' SER . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.494 ' C ' ' H ' ' A' ' 47' ' ' ASN . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.494 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.525 ' HG ' ' CD1' ' A' ' 43' ' ' ILE . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.519 ' HD1' ' N ' ' A' ' 58' ' ' THR . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.519 ' N ' ' HD1' ' A' ' 57' ' ' HIS . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.581 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.524 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.426 ' CG2' ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.402 ' ND1' ' H ' ' A' ' 96' ' ' ALA . 17.6 p80 -77.73 -154.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' GLN . 6.0 m-20 -50.92 -17.5 0.59 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.426 -0.796 . . . . 0.0 110.006 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.402 ' H ' ' ND1' ' A' ' 94' ' ' HIS . . . -47.77 -18.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.054 -1.029 . . . . 0.0 109.303 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 95' ' ' ASP . 21.7 mt-30 -58.14 -48.94 78.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -62.07 -52.23 64.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.262 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.43 ' CD ' ' N ' ' A' ' 99' ' ' ARG . 11.6 mpt_? -68.89 7.94 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.113 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.521 ' H ' ' C ' ' A' ' 98' ' ' ALA . 29.6 ttm180 51.75 85.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.404 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -154.92 73.42 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 119' ' ' GLN . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.492 ' CB ' HD21 ' A' ' 4' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.2 t30 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.524 ' OE1' ' NZ ' ' A' ' 86' ' ' LYS . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . 0.432 ' C ' ' H ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.2 t30 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.493 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 168' ' ' GLN . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' SER . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.03 -53.35 3.17 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.23 99.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -75.85 116.85 16.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.935 . . . . 0.0 109.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.96 7.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 86.0 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.476 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.468 ' N ' ' OE2' ' A' ' 148' ' ' GLU . 75.8 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt -82.3 95.79 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -88.63 106.6 18.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -104.12 105.55 15.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.383 -0.823 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 17' ' ' ASP . 14.8 p -95.25 -57.79 2.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.241 -0.912 . . . . 0.0 109.109 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.56 ' H ' ' HG1' ' A' ' 16' ' ' THR . 51.1 t0 -156.99 17.07 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 109.317 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.31 -13.15 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -82.56 169.94 15.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -1.137 . . . . 0.0 109.633 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 -176.45 -164.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.561 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 172' ' ' ASN . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.598 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.551 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 39' ' ' ASP . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.436 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.513 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.529 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.529 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.411 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HZ2' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.419 ' O ' ' O ' ' A' ' 94' ' ' HIS . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.683 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.2 t-80 -60.5 -149.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.683 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 13.3 p-10 -54.37 -18.23 3.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.0 -19.24 1.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.053 . . . . 0.0 108.871 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' NE2' ' N ' ' A' ' 98' ' ' ALA . 5.4 pp0? -74.45 -32.27 62.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -61.67 -51.18 69.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.358 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.543 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.38 12.81 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 109.038 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.94 89.98 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.237 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -153.46 81.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' CG2' ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.439 ' C ' ' H ' ' A' ' 117' ' ' ASP . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.0 OUTLIER -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' ASN . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.549 ' O ' ' N ' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.555 ' C ' ' H ' ' A' ' 133' ' ' THR . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.555 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.508 ' CD ' ' HZ2' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 1' ' ' SER . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.49 ' H ' ' CD2' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.68 -54.16 2.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 23.0 mt -83.45 90.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -1.145 . . . . 0.0 109.472 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 15.3 m120 -73.19 140.3 46.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.942 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 45.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.29 163.08 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.562 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -132.87 106.85 7.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.9 m -98.15 105.69 17.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m -84.81 -64.09 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 20.1 p-10 -157.84 18.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.218 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.91 -24.5 0.41 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -82.54 156.43 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -176.13 149.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CD1' ' N ' ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 39' ' ' ASP . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.51 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.51 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.454 ' HG ' ' H ' ' A' ' 53' ' ' GLY . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.454 ' H ' ' HG ' ' A' ' 50' ' ' SER . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.427 ' OG1' ' OG ' ' A' ' 72' ' ' SER . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.427 ' OG ' ' OG1' ' A' ' 58' ' ' THR . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.513 ' C ' ' H ' ' A' ' 79' ' ' ALA . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 88' ' ' ILE . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.677 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 7.4 t-160 -62.0 -138.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.677 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 87.4 m-20 -63.96 -18.1 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.772 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.85 -19.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.14 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.4 ' N ' ' C ' ' A' ' 95' ' ' ASP . 17.8 pt20 -72.17 -35.42 69.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.478 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 100' ' ' ARG . . . -63.4 -52.59 60.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -75.98 10.58 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.234 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.407 ' H ' ' C ' ' A' ' 98' ' ' ALA . 9.9 tpp180 62.46 90.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.728 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -155.92 67.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 109.175 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.543 ' H ' ' HG1' ' A' ' 128' ' ' THR . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.482 ' C ' ' H ' ' A' ' 117' ' ' ASP . 10.6 m120 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.543 ' HG1' ' H ' ' A' ' 109' ' ' ALA . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.505 ' C ' ' H ' ' A' ' 132' ' ' SER . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.4 -53.38 2.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.0 tt -80.37 150.98 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.133 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.4 p-10 -74.07 127.2 32.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 48.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -175.66 43.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -132.89 106.9 7.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.46 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 6.6 p -86.59 122.43 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 18' ' ' GLY . 2.5 p -149.02 135.43 19.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 48.66 12.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.631 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 172.94 -156.53 24.95 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -80.43 -171.99 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 15' ' ' SER . 14.7 m-20 -83.78 -170.46 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.56 ' CD1' ' N ' ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.437 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.568 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.594 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.54 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 39' ' ' ASP . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.521 ' C ' ' H ' ' A' ' 47' ' ' ASN . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.521 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' CD2' ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.429 ' O ' ' OG ' ' A' ' 54' ' ' SER . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 53' ' ' GLY . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.75 HD21 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.75 ' H ' HD21 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.413 ' CA ' ' OD1' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.671 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.6 t-80 -73.27 -139.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.671 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 53.9 m-20 -52.82 -24.91 9.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 110.126 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.33 -18.94 1.8 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.06 -1.025 . . . . 0.0 108.727 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.7 -38.11 48.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.07 74.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 108.896 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.513 ' NH2' ' OE1' ' A' ' 101' ' ' GLN . 10.8 ptm180 -81.24 3.01 25.4 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 66.42 96.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.461 0.648 . . . . 0.0 109.878 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' OE1' ' NH2' ' A' ' 99' ' ' ARG . 21.4 mt-30 -157.57 80.04 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.212 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.429 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.548 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.53 ' N ' ' CD2' ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' CYS . . . . . 0.47 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.42 -47.51 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.2 tt -84.06 146.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -1.186 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 172' ' ' ASN . 2.0 m120 -79.93 130.27 35.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 19.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 172' ' ' ASN . 8.0 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.477 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HG ' ' A' ' 72' ' ' SER . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' ASN . 25.4 m120 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 53' ' ' GLY . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 63' ' ' THR . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.429 ' HG ' ' HA2' ' A' ' 8' ' ' GLY . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 5.1 t60 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 107' ' ' SER . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.6 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 113' ' ' LEU . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.285 0.564 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' LEU . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 83' ' ' ASP . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.493 ' OD1' ' SG ' ' A' ' 166' ' ' CYS . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' O ' HD13 ' A' ' 29' ' ' LEU . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 53' ' ' GLY . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' A' ' 37' ' ' ARG . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 5' ' ' VAL . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' N ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.621 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.603 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 165' ' ' VAL . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 161' ' ' GLY . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.507 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.5 m120 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 HD21 ' A' ' 113' ' ' LEU . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' N ' HD23 ' A' ' 6' ' ' LEU . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 29' ' ' LEU . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.717 HD11 ' ND2' ' A' ' 47' ' ' ASN . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' A' ' 43' ' ' ILE . 45.2 t-20 -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 55' ' ' VAL . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.448 ' H ' ' HG1' ' A' ' 58' ' ' THR . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 55' ' ' VAL . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 86' ' ' LYS . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 84' ' ' VAL . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 92' ' ' THR . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.444 HD11 ' CA ' ' A' ' 103' ' ' PHE . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.697 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.608 ' O ' HG22 ' A' ' 133' ' ' THR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 130' ' ' ASP . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 18.6 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.2 mtt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.743 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 29' ' ' LEU . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.531 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.517 HG22 ' NZ ' ' A' ' 74' ' ' LYS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.446 ' OG ' HG21 ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.517 ' NZ ' HG22 ' A' ' 58' ' ' THR . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 149' ' ' TRP . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' VAL . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' C ' HD12 ' A' ' 87' ' ' ILE . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 70.2 t60 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 107' ' ' SER . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 117' ' ' ASP . 66.9 m-80 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.443 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.2 ptp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 77' ' ' LEU . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.685 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 63' ' ' THR . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 62' ' ' ARG . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 58' ' ' THR . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 91' ' ' VAL . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.405 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 107' ' ' SER . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.588 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 117' ' ' ASP . 79.7 m-20 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.484 ' N ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 133' ' ' THR . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 130' ' ' ASP . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 77' ' ' LEU . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD11 ' OG ' ' A' ' 72' ' ' SER . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HD11 ' A' ' 6' ' ' LEU . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 107' ' ' SER . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.492 HH21 ' CD ' ' A' ' 121' ' ' GLU . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 128' ' ' THR . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.416 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' HD23 ' A' ' 6' ' ' LEU . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' HD13 ' A' ' 93' ' ' ILE . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.534 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 149' ' ' TRP . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 103' ' ' PHE . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.4 t60 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 107' ' ' SER . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' N ' HG22 ' A' ' 114' ' ' VAL . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 161' ' ' GLY . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.34 0.59 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 113' ' ' LEU . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 5' ' ' VAL . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' HD13 ' A' ' 29' ' ' LEU . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 116' ' ' ASP . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 77' ' ' LEU . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 127' ' ' LEU . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.672 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.626 ' H ' HG12 ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' CG1' ' A' ' 5' ' ' VAL . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.572 ' ND2' ' OG1' ' A' ' 120' ' ' THR . 2.0 p30 -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 74' ' ' LYS . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.452 ' N ' ' OD1' ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.439 ' OG1' ' OE2' ' A' ' 134' ' ' GLU . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.4 m120 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.507 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.653 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 161' ' ' GLY . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 51.2 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.302 0.572 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.762 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' HD13 ' A' ' 29' ' ' LEU . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 44' ' ' PHE . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 75' ' ' ILE . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 72' ' ' SER . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 58' ' ' THR . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 55' ' ' VAL . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 149' ' ' TRP . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 87' ' ' ILE . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.595 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HD12 ' A' ' 9' ' ' LEU . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.512 ' CB ' ' H ' ' A' ' 3' ' ' LYS . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.595 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 150' ' ' LYS . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.449 ' CD1' HD13 ' A' ' 77' ' ' LEU . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 142' ' ' LEU . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.464 ' CD1' HG11 ' A' ' 165' ' ' VAL . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.374 0.607 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 35' ' ' LYS . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 167' ' ' ALA . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 75' ' ' ILE . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.467 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 55' ' ' VAL . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG21 ' HZ2' ' A' ' 149' ' ' TRP . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.514 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 107' ' ' SER . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.529 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.514 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.516 ' HZ2' HG21 ' A' ' 80' ' ' VAL . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.6 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.6 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 51.6 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 2' ' ' MET . 19.9 m-20 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 113' ' ' LEU . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 54' ' ' SER . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 75' ' ' ILE . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 55' ' ' VAL . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.545 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 107' ' ' SER . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 HG11 ' A' ' 122' ' ' VAL . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.472 ' N ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 113' ' ' LEU . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.53 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 29' ' ' LEU . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.482 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' SER . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 142' ' ' LEU . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 165' ' ' VAL . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 161' ' ' GLY . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD2' HD13 ' A' ' 93' ' ' ILE . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.628 ' O ' HD13 ' A' ' 29' ' ' LEU . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' VAL . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 23' ' ' LEU . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 117' ' ' ASP . 58.3 m-20 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.617 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 31.5 t-20 -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 145' ' ' HIS . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.225 0.536 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD13 ' A' ' 29' ' ' LEU . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 75' ' ' ILE . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 55' ' ' VAL . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 8.9 t-160 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.4 0.619 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 127' ' ' LEU . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.605 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 107' ' ' SER . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 106' ' ' VAL . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 64.3 t30 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 161' ' ' GLY . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.566 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.437 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 63' ' ' THR . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 63.3 t60 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 115' ' ' ASN . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' HG22 ' A' ' 114' ' ' VAL . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 128' ' ' THR . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.528 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.414 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 165' ' ' VAL . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 161' ' ' GLY . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.315 0.579 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 6' ' ' LEU . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' HG22 ' A' ' 5' ' ' VAL . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.301 0.572 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.497 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.634 ' O ' HD13 ' A' ' 29' ' ' LEU . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 72' ' ' SER . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.65 ' ND2' ' H ' ' A' ' 64' ' ' GLY . 39.5 t-20 -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.65 ' H ' ' ND2' ' A' ' 61' ' ' ASN . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.542 ' H ' HG22 ' A' ' 58' ' ' THR . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' C ' ' N ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.497 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.4 ' H ' HG22 ' A' ' 84' ' ' VAL . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 13.6 t60 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.446 ' HA ' HG22 ' A' ' 135' ' ' THR . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 114' ' ' VAL . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 156' ' ' GLN . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' C ' HD22 ' A' ' 142' ' ' LEU . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.429 ' H ' ' HB3' ' A' ' 138' ' ' LEU . 5.4 mm100 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 6' ' ' LEU . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.742 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 55' ' ' VAL . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB2' ' A' ' 50' ' ' SER . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.456 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.4 HD11 ' CA ' ' A' ' 103' ' ' PHE . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 57.3 p-80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.548 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 114' ' ' VAL . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 115' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' VAL . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.828 ' C ' HD12 ' A' ' 142' ' ' LEU . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' C ' ' A' ' 141' ' ' GLU . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 161' ' ' GLY . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 113' ' ' LEU . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' CD2' HD13 ' A' ' 93' ' ' ILE . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 29' ' ' LEU . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 47' ' ' ASN . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 43' ' ' ILE . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 80' ' ' VAL . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 77' ' ' LEU . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.555 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 93' ' ' ILE . 6.2 t-80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 107' ' ' SER . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 ' CG2' ' A' ' 5' ' ' VAL . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' N ' HG22 ' A' ' 114' ' ' VAL . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.493 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.541 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.491 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.547 HG23 ' H ' ' A' ' 161' ' ' GLY . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.739 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.661 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 80' ' ' VAL . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 77' ' ' LEU . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' ILE . 7.4 t-160 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 107' ' ' SER . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 115' ' ' ASN . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.488 ' N ' HG22 ' A' ' 114' ' ' VAL . 72.8 m-20 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 132' ' ' SER . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.484 ' CG ' ' CE2' ' A' ' 125' ' ' TYR . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.423 ' CE1' HG11 ' A' ' 165' ' ' VAL . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 113' ' ' LEU . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.327 0.584 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 75' ' ' ILE . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.727 ' H ' HD22 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 55' ' ' VAL . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.5 t60 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 5' ' ' VAL . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 120' ' ' THR . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.465 ' C ' HG23 ' A' ' 114' ' ' VAL . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 128' ' ' THR . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.7 mtt -52.0 114.81 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.9 t-20 -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HG ' ' A' ' 72' ' ' SER . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -132.81 106.78 7.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 t -93.68 105.59 17.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -84.41 -52.05 6.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.71 16.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.72 -27.76 2.32 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -83.74 150.96 25.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -1.117 . . . . 0.0 109.7 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -157.88 172.3 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -0.82 . . . . 0.0 109.314 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 46' ' ' ASN . 25.4 m120 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 53' ' ' GLY . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 63' ' ' THR . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.429 ' HG ' ' HA2' ' A' ' 8' ' ' GLY . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 5.1 t60 -61.88 -138.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.641 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 25.4 m-20 -71.15 -18.2 62.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.18 -19.27 1.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 109.144 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -62.9 -42.72 99.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -61.0 -47.48 86.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.12 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.57 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.4 mpt_? -71.14 11.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 98' ' ' ALA . 18.7 mmt180 58.98 79.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.439 -0.788 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -150.95 64.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 107' ' ' SER . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.6 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.99 -18.0 66.14 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 171' ' ' ILE . 18.2 tt -138.36 133.69 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -1.083 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -77.57 147.24 35.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.48 175.76 10.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.473 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt -73.72 53.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 113' ' ' LEU . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -86.43 106.86 17.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -96.13 128.98 43.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 t -158.18 -35.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.314 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -158.1 40.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.196 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.32 -19.32 23.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 -61.53 151.1 33.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -162.67 150.73 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 83' ' ' ASP . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.493 ' OD1' ' SG ' ' A' ' 166' ' ' CYS . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' O ' HD13 ' A' ' 29' ' ' LEU . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 53' ' ' GLY . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' A' ' 37' ' ' ARG . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.414 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -97.63 -56.88 2.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -49.63 -18.14 0.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -64.15 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -50.55 -38.26 44.04 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.665 -1.272 . . . . 0.0 109.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.508 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -91.2 -53.18 4.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.204 -0.935 . . . . 0.0 111.284 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.53 -11.31 20.22 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.938 -1.101 . . . . 0.0 111.271 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' ALA . 37.5 ttt180 59.2 89.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.984 -1.072 . . . . 0.0 109.345 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 -139.8 146.11 39.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 108.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 5' ' ' VAL . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' N ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.621 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.603 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 165' ' ' VAL . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 161' ' ' GLY . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.06 -43.99 7.86 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.3 tt -72.94 145.88 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.097 -1.237 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.5 p-10 -65.98 113.7 4.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.513 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 110.88 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.479 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.467 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 42.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -174.08 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.382 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.507 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.5 m120 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 HD21 ' A' ' 113' ' ' LEU . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' N ' HD23 ' A' ' 6' ' ' LEU . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -132.79 106.93 8.03 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 m -120.65 105.78 11.11 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.63 -90.35 0.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.892 . . . . 0.0 109.285 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.46 -20.68 39.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.01 -21.87 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -56.56 176.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -1.142 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -175.92 -166.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 29' ' ' LEU . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.717 HD11 ' ND2' ' A' ' 47' ' ' ASN . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 0.2 OUTLIER -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.717 ' ND2' HD11 ' A' ' 43' ' ' ILE . 45.2 t-20 -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 55' ' ' VAL . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.448 ' H ' ' HG1' ' A' ' 58' ' ' THR . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 55' ' ' VAL . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 86' ' ' LYS . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 84' ' ' VAL . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 92' ' ' THR . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 0.8 OUTLIER -81.96 -134.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 19.6 p-10 -56.67 -27.79 59.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.091 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . . . -52.52 -19.27 2.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 108.784 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.65 -45.27 65.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -64.27 -48.03 77.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.2 mpt_? -73.55 15.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.9 . . . . 0.0 108.98 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 98' ' ' ALA . 17.3 tpt180 53.5 78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.492 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 33.4 mt-30 -150.0 74.09 1.19 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.697 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 1' ' ' SER . 21.6 m120 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.608 ' O ' HG22 ' A' ' 133' ' ' THR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 130' ' ' ASP . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 18.6 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -88.67 -31.08 13.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.1 pt -138.36 145.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.385 -1.068 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -80.45 147.57 30.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 158.56 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.489 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.284 0.564 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.418 ' H ' ' HB2' ' A' ' 149' ' ' TRP . 27.2 mtt -77.26 113.09 14.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -132.76 106.72 7.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.5 p -112.83 105.64 13.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.683 . . . . 0.0 109.483 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -96.71 -57.22 2.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.935 . . . . 0.0 109.111 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -158.65 18.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.08 -18.3 0.93 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -81.59 127.05 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.147 . . . . 0.0 109.624 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.67 141.13 11.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.743 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 29' ' ' LEU . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.531 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.517 HG22 ' NZ ' ' A' ' 74' ' ' LYS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.446 ' OG ' HG21 ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.517 ' NZ ' HG22 ' A' ' 58' ' ' THR . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 149' ' ' TRP . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' VAL . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' C ' HD12 ' A' ' 87' ' ' ILE . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 96' ' ' ALA . 70.2 t60 -87.08 -62.75 1.43 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.25 -18.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.654 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.87 -38.86 87.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -52.81 -33.34 48.67 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.734 -1.229 . . . . 0.0 109.417 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.96 -53.1 4.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.25 -0.906 . . . . 0.0 111.242 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -107.9 -6.38 16.69 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.212 -0.93 . . . . 0.0 111.069 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.8 ttt180 57.63 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.951 -1.093 . . . . 0.0 109.427 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 37.7 mm-40 -143.67 142.52 31.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.255 -0.903 . . . . 0.0 109.212 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 107' ' ' SER . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 117' ' ' ASP . 66.9 m-80 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.443 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -155.36 40.5 0.61 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 167' ' ' ALA . 15.3 tt -76.39 154.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -79.21 124.46 28.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.55 36.2 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.495 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 2' ' ' MET . 95.8 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.504 ' N ' ' OG ' ' A' ' 1' ' ' SER . 13.2 ptp -160.51 43.85 0.19 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 77' ' ' LEU . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -92.34 106.99 18.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -93.27 129.59 39.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.89 -38.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -158.03 44.58 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.22 -18.18 10.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -78.68 130.4 35.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.17 171.44 20.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.685 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 63' ' ' THR . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 62' ' ' ARG . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 58' ' ' THR . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 91' ' ' VAL . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 96' ' ' ALA . 14.5 t-80 -95.93 -56.65 2.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -48.68 -18.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.631 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -49.51 -52.92 26.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -56.25 -25.67 48.68 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 109.651 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -53.95 4.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.101 -1.0 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.15 -3.67 14.62 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.121 -0.987 . . . . 0.0 110.719 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.0 ttt180 55.19 95.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 -158.84 152.53 23.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 107' ' ' SER . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.588 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 117' ' ' ASP . 79.7 m-20 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.484 ' N ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 1' ' ' SER . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 133' ' ' THR . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 130' ' ' ASP . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.09 -40.93 7.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 88.7 mt -75.55 142.5 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 172' ' ' ASN . 1.4 m-80 -77.6 107.48 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 15.76 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.305 0.574 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt -49.5 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 77' ' ' LEU . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD11 ' OG ' ' A' ' 72' ' ' SER . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -132.86 106.81 7.93 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -95.83 129.9 42.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.226 -0.921 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.5 p -152.82 -81.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.339 -0.851 . . . . 0.0 108.98 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -84.6 25.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.4 -3.59 86.95 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -82.96 168.71 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -176.22 157.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HD11 ' A' ' 6' ' ' LEU . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' ALA . 86.2 t60 -98.69 -66.29 0.91 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.67 -17.87 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.01 -18.17 22.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.434 -0.791 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -70.73 -61.98 1.56 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.937 -1.102 . . . . 0.0 109.659 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.82 -42.34 10.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 111.056 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -83.28 -19.12 36.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.052 -1.03 . . . . 0.0 110.782 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 99' ' ' ARG . 52.4 ttt180 54.8 98.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 0.0 109.374 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 -165.93 147.36 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 107' ' ' SER . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.492 HH21 ' CD ' ' A' ' 121' ' ' GLU . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 128' ' ' THR . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.416 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.13 7.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 91.0 mt -76.94 112.82 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.4 107.29 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.52 162.98 24.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.483 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt -55.17 141.13 36.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' HD23 ' A' ' 6' ' ' LEU . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -132.99 106.79 7.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -98.04 105.89 18.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.279 -0.888 . . . . 0.0 109.451 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.3 p -82.31 -59.83 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.4 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 20.0 p-10 -158.35 18.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.29 -23.85 0.52 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 4.4 mp0 -81.02 159.41 24.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -174.7 149.31 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' HD13 ' A' ' 93' ' ' ILE . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.534 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 149' ' ' TRP . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 103' ' ' PHE . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.607 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.4 t60 -64.71 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.607 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.2 m-20 -72.7 -19.29 61.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.923 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -51.68 -19.32 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 108.921 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.1 tt0 -70.22 -49.33 51.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -58.39 -48.14 81.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.563 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.9 mpt_? -73.74 14.23 0.4 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.101 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 98' ' ' ALA . 8.9 tpm_? 54.57 79.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.446 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 22.8 mt-30 -154.14 77.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 107' ' ' SER . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' N ' HG22 ' A' ' 114' ' ' VAL . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 161' ' ' GLY . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.73 -24.62 41.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.38 141.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -1.197 . . . . 0.0 109.355 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.495 ' H ' ' NZ ' ' A' ' 35' ' ' LYS . 41.3 t30 -74.29 116.15 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 166.59 21.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.483 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -84.73 95.48 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 113' ' ' LEU . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 5' ' ' VAL . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.615 ' NH1' HE21 ' A' ' 19' ' ' GLN . 83.8 mtt180 -131.32 161.18 32.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m -85.75 166.53 16.03 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 18' ' ' GLY . 12.8 t -47.68 -26.35 1.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.88 -0.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' THR . . . -157.51 151.93 23.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.615 HE21 ' NH1' ' A' ' 14' ' ' ARG . 5.1 pm0 -46.77 147.03 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -1.137 . . . . 0.0 109.716 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 -93.17 -176.2 4.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' HD13 ' A' ' 29' ' ' LEU . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 116' ' ' ASP . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 77' ' ' LEU . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' ALA . 53.6 t-80 -99.55 -70.23 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD2' ' OE1' ' A' ' 101' ' ' GLN . 8.3 p-10 -47.57 -17.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 109.714 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.75 -18.36 3.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.727 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.63 -60.24 2.45 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.925 -1.11 . . . . 0.0 109.833 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.02 -43.17 10.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.248 -0.907 . . . . 0.0 111.302 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -85.62 -16.73 38.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.927 -1.108 . . . . 0.0 111.112 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.2 OUTLIER 55.49 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.732 -1.23 . . . . 0.0 108.977 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 77.2 mt-30 -152.25 140.96 20.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 127' ' ' LEU . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.672 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.626 ' H ' HG12 ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' CG1' ' A' ' 5' ' ' VAL . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.572 ' ND2' ' OG1' ' A' ' 120' ' ' THR . 2.0 p30 -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 74' ' ' LYS . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.452 ' N ' ' OD1' ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.439 ' OG1' ' OE2' ' A' ' 134' ' ' GLU . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 35.4 m120 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.507 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.653 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 161' ' ' GLY . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 51.2 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.29 -41.81 7.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -138.35 136.81 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.422 -1.046 . . . . 0.0 109.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.84 111.36 17.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 40.05 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? -79.66 142.66 35.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.359 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -132.94 107.09 8.07 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -91.92 129.33 37.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 m -154.19 -47.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 16.9 p-10 -146.1 34.68 1.0 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.63 -6.34 80.05 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.498 ' NE2' ' OD1' ' A' ' 17' ' ' ASP . 32.4 mt-30 -71.59 141.89 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -160.32 144.79 14.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.762 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 m-20 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' HD13 ' A' ' 29' ' ' LEU . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 44' ' ' PHE . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 75' ' ' ILE . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 72' ' ' SER . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 58' ' ' THR . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 55' ' ' VAL . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 149' ' ' TRP . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 87' ' ' ILE . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -108.79 -61.47 1.6 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -47.41 -19.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 93' ' ' ILE . . . -59.11 -18.56 36.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.878 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -62.72 -59.59 4.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.773 -1.204 . . . . 0.0 109.172 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -33.82 15.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.821 . . . . 0.0 111.075 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -95.29 -19.52 19.92 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.907 -1.12 . . . . 0.0 111.447 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 100' ' ' ARG . 13.3 ttm-85 53.63 85.12 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.672 -1.268 . . . . 0.0 109.186 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.442 ' NE2' ' O ' ' A' ' 100' ' ' ARG . 78.6 mm-40 -142.9 150.88 40.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.595 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 14.7 tp60 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HD12 ' A' ' 9' ' ' LEU . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.512 ' CB ' ' H ' ' A' ' 3' ' ' LYS . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.595 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 150' ' ' LYS . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.449 ' CD1' HD13 ' A' ' 77' ' ' LEU . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 142' ' ' LEU . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.464 ' CD1' HG11 ' A' ' 165' ' ' VAL . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.31 -26.36 52.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.47 120.26 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.421 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.98 129.27 39.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.476 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.47 160.42 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -73.44 89.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' A' ' 19' ' ' GLN . 41.0 ttp180 -85.29 106.72 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 p -101.58 132.02 47.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.376 -0.828 . . . . 0.0 109.333 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.403 ' CG2' ' CD ' ' A' ' 19' ' ' GLN . 6.1 t -161.36 -34.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 17.8 t70 -157.19 42.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.66 -30.16 4.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 10.8 pt20 -54.66 163.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.446 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.15 -162.65 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 35' ' ' LYS . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 167' ' ' ALA . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 75' ' ' ILE . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.467 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 55' ' ' VAL . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG21 ' HZ2' ' A' ' 149' ' ' TRP . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.514 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.6 t60 -96.34 -65.48 0.97 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.45 -18.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -63.07 -40.96 99.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.847 . . . . 0.0 109.635 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -53.5 -32.44 50.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.21 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.98 -53.68 4.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 111.273 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -111.97 3.05 17.22 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.125 -0.984 . . . . 0.0 111.127 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.7 ttp180 56.96 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.952 -1.092 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.405 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 80.2 mt-30 -150.15 134.34 17.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.26 -0.9 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 107' ' ' SER . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.529 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.514 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.516 ' HZ2' HG21 ' A' ' 80' ' ' VAL . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.6 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.6 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 51.6 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -93.01 -35.07 6.48 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.9 tt -138.15 140.61 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -1.04 . . . . 0.0 109.137 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -66.55 143.17 57.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 -171.94 3.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.903 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.454 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt -79.66 42.35 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' O ' ' OD2' ' A' ' 78' ' ' ASP . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.414 ' N ' ' C ' ' A' ' 2' ' ' MET . 19.9 m-20 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 113' ' ' LEU . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.09 111.89 11.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -75.7 117.33 17.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 18' ' ' GLY . 4.0 p -148.82 139.35 22.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.367 -0.833 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 49.99 16.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 16' ' ' THR . . . 87.72 -11.16 67.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.03 174.77 10.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.538 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -175.88 160.68 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 54' ' ' SER . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 75' ' ' ILE . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 55' ' ' VAL . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.545 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' C ' ' N ' ' A' ' 96' ' ' ALA . 14.1 t-160 -93.13 -63.57 1.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.63 -18.15 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.693 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -62.19 -41.46 98.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.713 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.45 -34.03 47.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.592 -1.318 . . . . 0.0 109.268 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -53.29 4.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.3 -1.39 20.12 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.092 -1.005 . . . . 0.0 111.128 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 96' ' ' ALA . 44.8 ttt180 57.27 102.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.919 -1.113 . . . . 0.0 109.354 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -150.17 135.22 17.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.36 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 107' ' ' SER . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 HG11 ' A' ' 122' ' ' VAL . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.472 ' N ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 113' ' ' LEU . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.21 -55.28 3.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 pt -76.56 139.73 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -1.135 . . . . 0.0 109.394 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.19 114.06 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -159.5 0.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.489 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -175.21 -179.14 1.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.53 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -132.5 106.87 8.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.9 p -83.26 105.77 14.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.598 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.35 -57.19 3.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.113 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.96 15.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.42 -16.47 1.29 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -80.66 168.64 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -1.211 . . . . 0.0 109.618 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 8.9 p30 -176.55 150.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.362 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 29' ' ' LEU . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.7 t-80 -94.56 -63.72 1.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 20' ' ' ASP . 81.2 m-20 -48.68 -18.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.23 -51.28 64.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.721 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -54.68 -27.5 40.72 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.684 -1.26 . . . . 0.0 109.713 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.79 -53.56 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.162 -0.962 . . . . 0.0 111.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -111.83 -4.44 14.61 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.202 -0.936 . . . . 0.0 110.825 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.3 ttt180 58.96 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.064 -1.023 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -153.14 145.46 23.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.2 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.482 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' SER . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 142' ' ' LEU . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 165' ' ' VAL . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 161' ' ' GLY . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.14 27.79 0.9 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.16 130.76 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -1.134 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.99 109.81 16.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.427 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.37 134.63 36.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.461 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt -74.08 88.9 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -87.69 106.77 18.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -99.68 133.02 44.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.306 -0.872 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -157.03 -79.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -92.36 24.15 3.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 108.948 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.38 -1.31 81.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -84.13 174.46 10.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -1.128 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -175.85 -163.86 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.388 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD2' HD13 ' A' ' 93' ' ' ILE . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.628 ' O ' HD13 ' A' ' 29' ' ' LEU . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' VAL . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 96' ' ' ALA . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.647 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 7.5 t-80 -69.07 -141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.647 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 43.5 p30 -57.03 -24.28 52.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -49.42 -19.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.045 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 95' ' ' ASP . 14.9 tt0 -69.74 -45.24 68.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -62.2 -51.86 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.534 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.9 mpt_? -71.52 12.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 98' ' ' ALA . 16.5 mmm180 56.37 81.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 77.1 mt-30 -150.47 75.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 117' ' ' ASP . 58.3 m-20 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.617 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 31.5 t-20 -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 145' ' ' HIS . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -94.67 -50.33 2.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -81.72 103.25 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -77.0 132.16 38.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 -56.47 4.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.474 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt -80.0 98.21 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.577 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -132.83 106.72 7.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -92.84 128.8 38.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.8 m -153.28 -78.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 108.99 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.73 22.29 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.11 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.76 -8.88 70.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -84.25 177.97 7.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -1.125 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.21 167.25 2.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD13 ' A' ' 29' ' ' LEU . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 75' ' ' ILE . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 55' ' ' VAL . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.615 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 8.9 t-160 -62.0 -130.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.7 m-20 -68.3 -18.73 64.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -51.93 -19.37 1.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.066 -1.021 . . . . 0.0 108.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -73.2 -38.19 66.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.34 78.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.08 10.46 4.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.92 88.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 109.43 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.534 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 62.6 mt-30 -154.68 76.02 1.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 127' ' ' LEU . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.605 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 107' ' ' SER . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 106' ' ' VAL . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 64.3 t30 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 161' ' ' GLY . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.8 -50.74 8.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.15 116.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -1.18 . . . . 0.0 109.299 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -65.92 104.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.561 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 -178.48 6.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.471 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 2' ' ' MET . 10.9 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.413 ' N ' ' OG ' ' A' ' 1' ' ' SER . 42.5 mtt -73.45 102.87 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -82.43 106.77 14.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -107.25 127.3 53.41 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.45 -0.781 . . . . 0.0 109.259 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 p -145.56 -45.79 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -156.64 41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -25.27 28.9 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.95 133.12 44.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -1.148 . . . . 0.0 109.293 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -158.17 157.57 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.574 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.566 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.437 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 63' ' ' THR . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.607 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 15.9 t-80 -79.2 -133.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.607 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 45.3 p-10 -71.41 -18.5 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.814 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . . . -51.6 -19.24 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.051 -1.03 . . . . 0.0 108.886 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.63 -36.39 84.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.351 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.17 -34.75 56.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.57 15.34 2.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.236 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 53.82 69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.892 . . . . 0.0 109.49 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -151.27 64.75 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.901 . . . . 0.0 109.255 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 115' ' ' ASN . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' HG22 ' A' ' 114' ' ' VAL . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 128' ' ' THR . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.528 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 0.7 OUTLIER -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 165' ' ' VAL . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 161' ' ' GLY . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.94 -49.69 6.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.77 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -79.91 136.18 36.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.02 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.459 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt -74.92 94.47 2.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' N ' ' A' ' 6' ' ' LEU . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' HG22 ' A' ' 5' ' ' VAL . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -78.09 107.02 10.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -92.3 129.23 38.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.301 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.5 m -154.55 -46.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 6.2 p30 -148.05 32.76 0.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -17.17 58.62 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' NE2' ' OD2' ' A' ' 17' ' ' ASP . 2.6 pt20 -69.94 150.7 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -1.166 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -158.4 -162.93 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.497 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.634 ' O ' HD13 ' A' ' 29' ' ' LEU . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 72' ' ' SER . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.65 ' ND2' ' H ' ' A' ' 64' ' ' GLY . 39.5 t-20 -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.65 ' H ' ' ND2' ' A' ' 61' ' ' ASN . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.542 ' H ' HG22 ' A' ' 58' ' ' THR . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' C ' ' N ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.497 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.4 ' H ' HG22 ' A' ' 84' ' ' VAL . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.6 t60 -61.34 -136.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 89.8 m-20 -61.43 -19.34 61.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.424 -0.797 . . . . 0.0 110.414 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -53.65 -19.26 3.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.898 -1.127 . . . . 0.0 108.743 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 159' ' ' ALA . 19.7 tt0 -78.58 -21.68 48.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.56 63.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.908 . . . . 0.0 109.079 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -87.06 10.62 15.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.93 . . . . 0.0 108.884 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.54 95.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.673 . . . . 0.0 109.712 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.459 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 66.9 mt-30 -154.16 78.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.237 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.446 ' HA ' HG22 ' A' ' 135' ' ' THR . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 114' ' ' VAL . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 156' ' ' GLN . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' C ' HD22 ' A' ' 142' ' ' LEU . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.429 ' H ' ' HB3' ' A' ' 138' ' ' LEU . 5.4 mm100 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' A' ' 97' ' ' GLN . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.56 -40.46 8.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 86.6 mt -72.04 148.38 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.148 . . . . 0.0 109.475 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -79.78 106.75 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -156.91 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.514 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.23 100.54 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 6' ' ' LEU . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -132.95 128.24 36.01 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -81.74 122.45 27.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.4 m -153.61 133.06 12.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.43 13.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.363 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 79.72 62.54 2.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -150.73 170.54 18.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -1.171 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.83 152.83 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.742 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 55' ' ' VAL . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB2' ' A' ' 50' ' ' SER . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.456 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.585 ' CE1' ' HB2' ' A' ' 96' ' ' ALA . 17.6 p80 -77.73 -154.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' GLN . 6.0 m-20 -50.92 -17.5 0.59 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.426 -0.796 . . . . 0.0 110.006 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 101' ' ' GLN . . . -47.77 -18.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.054 -1.029 . . . . 0.0 109.303 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 95' ' ' ASP . 21.7 mt-30 -58.14 -48.94 78.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.543 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -62.07 -52.23 64.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.262 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.543 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.6 mpt_? -68.89 7.94 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.113 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 98' ' ' ALA . 29.6 ttm180 51.75 85.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.404 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.694 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 40.5 mt-30 -154.92 73.42 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.548 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 114' ' ' VAL . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.434 ' H ' ' C ' ' A' ' 115' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' VAL . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.828 ' C ' HD12 ' A' ' 142' ' ' LEU . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' C ' ' A' ' 141' ' ' GLU . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 161' ' ' GLY . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.03 -53.35 3.17 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.23 99.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -75.85 116.85 16.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.935 . . . . 0.0 109.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.96 7.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 86.0 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.476 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.468 ' N ' ' OE2' ' A' ' 148' ' ' GLU . 75.8 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt -82.3 95.79 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 113' ' ' LEU . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -88.63 106.6 18.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -104.12 105.55 15.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.383 -0.823 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.436 ' OG1' ' N ' ' A' ' 17' ' ' ASP . 14.8 p -95.25 -57.79 2.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.241 -0.912 . . . . 0.0 109.109 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 16' ' ' THR . 51.1 t0 -156.99 17.07 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 109.317 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.31 -13.15 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -82.56 169.94 15.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -1.137 . . . . 0.0 109.633 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 -176.45 -164.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' CD2' HD13 ' A' ' 93' ' ' ILE . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 172' ' ' ASN . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 29' ' ' LEU . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 47' ' ' ASN . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 43' ' ' ILE . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 80' ' ' VAL . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 77' ' ' LEU . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.555 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 96' ' ' ALA . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.2 t-80 -60.5 -149.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.654 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 13.3 p-10 -54.37 -18.23 3.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -52.0 -19.24 1.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.053 . . . . 0.0 108.871 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -32.27 62.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.67 -51.18 69.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.358 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.38 12.81 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 109.038 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.94 89.98 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.237 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.545 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 70.8 mt-30 -153.46 81.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 107' ' ' SER . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 ' CG2' ' A' ' 5' ' ' VAL . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' N ' HG22 ' A' ' 114' ' ' VAL . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.493 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.541 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 1' ' ' SER . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.491 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.547 HG23 ' H ' ' A' ' 161' ' ' GLY . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.68 -54.16 2.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 171' ' ' ILE . 23.0 mt -83.45 90.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -1.145 . . . . 0.0 109.472 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 15.3 m120 -73.19 140.3 46.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.942 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 45.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.29 163.08 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -132.87 106.85 7.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.9 m -98.15 105.69 17.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m -84.81 -64.09 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 20.1 p-10 -157.84 18.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.218 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.91 -24.5 0.41 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -82.54 156.43 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -176.13 149.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.739 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.661 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 80' ' ' VAL . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 77' ' ' LEU . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 7.4 t-160 -62.0 -138.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 87.4 m-20 -63.96 -18.1 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.772 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -49.85 -19.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.14 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.4 ' N ' ' C ' ' A' ' 95' ' ' ASP . 17.8 pt20 -72.17 -35.42 69.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.478 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.59 60.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 3.6 ptp180 -75.98 10.58 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 62.46 90.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.728 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.55 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 68.9 mt-30 -155.92 67.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 109.175 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 107' ' ' SER . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 115' ' ' ASN . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.488 ' N ' HG22 ' A' ' 114' ' ' VAL . 72.8 m-20 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 132' ' ' SER . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.484 ' CG ' ' CE2' ' A' ' 125' ' ' TYR . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.423 ' CE1' HG11 ' A' ' 165' ' ' VAL . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.4 -53.38 2.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.0 tt -80.37 150.98 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.133 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.4 p-10 -74.07 127.2 32.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 48.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -175.66 43.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 113' ' ' LEU . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -132.89 106.9 7.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.46 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 6.6 p -86.59 122.43 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 18' ' ' GLY . 2.5 p -149.02 135.43 19.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 48.66 12.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.631 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 172.94 -156.53 24.95 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -80.43 -171.99 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 15' ' ' SER . 14.7 m-20 -83.78 -170.46 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 75' ' ' ILE . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.727 ' H ' HD22 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 55' ' ' VAL . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.629 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.6 t-80 -73.27 -139.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 53.9 m-20 -52.82 -24.91 9.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 110.126 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -52.33 -18.94 1.8 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.06 -1.025 . . . . 0.0 108.727 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.7 -38.11 48.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.07 74.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 108.896 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.513 ' NH2' ' OE1' ' A' ' 101' ' ' GLN . 10.8 ptm180 -81.24 3.01 25.4 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 66.42 96.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.461 0.648 . . . . 0.0 109.878 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 21.4 mt-30 -157.57 80.04 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.212 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 5' ' ' VAL . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 120' ' ' THR . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.465 ' C ' HG23 ' A' ' 114' ' ' VAL . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 128' ' ' THR . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.42 -47.51 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.2 tt -84.06 146.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -1.186 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -79.93 130.27 35.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 19.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.477 -179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.7 mtt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.631 ' N ' HD22 ' A' ' 4' ' ' ASN . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HG ' ' A' ' 72' ' ' SER . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 . . . . . 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.481 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.481 ' ND2' ' OD1' ' A' ' 46' ' ' ASN . 85.6 m-20 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 53' ' ' GLY . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 63' ' ' THR . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.429 ' HG ' ' HA2' ' A' ' 8' ' ' GLY . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 5.1 t60 . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.401 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 107' ' ' SER . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.6 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 113' ' ' LEU . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.285 0.564 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' O ' ' OD1' ' A' ' 24' ' ' ASP . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' OD1' ' O ' ' A' ' 23' ' ' LEU . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 83' ' ' ASP . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.493 ' OD1' ' SG ' ' A' ' 166' ' ' CYS . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' O ' HD13 ' A' ' 29' ' ' LEU . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 53' ' ' GLY . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' A' ' 37' ' ' ARG . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 . . . . . 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 5' ' ' VAL . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' N ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.621 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.603 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 165' ' ' VAL . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 161' ' ' GLY . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 HD21 ' A' ' 113' ' ' LEU . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.46 ' N ' HD23 ' A' ' 6' ' ' LEU . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 . . . . . 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.74 HD22 ' H ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 29' ' ' LEU . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.566 HD11 ' OD1' ' A' ' 47' ' ' ASN . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 9.7 t-20 -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.566 ' OD1' HD11 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.538 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 55' ' ' VAL . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.448 ' H ' ' HG1' ' A' ' 58' ' ' THR . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 55' ' ' VAL . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 86' ' ' LYS . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 84' ' ' VAL . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 92' ' ' THR . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.444 HD11 ' CA ' ' A' ' 103' ' ' PHE . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.697 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.608 ' O ' HG22 ' A' ' 133' ' ' THR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 130' ' ' ASP . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 40.0 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.466 ' CE ' HD21 ' A' ' 115' ' ' ASN . 27.2 mtt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.287 0.565 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.743 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 29' ' ' LEU . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.531 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.517 HG22 ' NZ ' ' A' ' 74' ' ' LYS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 75.8 m-20 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.446 ' OG ' HG21 ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.517 ' NZ ' HG22 ' A' ' 58' ' ' THR . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 149' ' ' TRP . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' VAL . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.514 ' C ' HD12 ' A' ' 87' ' ' ILE . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.695 ' NE2' HE21 ' A' ' 105' ' ' GLN . 2.9 mm100 . . . . . 0 N--CA 1.496 1.828 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.695 HE21 ' NE2' ' A' ' 101' ' ' GLN . 4.0 tp-100 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 107' ' ' SER . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 117' ' ' ASP . 34.9 m120 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.443 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 13.2 ptp . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 77' ' ' LEU . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.685 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 63' ' ' THR . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 62' ' ' ARG . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 58' ' ' THR . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 91' ' ' VAL . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.405 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 107' ' ' SER . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.588 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 117' ' ' ASP . 10.1 m120 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.484 ' N ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.402 ' OD1' ' N ' ' A' ' 118' ' ' ASN . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 133' ' ' THR . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 130' ' ' ASP . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.517 HD22 ' CB ' ' A' ' 117' ' ' ASP . 13.5 m-80 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 77' ' ' LEU . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD11 ' OG ' ' A' ' 72' ' ' SER . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 . . . . . 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HD11 ' A' ' 6' ' ' LEU . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 107' ' ' SER . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.492 HH21 ' CD ' ' A' ' 121' ' ' GLU . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.517 ' CB ' HD22 ' A' ' 4' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.492 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 128' ' ' THR . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.416 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' HD23 ' A' ' 6' ' ' LEU . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 . . . . . 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' HD13 ' A' ' 93' ' ' ILE . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.534 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 149' ' ' TRP . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 103' ' ' PHE . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.4 t60 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 107' ' ' SER . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.536 ' N ' HG22 ' A' ' 114' ' ' VAL . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.439 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 161' ' ' GLY . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.34 0.59 . . . . 0.0 109.433 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 113' ' ' LEU . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 5' ' ' VAL . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.8 mtt180 . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.37 0.605 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' HD13 ' A' ' 29' ' ' LEU . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.416 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 116' ' ' ASP . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 77' ' ' LEU . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 127' ' ' LEU . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.672 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.626 ' H ' HG12 ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' CG1' ' A' ' 5' ' ' VAL . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.714 HD22 ' H ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 74' ' ' LYS . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.714 ' H ' HD22 ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.702 ' H ' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.439 ' OG1' ' OE2' ' A' ' 134' ' ' GLU . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 69.6 m-80 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.507 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.653 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 161' ' ' GLY . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 8.6 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.302 0.572 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.762 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.5 m120 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' HD13 ' A' ' 29' ' ' LEU . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 44' ' ' PHE . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 75' ' ' ILE . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 72' ' ' SER . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 58' ' ' THR . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 55' ' ' VAL . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 149' ' ' TRP . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 87' ' ' ILE . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.595 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HD12 ' A' ' 9' ' ' LEU . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.512 ' CB ' ' H ' ' A' ' 3' ' ' LYS . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.595 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 150' ' ' LYS . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.449 ' CD1' HD13 ' A' ' 77' ' ' LEU . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 142' ' ' LEU . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.464 ' CD1' HG11 ' A' ' 165' ' ' VAL . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.374 0.607 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 35' ' ' LYS . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 167' ' ' ALA . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 75' ' ' ILE . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.467 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 55' ' ' VAL . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.516 HG21 ' HZ2' ' A' ' 149' ' ' TRP . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.514 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.6 t60 . . . . . 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 . . . . . 0 N--CA 1.494 1.739 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 107' ' ' SER . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.529 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.514 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.516 ' HZ2' HG21 ' A' ' 80' ' ' VAL . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.6 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.6 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 6.5 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.354 0.597 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.1 m120 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 113' ' ' LEU . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 . . . . . 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.2 m120 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 54' ' ' SER . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 75' ' ' ILE . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 55' ' ' VAL . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.545 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 107' ' ' SER . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 HG11 ' A' ' 122' ' ' VAL . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.472 ' N ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 113' ' ' LEU . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.53 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 29' ' ' LEU . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.482 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' SER . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 142' ' ' LEU . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 165' ' ' VAL . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 161' ' ' GLY . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD2' HD13 ' A' ' 93' ' ' ILE . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.628 ' O ' HD13 ' A' ' 29' ' ' LEU . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' VAL . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.606 HD13 ' CD2' ' A' ' 23' ' ' LEU . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 117' ' ' ASP . 3.4 m120 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.617 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 0.1 OUTLIER -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 145' ' ' HIS . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.225 0.536 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 . . . . . 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD13 ' A' ' 29' ' ' LEU . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 75' ' ' ILE . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 70.7 m-20 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 55' ' ' VAL . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 8.9 t-160 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 121.4 0.619 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 127' ' ' LEU . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.605 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 107' ' ' SER . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 106' ' ' VAL . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 161' ' ' GLY . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.298 0.57 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.432 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.566 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.437 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.437 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.432 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 63' ' ' THR . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 63.3 t60 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 . . . . . 0 N--CA 1.493 1.686 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 115' ' ' ASN . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' HG22 ' A' ' 114' ' ' VAL . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 128' ' ' THR . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.528 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-160 -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.414 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 165' ' ' VAL . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 161' ' ' GLY . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.315 0.579 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.651 ' N ' HD22 ' A' ' 4' ' ' ASN . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' HG22 ' A' ' 5' ' ' VAL . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.301 0.572 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.497 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.634 ' O ' HD13 ' A' ' 29' ' ' LEU . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 72' ' ' SER . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.732 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.732 ' H ' HD22 ' A' ' 61' ' ' ASN . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.542 ' H ' HG22 ' A' ' 58' ' ' THR . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.468 ' C ' ' N ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.497 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.4 ' H ' HG22 ' A' ' 84' ' ' VAL . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.421 ' O ' ' O ' ' A' ' 93' ' ' ILE . 13.6 t60 . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 . . . . . 0 N--CA 1.493 1.696 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.446 ' HA ' HG22 ' A' ' 135' ' ' THR . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.479 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 114' ' ' VAL . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 156' ' ' GLN . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.41 ' C ' HD22 ' A' ' 142' ' ' LEU . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.533 ' CG1' HE21 ' A' ' 156' ' ' GLN . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.533 HE21 ' CG1' ' A' ' 154' ' ' VAL . 60.7 mm-40 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.528 HD22 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 6' ' ' LEU . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 . . . . . 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.44 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.742 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 55' ' ' VAL . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB2' ' A' ' 50' ' ' SER . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.456 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.4 HD11 ' CA ' ' A' ' 103' ' ' PHE . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 22' ' ' ASP . 17.6 p80 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.385 0.612 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.548 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 114' ' ' VAL . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.528 ' CB ' HD22 ' A' ' 4' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.2 t30 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' VAL . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.828 ' C ' HD12 ' A' ' 142' ' ' LEU . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' C ' ' A' ' 141' ' ' GLU . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.2 t30 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 161' ' ' GLY . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 113' ' ' LEU . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.488 ' CD2' HD13 ' A' ' 93' ' ' ILE . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 29' ' ' LEU . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 47' ' ' ASN . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 43' ' ' ILE . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 80' ' ' VAL . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 77' ' ' LEU . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.555 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.419 ' O ' ' O ' ' A' ' 93' ' ' ILE . 6.2 t-80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.392 0.615 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 107' ' ' SER . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 ' CG2' ' A' ' 5' ' ' VAL . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.535 ' N ' HG22 ' A' ' 114' ' ' VAL . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.0 OUTLIER -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.493 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.541 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.491 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.547 HG23 ' H ' ' A' ' 161' ' ' GLY . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.739 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.661 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.425 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.425 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 80' ' ' VAL . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 77' ' ' LEU . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 94' ' ' HIS . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.426 ' O ' ' O ' ' A' ' 93' ' ' ILE . 7.4 t-160 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 107' ' ' SER . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 115' ' ' ASN . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.488 ' N ' HG22 ' A' ' 114' ' ' VAL . 10.6 m120 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 132' ' ' SER . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.484 ' CG ' ' CE2' ' A' ' 125' ' ' TYR . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.423 ' CE1' HG11 ' A' ' 165' ' ' VAL . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 113' ' ' LEU . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 . . . . . 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.327 0.584 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 75' ' ' ILE . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.727 ' H ' HD22 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 55' ' ' VAL . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 5' ' ' VAL . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 120' ' ' THR . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.465 ' C ' HG23 ' A' ' 114' ' ' VAL . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 128' ' ' THR . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 58.7 mtt -52.0 114.81 1.42 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.468 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 mtpp -83.06 -25.68 31.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.284 -0.885 . . . . 0.0 109.413 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.631 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -145.96 128.31 15.86 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.631 ' N ' HD22 ' A' ' 4' ' ' ASN . 80.5 t -115.03 151.6 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-O 121.583 0.706 . . . . 0.0 109.63 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.4 tt -148.8 107.56 3.84 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.82 151.23 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.168 -0.957 . . . . 0.0 109.171 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' HG ' ' A' ' 72' ' ' SER . . . -143.11 117.17 1.08 Allowed Glycine 0 N--CA 1.496 2.682 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 22.0 tp -105.91 138.8 41.49 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.56 152.1 24.19 Favored Glycine 0 N--CA 1.496 2.679 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -164.73 159.29 18.55 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.39 -1.065 . . . . 0.0 109.911 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -83.57 128.57 34.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.48 -0.762 . . . . 0.0 109.642 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.44 152.74 20.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.23 -0.919 . . . . 0.0 109.386 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 66.5 ttt180 -132.81 106.78 7.94 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.41 -0.806 . . . . 0.0 109.177 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.5 t -93.68 105.59 17.62 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.229 -0.919 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.3 m -84.41 -52.05 6.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -155.71 16.18 0.37 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 109.328 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.72 -27.76 2.32 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -83.74 150.96 25.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.3 -1.117 . . . . 0.0 109.7 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -157.88 172.3 18.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -0.82 . . . . 0.0 109.314 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -96.22 134.99 38.65 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.154 -0.966 . . . . 0.0 109.238 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -141.07 103.11 4.39 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.309 -0.869 . . . . 0.0 109.747 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -83.38 163.16 20.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.921 . . . . 0.0 108.585 179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -127.7 130.36 48.72 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.61 145.24 26.48 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.385 -0.822 . . . . 0.0 109.219 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.0 t -149.46 167.73 25.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.292 -0.88 . . . . 0.0 109.82 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.32 123.37 12.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -105.24 132.5 51.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.299 -0.876 . . . . 0.0 110.133 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.675 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.6 mp -77.73 151.62 34.05 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.67 124.32 11.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.927 -1.108 . . . . 0.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -78.57 169.8 17.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 109.59 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.58 -2.12 56.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.285 -0.884 . . . . 0.0 109.092 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -74.86 -8.55 56.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.227 -0.92 . . . . 0.0 109.306 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -3.49 49.62 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -145.52 139.26 26.65 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.341 -1.094 . . . . 0.0 108.899 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.563 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.4 p -66.31 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.067 -1.021 . . . . 0.0 109.572 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -66.2 4.86 0.62 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.95 100.08 0.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 14.9 p-10 -52.75 -35.78 56.78 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.215 -1.168 . . . . 0.0 109.284 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.3 -2.7 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.639 -0.663 . . . . 0.0 109.772 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.4 m-20 -92.13 27.14 2.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.107 -0.996 . . . . 0.0 108.839 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -90.7 141.21 29.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.382 -0.824 . . . . 0.0 109.599 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 24.9 mm -78.36 140.59 16.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.935 0.874 . . . . 0.0 109.847 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -152.62 -166.41 2.46 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.462 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 11.9 p90 -68.28 -17.57 64.31 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.793 -1.192 . . . . 0.0 109.51 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.481 ' OD1' ' ND2' ' A' ' 47' ' ' ASN . 19.2 p30 -80.07 9.2 5.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.256 -0.902 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.481 ' ND2' ' OD1' ' A' ' 46' ' ' ASN . 85.6 m-20 -149.03 104.37 3.42 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.31 -0.869 . . . . 0.0 109.236 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 11.0 tp -53.05 -38.59 62.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -169.23 158.32 8.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.284 -0.885 . . . . 0.0 109.622 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.6 t -71.58 143.12 49.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -0.894 . . . . 0.0 109.355 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.57 -42.38 35.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.197 -0.94 . . . . 0.0 109.511 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -116.15 -7.44 11.85 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.664 -0.647 . . . . 0.0 109.479 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.424 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -82.65 -9.79 84.17 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.5 t 57.33 15.33 2.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.274 -1.133 . . . . 0.0 109.377 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 53' ' ' GLY . 4.7 t -93.08 146.59 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.277 -0.89 . . . . 0.0 109.018 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.95 131.21 19.54 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.102 -0.999 . . . . 0.0 109.667 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.6 t-80 -92.52 132.34 36.9 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.409 -0.807 . . . . 0.0 109.264 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.5 m -63.89 -52.67 58.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.971 . . . . 0.0 109.55 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.88 135.27 1.79 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -83.98 116.06 22.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -1.122 . . . . 0.0 109.444 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -68.05 -171.57 0.24 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.357 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' O ' HG23 ' A' ' 63' ' ' THR . 50.3 mtp180 -141.1 5.23 1.89 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 62' ' ' ARG . 26.9 p -157.09 -34.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.219 -0.926 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.45 6.73 30.98 Favored Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -58.42 110.45 0.97 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -1.123 . . . . 0.0 109.433 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 159.62 119.37 0.54 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -77.57 43.94 0.42 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -1.128 . . . . 0.0 109.488 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.7 -164.75 19.55 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -62.25 99.36 0.13 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -1.13 . . . . 0.0 109.487 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 82.0 m-20 -50.41 -81.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -86.57 166.83 15.11 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.231 -0.918 . . . . 0.0 109.307 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.429 ' HG ' ' HA2' ' A' ' 8' ' ' GLY . 72.3 m -166.98 165.08 16.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.203 -0.935 . . . . 0.0 109.783 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.514 HD12 ' CG ' ' A' ' 57' ' ' HIS . 1.1 tp -144.17 126.92 16.19 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.28 -0.888 . . . . 0.0 109.185 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -97.58 130.75 44.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.223 -0.923 . . . . 0.0 108.989 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 75' ' ' ILE . 2.3 mp -135.21 108.5 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.304 -0.873 . . . . 0.0 109.74 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -87.23 81.78 7.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.207 -0.933 . . . . 0.0 108.68 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 0.9 OUTLIER -48.86 -22.91 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.302 -0.874 . . . . 0.0 109.482 -179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.38 5.18 2.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.911 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.46 22.01 2.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.178 -0.951 . . . . 0.0 109.957 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.417 ' O ' ' O ' ' A' ' 81' ' ' PRO . 23.6 t -87.91 114.13 57.79 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.155 -0.966 . . . . 0.0 108.993 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.0 Cg_exo -44.34 174.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.905 1.737 . . . . 0.0 112.363 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -87.89 0.41 84.33 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -69.31 -59.47 2.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -1.153 . . . . 0.0 109.323 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.405 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 17.4 m -79.61 148.91 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.297 -0.877 . . . . 0.0 109.108 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 84' ' ' VAL . 33.2 m-20 -134.58 -1.88 2.76 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.434 -0.792 . . . . 0.0 109.503 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -154.8 131.14 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.146 -0.971 . . . . 0.0 108.882 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 78.5 mt -131.38 153.82 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.531 -0.731 . . . . 0.0 109.223 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.562 ' CD1' ' CZ ' ' A' ' 169' ' ' TYR . 15.0 pt -136.93 152.32 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.377 -0.827 . . . . 0.0 109.981 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -112.21 148.85 33.21 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 6.0 t -146.52 156.48 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.149 -0.969 . . . . 0.0 110.69 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 76.2 t -135.42 113.22 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -116.02 150.82 36.64 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.482 -0.761 . . . . 0.0 110.578 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 94' ' ' HIS . 2.0 mm -74.34 138.93 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.641 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 5.1 t60 -61.88 -138.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.245 -0.909 . . . . 0.0 109.832 -179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.641 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 25.4 m-20 -71.15 -18.2 62.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.87 . . . . 0.0 109.816 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -51.18 -19.27 1.12 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 109.144 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -62.9 -42.72 99.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.275 -0.89 . . . . 0.0 109.072 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.57 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -61.0 -47.48 86.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.12 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.57 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.4 mpt_? -71.14 11.22 0.44 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -0.881 . . . . 0.0 108.961 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 98' ' ' ALA . 18.7 mmt180 58.98 79.71 0.21 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.439 -0.788 . . . . 0.0 109.394 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -150.95 64.42 0.91 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.308 -0.87 . . . . 0.0 109.314 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 9.0 p -56.09 165.8 0.92 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.314 -0.867 . . . . 0.0 109.281 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.64 -34.29 7.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.143 -0.973 . . . . 0.0 109.556 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.401 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -50.9 -33.55 28.6 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -57.6 -24.09 54.45 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.291 -1.123 . . . . 0.0 109.148 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 107' ' ' SER . 23.6 t -74.67 173.83 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 0.0 109.209 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.6 ' H ' HG12 ' A' ' 106' ' ' VAL . 3.4 p -78.09 -19.54 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.149 -0.969 . . . . 0.0 109.944 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.26 82.16 0.03 OUTLIER Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.64 164.55 26.18 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -1.102 . . . . 0.0 109.02 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -152.38 146.8 25.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.946 -1.096 . . . . 0.0 110.492 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.7 mt -105.73 152.64 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -144.05 140.65 29.64 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.142 -0.974 . . . . 0.0 109.928 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.8 tp -130.43 136.79 49.39 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.4 p -147.61 147.77 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.249 -0.907 . . . . 0.0 109.534 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.5 p30 -87.61 103.1 15.25 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -55.88 -7.3 0.3 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.139 -0.976 . . . . 0.0 108.682 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -84.06 -52.04 6.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.501 -0.749 . . . . 0.0 109.728 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -93.95 -17.48 22.91 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.338 -0.851 . . . . 0.0 109.798 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 63.02 55.55 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 20.2 p -140.43 116.23 10.29 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.408 -0.807 . . . . 0.0 109.198 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -46.12 128.01 9.06 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.307 -0.871 . . . . 0.0 109.827 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 75.1 t -91.05 -49.61 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.267 -0.896 . . . . 0.0 109.739 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.83 174.71 4.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.874 -1.141 . . . . 0.0 110.271 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -160.49 121.88 3.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.46 -0.775 . . . . 0.0 109.176 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.465 ' CZ ' ' OD2' ' A' ' 130' ' ' ASP . 6.9 t80 -92.86 148.02 22.37 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.075 -1.015 . . . . 0.0 109.513 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -98.99 117.46 33.56 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 0.0 109.59 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.542 ' O ' ' N ' ' A' ' 131' ' ' ALA . 4.2 mm? -61.22 -46.08 91.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.7 m -45.14 -19.48 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.0 109.635 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 127' ' ' LEU . 91.9 mt-10 -90.53 -54.74 3.86 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.371 -0.831 . . . . 0.0 109.579 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' OD2' ' CZ ' ' A' ' 125' ' ' TYR . 50.5 m-20 -94.77 18.27 12.02 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.28 -0.888 . . . . 0.0 109.155 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -86.51 -52.7 5.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.293 -0.88 . . . . 0.0 109.978 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 58.8 m -61.83 2.93 0.17 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.447 -0.783 . . . . 0.0 109.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 131' ' ' ALA . 95.0 m -91.04 -32.11 16.03 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.132 -0.98 . . . . 0.0 110.451 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.521 ' N ' ' OE2' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -166.34 -150.24 0.11 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.7 -1.25 . . . . 0.0 110.164 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.54 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -118.46 -35.95 3.64 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -179.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -108.44 164.77 12.04 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.446 -0.784 . . . . 0.0 108.929 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.3 ttt -162.6 152.8 16.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.505 -1.372 . . . . 0.0 110.902 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.1 128.5 55.48 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -71.04 -56.83 5.33 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.066 -1.021 . . . . 0.0 109.907 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.55 -150.83 6.4 Favored Glycine 0 N--CA 1.493 2.445 0 C-N-CA 119.185 -1.483 . . . . 0.0 110.504 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.482 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 18.5 tt0 -147.61 165.84 29.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.353 -1.086 . . . . 0.0 109.656 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.482 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 8.2 tp -136.27 136.59 39.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -150.94 166.05 31.83 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.86 -1.15 . . . . 0.0 110.101 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.403 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.2 ptm180 -91.93 148.08 22.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.411 -0.806 . . . . 0.0 109.862 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -147.03 118.18 7.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.304 -0.872 . . . . 0.0 109.152 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 56.21 28.14 12.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 15.76 76.42 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -127.84 133.56 49.38 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.525 -0.985 . . . . 0.0 109.429 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 67.2 m95 -67.11 151.65 47.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.644 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -153.89 128.46 9.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.323 -0.86 . . . . 0.0 109.259 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -89.42 150.55 22.47 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -0.839 . . . . 0.0 109.621 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -148.97 116.59 6.22 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.33 -0.856 . . . . 0.0 109.391 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.55 154.97 34.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.567 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 26.4 t -137.15 -33.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.346 -0.846 . . . . 0.0 109.302 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.35 88.39 0.05 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -126.69 167.74 15.31 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.641 -0.917 . . . . 0.0 108.938 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -150.89 126.4 2.11 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 160' ' ' GLY . 12.3 m-85 -101.96 137.68 39.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.436 -1.037 . . . . 0.0 108.981 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.18 39.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 85.82 99.93 0.73 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -161.13 43.67 0.4 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 26.7 tp -43.65 -40.91 4.41 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.506 -0.997 . . . . 0.0 110.103 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.31 -24.62 34.55 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.023 -1.048 . . . . 0.0 110.032 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 47.1 t -85.92 -53.13 5.29 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 0.0 109.808 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.533 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 14.4 m -50.26 -20.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.153 -0.967 . . . . 0.0 109.604 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 42.2 t -75.06 -61.61 1.83 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.0 110.061 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -78.51 -23.64 46.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.765 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -53.02 -28.64 25.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.562 ' CZ ' ' CD1' ' A' ' 88' ' ' ILE . 50.1 m-85 -71.43 -18.36 62.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.126 -0.984 . . . . 0.0 109.325 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.99 -18.0 66.14 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.409 ' O ' HG23 ' A' ' 171' ' ' ILE . 18.2 tt -138.36 133.69 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.36 -1.083 . . . . 0.0 109.335 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.555 HD22 ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -77.57 147.24 35.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 109.519 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.555 ' N ' HD22 ' A' ' 172' ' ' ASN . . . -80.48 175.76 10.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.933 . . . . 0.0 109.452 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.2 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.473 -179.991 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.408 ' C ' ' N ' ' A' ' 4' ' ' ASN . 42.9 mtt -73.72 53.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.24 -0.913 . . . . 0.0 109.484 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.525 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 43.5 mttp -48.55 -19.43 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.327 -0.858 . . . . 0.0 109.473 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 5.3 m120 -146.14 128.09 15.48 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.253 -0.904 . . . . 0.0 109.373 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' CG2' HD11 ' A' ' 113' ' ' LEU . 4.4 p -123.42 153.9 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.431 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.2 tt -148.81 107.8 3.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 0.0 109.485 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.2 t -85.97 151.12 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.359 -0.838 . . . . 0.0 108.802 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.43 117.1 1.05 Allowed Glycine 0 N--CA 1.496 2.639 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.6 tp -105.03 133.84 49.14 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -145.51 148.47 20.23 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.6 p90 -156.88 154.84 30.45 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.356 -1.084 . . . . 0.0 109.95 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -85.62 128.05 34.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 109.57 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.34 129.39 34.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.362 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.1 ttt180 -86.43 106.86 17.75 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.241 -0.912 . . . . 0.0 109.612 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -96.13 128.98 43.52 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.321 -0.862 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 t -158.18 -35.21 0.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.314 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -158.1 40.73 0.27 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.196 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.32 -19.32 23.76 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -61.53 151.1 33.95 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.314 -1.109 . . . . 0.0 109.421 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -162.67 150.73 14.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.527 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 80.2 m-85 -96.42 147.76 23.49 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -141.25 99.57 3.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.286 -0.884 . . . . 0.0 109.96 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.96 163.87 18.66 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -134.66 126.06 28.37 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.219 -0.926 . . . . 0.0 109.423 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.95 145.98 25.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -0.838 . . . . 0.0 109.664 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 13.0 p -149.05 167.56 25.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.362 -0.836 . . . . 0.0 109.553 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -139.71 140.03 36.71 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.343 -0.848 . . . . 0.0 109.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -125.64 143.63 50.94 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.518 -0.739 . . . . 0.0 110.001 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.727 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.3 mp -86.26 157.76 19.86 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.493 -0.754 . . . . 0.0 109.429 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.7 tp -146.98 134.42 20.8 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.108 -0.995 . . . . 0.0 109.229 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -89.68 174.32 7.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.071 -1.018 . . . . 0.0 109.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.2 -11.11 55.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.409 -0.807 . . . . 0.0 109.535 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -69.16 -5.6 23.5 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 109.251 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.68 -3.44 61.0 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 108.65 -1.78 . . . . 0.0 108.65 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 41.1 mttp -140.69 140.17 34.88 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.603 -0.939 . . . . 0.0 108.472 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.567 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.3 p -65.7 143.59 15.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 120.975 -1.078 . . . . 0.0 109.541 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.4 HH12 ' CG ' ' A' ' 83' ' ' ASP . 35.1 ttm180 -63.21 1.9 0.43 Allowed 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.83 100.71 0.2 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.493 ' OD1' ' SG ' ' A' ' 166' ' ' CYS . 3.3 p30 -53.34 -33.27 52.86 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -1.172 . . . . 0.0 109.205 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -55.68 -5.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.639 -0.663 . . . . 0.0 109.701 -179.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' O ' HD13 ' A' ' 29' ' ' LEU . 12.1 m-20 -91.32 23.51 3.34 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -90.81 135.86 33.45 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.612 0.72 . . . . 0.0 109.64 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.4 tp -76.49 124.04 33.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.667 -0.646 . . . . 0.0 109.723 -178.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.446 ' CG ' ' N ' ' A' ' 45' ' ' TYR . 23.7 t80 -171.27 -162.63 0.25 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.446 ' N ' ' CG ' ' A' ' 44' ' ' PHE . 49.5 m-85 54.05 -113.17 0.76 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.289 -0.882 . . . . 0.0 109.562 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -111.32 9.22 21.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.453 -0.779 . . . . 0.0 109.518 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -71.09 66.03 0.39 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.5 mt -50.78 -25.45 4.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.337 -0.852 . . . . 0.0 109.644 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.5 pttt -164.74 156.4 15.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.126 -0.984 . . . . 0.0 109.808 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -95.32 158.19 15.57 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -0.847 . . . . 0.0 109.252 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.03 -48.67 10.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.205 -0.935 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -110.88 -3.89 15.46 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.592 -0.692 . . . . 0.0 109.42 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.15 -10.11 86.4 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m 56.56 13.38 1.34 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -1.127 . . . . 0.0 109.586 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 53' ' ' GLY . 2.5 t -93.29 151.68 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.284 -0.885 . . . . 0.0 108.983 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.8 p -147.91 121.68 9.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.937 -1.102 . . . . 0.0 109.831 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.517 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -92.74 132.28 37.08 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.365 -0.835 . . . . 0.0 109.036 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 98.3 m -64.66 -54.01 38.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 109.497 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 135.16 1.79 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -86.46 111.01 20.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.247 -1.149 . . . . 0.0 109.484 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.485 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 9.3 t-20 -64.94 -166.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.327 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 11.8 ptm180 -148.64 9.51 0.81 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.95 . . . . 0.0 109.761 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 p -153.52 -34.61 0.11 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.152 -0.967 . . . . 0.0 109.552 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.94 4.05 45.3 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.32 110.3 0.93 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.44 -1.035 . . . . 0.0 109.349 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 156.45 117.68 0.56 Allowed Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.44 ' OD1' ' N ' ' A' ' 67' ' ' ASP . 16.3 p-10 -75.95 58.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -1.145 . . . . 0.0 109.486 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -177.23 -156.02 15.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.73 114.97 10.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.288 -1.125 . . . . 0.0 109.449 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' LEU . 61.5 m-20 -65.57 -78.15 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.215 -0.928 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -89.01 171.16 10.06 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.235 -0.915 . . . . 0.0 109.158 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.517 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 27.5 m -169.9 164.35 9.67 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.815 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.86 120.72 8.72 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.297 -0.877 . . . . 0.0 108.904 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -104.37 123.46 47.46 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.489 -0.757 . . . . 0.0 109.263 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -125.61 126.66 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.618 -0.676 . . . . 0.0 109.722 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.9 mttm -90.27 82.73 5.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.399 -0.813 . . . . 0.0 108.856 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 77' ' ' LEU . 5.9 mt -53.12 -7.77 0.09 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' ND2' ' A' ' 4' ' ' ASN . 1.8 p30 -85.07 4.94 31.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.2 -0.937 . . . . 0.0 109.704 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -135.36 17.8 3.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.415 -0.803 . . . . 0.0 109.678 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' ' 81' ' ' PRO . 37.8 t -82.28 115.69 59.26 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 80' ' ' VAL . 82.1 Cg_exo -44.73 176.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 121.872 1.715 . . . . 0.0 112.297 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.99 -0.57 85.48 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.4 ' CG ' HH12 ' A' ' 37' ' ' ARG . 66.9 m-20 -71.8 -60.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -1.152 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 t -69.9 148.8 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.302 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.4 t70 -129.94 -9.0 4.4 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.493 -0.754 . . . . 0.0 109.571 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -154.99 146.4 23.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.168 -0.958 . . . . 0.0 109.313 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.0 mt -135.77 154.11 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.539 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 12.5 pt -137.69 163.77 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.335 -0.853 . . . . 0.0 110.325 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -129.9 139.35 51.16 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.9 p -146.73 140.19 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.046 -1.034 . . . . 0.0 109.751 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.3 m -112.74 141.86 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.6 p -132.4 143.79 50.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.495 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.414 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.2 mm -72.85 133.25 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.874 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -97.63 -56.88 2.38 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.197 -0.94 . . . . 0.0 109.806 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -49.63 -18.14 0.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -64.15 -38.67 91.89 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -0.916 . . . . 0.0 109.695 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.527 ' OE1' ' N ' ' A' ' 97' ' ' GLN . 1.2 mp0 -50.55 -38.26 44.04 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.665 -1.272 . . . . 0.0 109.244 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.508 ' CB ' ' HE ' ' A' ' 99' ' ' ARG . . . -91.2 -53.18 4.47 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.204 -0.935 . . . . 0.0 111.284 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.552 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -100.53 -11.31 20.22 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 120.938 -1.101 . . . . 0.0 111.271 -178.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.555 ' N ' ' O ' ' A' ' 96' ' ' ALA . 37.5 ttt180 59.2 89.43 0.06 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.984 -1.072 . . . . 0.0 109.345 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.491 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 15.3 mm100 -139.8 146.11 39.03 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.435 -0.791 . . . . 0.0 108.904 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.6 t -104.76 165.61 10.95 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.347 -0.845 . . . . 0.0 109.552 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 25.1 m-85 -48.35 -42.16 30.69 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.293 -0.879 . . . . 0.0 109.426 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -52.18 -22.41 9.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.517 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 25.9 mm-40 -77.44 -19.82 55.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.313 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 107' ' ' SER . 21.5 t -76.74 165.22 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.495 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.9 t -70.55 -22.4 62.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.778 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.41 80.26 0.03 OUTLIER Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.24 164.66 25.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.294 -1.121 . . . . 0.0 109.595 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -158.07 138.29 12.53 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.142 -0.974 . . . . 0.0 110.373 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.5 mt -100.66 147.55 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -139.44 152.1 46.77 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.187 -0.946 . . . . 0.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.422 HD11 ' CG2' ' A' ' 5' ' ' VAL . 28.0 tp -138.35 136.65 36.58 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.311 -0.868 . . . . 0.0 109.244 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.0 148.45 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.351 -0.843 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' N ' ' A' ' 117' ' ' ASP . 18.9 m120 -88.22 102.92 15.29 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -53.21 -10.77 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.012 -1.055 . . . . 0.0 108.524 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' N ' ' C ' ' A' ' 115' ' ' ASN . 26.6 t0 -86.97 -52.09 5.65 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.612 -0.68 . . . . 0.0 109.913 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -88.6 -17.81 29.35 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.292 -0.88 . . . . 0.0 110.075 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 59.79 52.05 5.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -0.897 . . . . 0.0 109.488 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.1 p -143.57 127.19 17.02 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.328 -0.857 . . . . 0.0 109.366 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -46.06 127.9 8.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.244 -0.91 . . . . 0.0 109.747 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 78.7 t -96.22 -48.49 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.204 -0.935 . . . . 0.0 109.931 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.64 174.78 5.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.783 -1.198 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -152.86 154.08 34.36 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.516 ' CE2' ' OD2' ' A' ' 130' ' ' ASP . 13.0 t80 -132.47 143.05 49.5 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.392 -0.818 . . . . 0.0 109.41 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' O ' ' OD2' ' A' ' 130' ' ' ASP . 18.9 m-20 -97.88 112.84 24.61 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.271 -0.893 . . . . 0.0 109.355 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 20.0 mt -79.36 -53.27 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.198 -0.939 . . . . 0.0 109.601 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.8 t -48.18 -26.06 1.76 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.276 -0.89 . . . . 0.0 109.552 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -95.79 -33.37 12.29 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.357 -0.839 . . . . 0.0 110.127 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.516 ' OD2' ' CE2' ' A' ' 125' ' ' TYR . 25.2 m-20 -87.06 -73.22 0.48 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.41 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -79.48 20.09 0.58 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.696 0.76 . . . . 0.0 109.596 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 130' ' ' ASP . 1.5 p -43.64 -17.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.802 -0.561 . . . . 0.0 110.318 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 131' ' ' ALA . 29.4 p -121.38 -20.51 6.63 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.38 -0.825 . . . . 0.0 110.035 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -88.64 -170.57 2.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.045 -1.034 . . . . 0.0 109.391 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.55 12.12 2.31 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.364 -0.835 . . . . 0.0 108.758 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -166.73 142.51 4.45 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.1 ttt -164.34 149.51 10.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.9 -1.125 . . . . 0.0 110.173 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 tt -85.36 122.82 30.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.482 -0.761 . . . . 0.0 109.55 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -67.23 -57.03 7.47 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.153 -0.967 . . . . 0.0 109.084 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -166.07 -166.08 24.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.034 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.57 161.29 42.94 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.309 -1.112 . . . . 0.0 109.98 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.76 151.67 51.49 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.522 -0.736 . . . . 0.0 109.247 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -146.39 166.62 25.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.277 -0.89 . . . . 0.0 109.601 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.621 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -100.69 135.45 42.11 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.394 -0.816 . . . . 0.0 109.523 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.603 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.7 t60 -109.97 -117.17 0.29 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.547 -0.721 . . . . 0.0 109.256 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 15.0 m120 -78.74 53.7 1.4 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.14 12.84 82.81 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -127.76 127.21 43.19 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.511 -0.994 . . . . 0.0 109.335 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -67.32 151.56 47.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.918 . . . . 0.0 109.409 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.8 mttp -141.09 176.54 8.74 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.317 -0.865 . . . . 0.0 108.888 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -138.13 139.29 39.35 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.455 -0.778 . . . . 0.0 109.601 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.7 tpp180 -148.76 107.33 3.8 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.292 -0.88 . . . . 0.0 109.171 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -64.61 154.78 35.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.26 -0.9 . . . . 0.0 109.584 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.67 -31.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.457 -0.777 . . . . 0.0 109.235 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.05 87.49 0.03 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.453 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 5.0 tp-100 -128.6 104.32 7.6 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.648 -0.913 . . . . 0.0 109.094 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.0 141.53 15.65 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.453 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.8 OUTLIER -150.21 124.73 9.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.305 -1.115 . . . . 0.0 109.053 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -84.49 35.67 0.56 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.886 . . . . 0.0 109.51 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -77.23 -118.61 0.18 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.535 ' H ' HG23 ' A' ' 165' ' ' VAL . . . -165.64 150.75 18.75 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.35 -13.45 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.261 -1.141 . . . . 0.0 109.617 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -76.55 -60.53 2.3 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.236 -0.915 . . . . 0.0 109.557 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 166' ' ' CYS . 14.9 t -76.33 -44.13 38.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.215 -0.928 . . . . 0.0 109.507 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.535 HG23 ' H ' ' A' ' 161' ' ' GLY . 77.8 t -46.86 -20.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.274 -0.891 . . . . 0.0 109.453 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.493 ' SG ' ' OD1' ' A' ' 39' ' ' ASP . 11.9 t -75.96 -61.26 1.99 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.399 -0.813 . . . . 0.0 109.48 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.55 -17.77 60.68 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.239 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -60.03 -24.61 64.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.319 -0.863 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.539 ' CE1' ' CD1' ' A' ' 88' ' ' ILE . 57.3 m-85 -71.74 -12.72 61.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.133 -0.98 . . . . 0.0 109.46 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.06 -43.99 7.86 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.3 tt -72.94 145.88 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.097 -1.237 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.562 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 1.6 p30 -65.98 113.7 4.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.892 . . . . 0.0 109.513 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 110.88 16.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.397 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.479 -179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.621 ' N ' ' ND2' ' A' ' 118' ' ' ASN . 42.2 t . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.4 ptt? -174.08 42.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.382 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -153.07 -38.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.262 -0.898 . . . . 0.0 109.272 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 16.2 m-20 -146.44 128.22 15.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.31 -0.869 . . . . 0.0 109.212 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG13 HD21 ' A' ' 113' ' ' LEU . 79.7 t -123.24 153.86 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.6 tt -148.64 109.85 4.36 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.287 -0.883 . . . . 0.0 109.454 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.46 ' N ' HD23 ' A' ' 6' ' ' LEU . 21.2 t -86.45 150.98 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.931 . . . . 0.0 108.843 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -137.04 144.52 16.13 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.3 tp -138.16 127.79 25.05 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -143.88 142.12 10.89 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -153.99 154.21 33.36 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.377 -1.073 . . . . 0.0 109.622 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -79.45 125.29 29.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.54 -0.725 . . . . 0.0 109.591 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -79.63 141.6 36.36 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.882 . . . . 0.0 109.414 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -132.79 106.93 8.03 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.461 -0.775 . . . . 0.0 109.34 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 6.2 m -120.65 105.78 11.11 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.559 -0.713 . . . . 0.0 109.28 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.5 p -91.63 -90.35 0.17 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.272 -0.892 . . . . 0.0 109.285 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -81.46 -20.68 39.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 109.361 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.01 -21.87 0.13 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -56.56 176.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.259 -1.142 . . . . 0.0 109.481 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 p30 -175.92 -166.18 0.18 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.492 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -152.75 128.25 10.0 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.419 ' OD1' ' O ' ' A' ' 61' ' ' ASN . 24.1 t0 -141.24 107.88 5.35 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.309 -0.869 . . . . 0.0 109.832 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.9 mp -83.44 163.26 20.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.193 -0.942 . . . . 0.0 108.594 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -127.39 115.52 19.06 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.449 -0.782 . . . . 0.0 109.298 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.06 135.55 39.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.294 -0.879 . . . . 0.0 109.303 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.4 p -149.24 167.75 25.17 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.258 -0.901 . . . . 0.0 109.588 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' C ' ' CD1' ' A' ' 28' ' ' PHE . . . -126.08 152.8 45.38 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 26.9 m-85 -134.78 134.71 41.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.459 -0.776 . . . . 0.0 109.362 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.725 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -77.99 156.11 30.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.283 -0.886 . . . . 0.0 109.336 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.47 130.44 16.26 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.007 -1.058 . . . . 0.0 109.023 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -83.73 169.71 14.97 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.107 -0.995 . . . . 0.0 109.299 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.64 -4.98 59.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.74 HD22 ' H ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -77.34 -3.69 41.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 -179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.68 -8.72 54.91 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.621 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 75.5 mttt -131.87 176.29 8.48 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.4 t -93.87 137.65 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.417 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -62.65 -2.59 1.16 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 177.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.77 82.37 0.05 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.8 p-10 -48.22 -41.75 28.28 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.391 -1.064 . . . . 0.0 109.58 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.54 3.33 0.13 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.536 -0.727 . . . . 0.0 109.793 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.574 ' O ' HD13 ' A' ' 29' ' ' LEU . 38.3 t0 -91.62 22.97 3.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.013 -1.054 . . . . 0.0 109.216 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.5 p90 -90.71 134.98 34.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.162 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.566 HD11 ' OD1' ' A' ' 47' ' ' ASN . 3.5 tp -90.14 133.56 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.628 -0.67 . . . . 0.0 110.069 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.7 OUTLIER -138.57 -172.66 3.35 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.38 -0.825 . . . . 0.0 109.545 179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' ASN . 28.5 p90 -48.89 -48.37 42.43 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.417 -0.802 . . . . 0.0 111.179 -178.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.504 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 9.7 t-20 -49.07 -10.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.957 -1.09 . . . . 0.0 109.832 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.566 ' OD1' HD11 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -141.97 111.29 6.45 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.268 -0.895 . . . . 0.0 109.215 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.54 -25.41 66.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.386 -0.821 . . . . 0.0 110.102 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.538 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 52.0 pttt -159.27 168.23 26.99 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.971 -1.08 . . . . 0.0 110.034 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 38.4 t -103.29 162.1 13.28 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.502 -0.749 . . . . 0.0 109.348 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.34 -48.53 11.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.446 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.423 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 57.3 t0 -116.19 -9.63 11.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.646 -0.659 . . . . 0.0 109.339 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' C ' ' H ' ' A' ' 55' ' ' VAL . . . -61.76 -17.26 53.94 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p 64.45 0.04 1.01 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.27 -1.135 . . . . 0.0 109.743 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 55' ' ' VAL . 2.6 m -92.91 152.06 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.196 -0.94 . . . . 0.0 108.921 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 49.9 m -144.64 126.3 15.14 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.118 -0.989 . . . . 0.0 109.732 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -93.25 133.65 36.24 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.359 -0.838 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.448 ' H ' ' HG1' ' A' ' 58' ' ' THR . 10.0 p -68.98 -57.48 5.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.96 . . . . 0.0 109.516 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.73 137.62 2.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 33.4 t70 -89.92 110.92 21.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.28 -1.129 . . . . 0.0 109.383 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.419 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 21.0 m120 -72.75 155.77 39.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.47 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -105.71 8.96 33.22 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.448 -0.782 . . . . 0.0 109.715 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 17.2 p -153.52 -34.16 0.11 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.139 -0.975 . . . . 0.0 109.667 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.73 14.42 27.27 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.961 -1.655 . . . . 0.0 108.961 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -58.15 110.36 0.93 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -1.067 . . . . 0.0 109.416 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.97 121.56 0.65 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -78.28 74.0 4.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.284 -1.127 . . . . 0.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.76 -149.2 18.7 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 -69.0 101.89 1.49 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -1.153 . . . . 0.0 109.437 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -56.31 -72.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.483 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.417 ' OE2' ' OD1' ' A' ' 60' ' ' ASP . 91.7 mt-10 -93.19 179.2 5.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.247 -0.908 . . . . 0.0 109.287 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -172.51 154.75 3.22 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 0.0 109.62 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -137.43 120.51 16.66 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.465 -0.772 . . . . 0.0 108.931 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -96.32 135.41 38.2 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.303 -0.873 . . . . 0.0 108.969 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.412 HG23 HG12 ' A' ' 55' ' ' VAL . 4.7 mp -136.27 147.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.352 -0.842 . . . . 0.0 110.183 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.0 mttm -125.62 99.68 6.11 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' C ' ' H ' ' A' ' 79' ' ' ALA . 20.7 mt -68.93 -23.29 64.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.163 -0.961 . . . . 0.0 109.843 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -66.59 5.01 0.66 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.98 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -130.11 13.87 5.69 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.362 -0.836 . . . . 0.0 109.55 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.15 126.73 66.75 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.178 -0.951 . . . . 0.0 108.705 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.08 -164.78 0.27 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.835 1.69 . . . . 0.0 112.166 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.32 2.48 78.34 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -65.37 -56.99 9.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.236 . . . . 0.0 109.145 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG22 ' H ' ' A' ' 86' ' ' LYS . 14.6 p -94.23 148.34 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.43 -0.794 . . . . 0.0 109.074 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -120.38 -7.74 9.71 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.553 -0.717 . . . . 0.0 109.425 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 84' ' ' VAL . 33.6 ttpt -153.1 143.43 22.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.163 -0.961 . . . . 0.0 109.297 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.5 mt -123.48 154.01 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.36 154.33 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.012 -179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -131.71 130.12 41.57 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 m -140.51 152.85 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.306 -0.871 . . . . 0.0 110.158 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 92' ' ' THR . 61.7 t -106.55 157.35 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.421 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.4 p -147.36 141.02 25.6 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.107 -0.996 . . . . 0.0 109.958 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.541 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 4.2 mm -74.14 145.16 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.631 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 11.8 t-160 -81.96 -134.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.194 -0.941 . . . . 0.0 110.117 -179.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 19.6 p-10 -56.67 -27.79 59.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 110.091 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.541 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . . . -52.52 -19.27 2.15 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.059 -1.025 . . . . 0.0 108.784 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -70.65 -45.27 65.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.58 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -64.27 -48.03 77.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.58 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.2 mpt_? -73.55 15.38 0.26 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.259 -0.9 . . . . 0.0 108.98 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 98' ' ' ALA . 17.3 tpt180 53.5 78.21 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.373 -0.829 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.492 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 33.4 mt-30 -150.0 74.09 1.19 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.277 -0.889 . . . . 0.0 109.138 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.1 m -56.46 161.23 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.328 -0.858 . . . . 0.0 109.693 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.49 -24.11 0.29 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.516 -0.74 . . . . 0.0 109.726 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.487 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.74 -34.2 50.27 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -62.76 -18.12 62.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.153 -1.204 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 107' ' ' SER . 21.8 t -73.76 166.77 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.301 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.1 t -75.88 -26.04 56.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.207 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 164.79 76.82 0.03 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.558 -1.306 . . . . 0.0 110.084 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.53 164.6 25.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -1.16 . . . . 0.0 108.935 179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 31.3 p90 -160.02 145.65 15.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.93 -1.106 . . . . 0.0 110.587 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 60.0 mt -109.52 149.22 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 27.2 ttm180 -140.41 147.16 39.3 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.153 -0.967 . . . . 0.0 109.395 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.697 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -135.16 128.86 32.86 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.697 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.3 p -136.4 149.92 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.314 -0.867 . . . . 0.0 109.402 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.48 ' C ' ' H ' ' A' ' 117' ' ' ASP . 88.7 m-20 -89.15 102.96 15.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -56.45 -7.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.144 -0.973 . . . . 0.0 108.542 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.48 ' H ' ' C ' ' A' ' 115' ' ' ASN . 31.3 t70 -85.69 -52.2 5.94 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.633 -0.667 . . . . 0.0 109.942 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.621 ' ND2' ' N ' ' A' ' 1' ' ' SER . 61.0 m-80 -94.55 -18.05 21.79 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.251 -0.906 . . . . 0.0 109.808 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 64.81 56.81 1.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.455 -0.778 . . . . 0.0 110.014 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.21 126.44 17.53 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.3 -0.875 . . . . 0.0 109.382 179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -51.48 119.22 3.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.517 -0.739 . . . . 0.0 109.491 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.3 t -82.26 -48.81 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.181 -0.949 . . . . 0.0 109.691 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.35 173.62 3.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.74 -1.225 . . . . 0.0 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 46.5 mtp180 -143.89 153.73 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.408 ' OH ' ' OD2' ' A' ' 130' ' ' ASP . 6.3 t80 -120.95 144.55 48.42 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.375 -0.828 . . . . 0.0 109.411 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -101.7 114.9 29.36 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.324 -0.86 . . . . 0.0 109.41 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.587 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.6 mm? -81.01 -38.1 28.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 74.4 p -46.12 -32.82 3.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.23 -0.919 . . . . 0.0 109.287 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -94.99 -42.55 8.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.544 -0.723 . . . . 0.0 109.598 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.608 ' O ' HG22 ' A' ' 133' ' ' THR . 4.5 m-20 -90.76 19.81 5.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.3 -0.875 . . . . 0.0 109.633 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -89.28 -50.46 6.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.6 m -59.21 2.76 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.512 -0.743 . . . . 0.0 110.236 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 130' ' ' ASP . 6.9 t -87.77 -33.8 18.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.908 -1.12 . . . . 0.0 110.359 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -173.56 -144.81 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.907 -1.121 . . . . 0.0 109.831 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 0.04 4.4 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -144.61 158.77 43.63 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.498 ' SD ' ' O ' ' A' ' 156' ' ' GLN . 3.9 tpt -164.42 146.75 8.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.889 -1.132 . . . . 0.0 110.173 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 tt -92.57 121.17 33.74 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.36 -0.837 . . . . 0.0 109.215 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -71.1 -49.58 42.84 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.137 -0.977 . . . . 0.0 109.722 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.55 -166.6 30.55 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.437 -1.363 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -151.33 166.77 29.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.349 -1.089 . . . . 0.0 110.041 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.4 mt -135.76 131.53 35.64 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.411 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 10.5 p90 -135.21 165.95 24.23 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.321 -0.862 . . . . 0.0 109.8 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.2 ptm180 -85.37 148.96 25.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.388 -0.82 . . . . 0.0 110.03 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.515 ' CE1' ' OD1' ' A' ' 146' ' ' ASN . 12.2 t-160 -154.56 123.75 6.39 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.201 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.515 ' OD1' ' CE1' ' A' ' 145' ' ' HIS . 7.6 m120 54.31 24.82 5.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.904 . . . . 0.0 109.358 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.82 12.24 80.18 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 73.9 mt-10 -127.86 137.9 52.5 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -1.031 . . . . 0.0 109.354 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -67.85 148.27 51.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.385 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -146.74 141.82 27.14 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.177 -0.952 . . . . 0.0 109.311 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 36.6 t80 -90.92 156.57 17.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.414 -0.804 . . . . 0.0 109.971 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.5 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 64.9 ttt180 -151.56 127.77 10.53 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.495 -0.753 . . . . 0.0 109.119 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -83.15 149.94 26.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.096 -1.003 . . . . 0.0 109.789 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 5.8 t -145.76 -35.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 51.71 80.78 0.06 OUTLIER Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.498 ' O ' ' SD ' ' A' ' 137' ' ' MET . 40.0 tt0 -111.75 150.03 30.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.707 -0.878 . . . . 0.0 109.184 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -133.23 130.25 5.67 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -150.78 158.66 44.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.219 -1.166 . . . . 0.0 109.583 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -117.01 25.39 10.53 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -56.8 -24.73 50.08 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.36 146.27 10.66 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.6 tp -50.73 -21.04 1.44 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -1.116 . . . . 0.0 109.316 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.81 -58.52 3.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -0.938 . . . . 0.0 109.831 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 5.2 m -76.49 -40.5 50.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 0.0 109.68 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.43 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 67.1 t -48.41 -20.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.223 -0.923 . . . . 0.0 109.729 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 44.4 t -80.83 -58.67 2.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.934 . . . . 0.0 109.898 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -79.11 -15.24 58.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 0.0 109.484 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.47 -34.82 74.58 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.577 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 59.4 m-85 -71.73 -19.7 62.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.226 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . 0.407 ' HA2' ' H ' ' A' ' 36' ' ' VAL . . . -88.67 -31.08 13.58 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.1 pt -138.36 145.1 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.385 -1.068 . . . . 0.0 109.383 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.9 p30 -80.45 147.57 30.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.247 -0.908 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 158.56 25.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.295 -0.878 . . . . 0.0 109.482 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.489 -179.991 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.6 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.284 0.564 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.466 ' CE ' HD21 ' A' ' 115' ' ' ASN . 27.2 mtt -77.26 113.09 14.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.425 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 65.2 mmtt -97.12 -20.42 18.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.247 -0.908 . . . . 0.0 109.263 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 25.3 m-20 -146.03 128.39 15.88 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.283 -0.886 . . . . 0.0 109.346 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.5 t -115.63 150.98 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.554 -0.716 . . . . 0.0 109.143 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.5 tp -148.94 110.71 4.54 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 109.397 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 t -86.28 151.97 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.376 -0.828 . . . . 0.0 109.048 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.32 136.61 9.22 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.54 126.23 20.63 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.414 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.78 143.9 11.0 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.876 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 17.2 p90 -154.2 155.5 35.39 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -1.096 . . . . 0.0 109.667 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -75.27 124.95 27.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.475 -0.765 . . . . 0.0 109.795 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.16 144.39 26.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 0.0 109.326 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 49.0 mtp180 -132.76 106.72 7.92 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.436 -0.79 . . . . 0.0 109.155 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.5 p -112.83 105.64 13.8 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.606 -0.683 . . . . 0.0 109.483 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 43.9 p -96.71 -57.22 2.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.205 -0.935 . . . . 0.0 109.111 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -158.65 18.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.0 109.393 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 151.08 -18.3 0.93 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -81.59 127.05 32.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.251 -1.147 . . . . 0.0 109.624 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -160.67 141.13 11.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -96.21 144.04 26.77 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.214 -0.929 . . . . 0.0 109.222 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -141.4 99.69 3.62 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.195 -0.941 . . . . 0.0 110.049 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.24 162.23 18.39 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -126.93 121.95 33.19 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.384 -0.823 . . . . 0.0 109.447 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -97.9 125.26 42.71 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.326 -0.859 . . . . 0.0 109.29 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 89.7 p -149.48 168.02 24.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.341 -0.849 . . . . 0.0 109.455 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.42 142.12 47.03 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.438 -0.789 . . . . 0.0 109.265 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 28.5 m-85 -114.93 135.35 54.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.607 -0.683 . . . . 0.0 109.245 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.743 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -74.51 159.72 31.86 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.211 -0.931 . . . . 0.0 109.559 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.55 132.78 19.44 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.21 176.33 8.42 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.048 -1.032 . . . . 0.0 109.876 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.71 -10.65 57.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 0.0 109.555 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -76.32 -0.37 22.31 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.985 . . . . 0.0 109.333 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.31 -14.47 64.35 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 67.4 mmtt -117.23 172.18 7.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.6 t -91.25 137.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.002 -1.061 . . . . 0.0 109.128 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -60.0 -4.69 0.8 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 171.43 85.27 0.06 OUTLIER Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -46.17 -41.63 12.88 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.415 -1.05 . . . . 0.0 109.766 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.57 7.64 0.22 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.543 -0.723 . . . . 0.0 109.749 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.602 ' O ' HD13 ' A' ' 29' ' ' LEU . 18.5 m-20 -92.71 22.54 4.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.052 -1.03 . . . . 0.0 109.35 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 16.2 p90 -90.89 124.03 34.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.194 -0.941 . . . . 0.0 109.077 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 17.6 mt -93.16 137.86 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.382 -0.823 . . . . 0.0 109.94 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 1.9 p90 -143.4 -163.76 1.72 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.51 -0.744 . . . . 0.0 109.395 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -44.07 -16.96 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.24 -0.912 . . . . 0.0 110.789 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 44' ' ' PHE . 8.4 t-20 -64.07 -14.88 57.74 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.877 -1.14 . . . . 0.0 109.447 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 43.6 t30 -148.0 113.33 5.58 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.176 -0.953 . . . . 0.0 109.366 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -50.05 -31.03 12.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 109.272 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.524 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 43.5 pttt -166.34 159.65 15.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.256 -0.903 . . . . 0.0 109.724 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.8 p -87.38 150.59 23.72 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.41 -48.56 13.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -116.41 -4.38 11.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -73.27 -10.02 77.96 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 1.5 m 61.37 5.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -1.112 . . . . 0.0 109.675 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 75.4 t -93.2 151.47 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.147 -0.971 . . . . 0.0 109.067 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 22.0 m -149.08 128.1 12.71 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.098 -1.001 . . . . 0.0 109.695 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.531 ' CG ' HD12 ' A' ' 73' ' ' LEU . 1.9 t-80 -92.4 130.21 38.13 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.517 HG22 ' NZ ' ' A' ' 74' ' ' LYS . 60.6 p -64.27 -41.66 96.82 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.026 -1.046 . . . . 0.0 109.669 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.78 115.72 0.46 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -83.07 110.83 18.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -1.144 . . . . 0.0 109.328 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 75.8 m-20 -79.74 -164.77 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.174 -0.954 . . . . 0.0 109.337 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.565 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.2 OUTLIER -147.07 13.76 1.13 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.245 -0.909 . . . . 0.0 109.38 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.495 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 24.8 p -151.93 -35.2 0.13 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.073 -1.017 . . . . 0.0 109.546 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.69 9.7 32.39 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -58.4 110.59 1.0 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.396 -1.061 . . . . 0.0 109.453 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.93 123.63 0.68 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.0 p-10 -78.4 51.14 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -1.149 . . . . 0.0 109.439 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 175.97 -137.97 3.94 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.479 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.9 m-20 -76.58 104.85 7.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -1.129 . . . . 0.0 109.429 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.512 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 4.9 m-20 -75.79 -34.47 60.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -133.64 144.4 49.2 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.478 -0.764 . . . . 0.0 109.221 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.446 ' OG ' HG21 ' A' ' 58' ' ' THR . 1.7 p -161.61 163.03 30.24 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.34 -0.85 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.531 HD12 ' CG ' ' A' ' 57' ' ' HIS . 2.0 tp -133.69 129.56 36.96 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.377 -0.827 . . . . 0.0 109.783 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.517 ' NZ ' HG22 ' A' ' 58' ' ' THR . 51.3 mttp -101.89 131.29 48.34 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.8 mt -135.72 146.98 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.318 -0.864 . . . . 0.0 109.855 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -126.14 108.37 11.26 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.448 HD13 ' CD2' ' A' ' 149' ' ' TRP . 16.2 mt -75.09 -13.82 60.52 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.94 . . . . 0.0 109.734 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.11 -29.32 65.41 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.149 -0.969 . . . . 0.0 109.605 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' HB3' ' OG ' ' A' ' 54' ' ' SER . . . -101.08 21.5 13.75 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.382 -0.824 . . . . 0.0 109.771 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.411 ' O ' HG13 ' A' ' 80' ' ' VAL . 13.2 p -60.93 135.23 92.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.106 -0.996 . . . . 0.0 108.998 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.69 -178.5 3.1 Favored 'Trans proline' 0 N--CA 1.495 1.588 0 C-N-CA 121.745 1.63 . . . . 0.0 111.928 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -92.29 42.62 2.71 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -142.82 -59.63 0.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.281 -1.129 . . . . 0.0 109.479 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.3 t -60.75 143.31 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.329 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -138.92 -1.69 1.77 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.356 -0.84 . . . . 0.0 110.019 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.514 ' C ' HD12 ' A' ' 87' ' ' ILE . 68.5 tttt -158.46 131.19 7.13 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.98 -1.075 . . . . 0.0 109.067 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.817 HD12 ' N ' ' A' ' 87' ' ' ILE . 2.7 mp -117.45 154.25 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.3 pt -134.69 155.61 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.423 -0.798 . . . . 0.0 109.314 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -133.16 129.68 38.16 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.57 -0.706 . . . . 0.0 109.112 -179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -141.02 157.93 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.323 -0.861 . . . . 0.0 109.761 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 52.2 t -127.61 113.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.3 p -105.1 149.91 25.46 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.556 -0.715 . . . . 0.0 109.946 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 5.4 mm -74.26 132.26 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.411 ' O ' ' N ' ' A' ' 96' ' ' ALA . 22.7 t-80 -87.08 -62.75 1.43 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.072 -1.017 . . . . 0.0 110.075 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.25 -18.41 0.21 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.194 -0.941 . . . . 0.0 109.654 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -60.87 -38.86 87.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.621 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -52.81 -33.34 48.67 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 120.734 -1.229 . . . . 0.0 109.417 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.96 -53.1 4.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.25 -0.906 . . . . 0.0 111.242 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -107.9 -6.38 16.69 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.212 -0.93 . . . . 0.0 111.069 -178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.557 ' N ' ' O ' ' A' ' 96' ' ' ALA . 53.8 ttt180 57.63 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.951 -1.093 . . . . 0.0 109.427 -179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.695 ' NE2' HE21 ' A' ' 105' ' ' GLN . 2.9 mm100 -143.67 142.52 31.03 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.255 -0.903 . . . . 0.0 109.212 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 103' ' ' PHE . 50.7 p -92.92 148.87 21.65 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.312 -0.868 . . . . 0.0 109.379 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.0 -28.61 0.27 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.51 -0.744 . . . . 0.0 109.952 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.466 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.63 -39.09 65.44 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.695 HE21 ' NE2' ' A' ' 101' ' ' GLN . 4.0 tp-100 -54.09 -15.0 1.24 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.219 -1.165 . . . . 0.0 109.152 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.567 HG12 ' N ' ' A' ' 107' ' ' SER . 35.4 t -79.99 169.49 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.272 -0.892 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' HG12 ' A' ' 106' ' ' VAL . 7.5 t -76.93 -32.38 57.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.2 -0.938 . . . . 0.0 110.087 -179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 173.56 73.76 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.89 161.88 27.25 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.264 -1.139 . . . . 0.0 109.342 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 34.5 p90 -154.45 169.64 23.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.012 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 92.6 mt -134.82 152.17 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -142.54 154.17 44.22 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.167 -0.958 . . . . 0.0 109.447 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 41.6 tp -140.53 137.06 33.5 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.234 -0.916 . . . . 0.0 108.693 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -152.48 146.83 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.172 -0.955 . . . . 0.0 109.52 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 117' ' ' ASP . 34.9 m120 -84.88 102.97 13.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -52.74 -8.86 0.1 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 115' ' ' ASN . 40.8 t0 -89.63 -52.25 5.11 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.511 -0.743 . . . . 0.0 109.862 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -87.31 -17.93 31.32 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.869 . . . . 0.0 109.738 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 59.18 49.97 8.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.264 -0.898 . . . . 0.0 109.617 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m -131.66 119.76 21.85 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.538 -0.726 . . . . 0.0 109.107 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -50.63 122.14 6.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.437 -0.789 . . . . 0.0 109.727 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.19 -58.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.1 174.57 2.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.88 -1.138 . . . . 0.0 110.501 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -142.18 130.75 22.58 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -91.37 143.48 26.58 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.125 -0.985 . . . . 0.0 109.548 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -93.32 115.6 28.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.298 -0.876 . . . . 0.0 109.578 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -83.91 -46.98 11.52 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.274 -0.891 . . . . 0.0 109.565 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 48.7 p -46.58 -26.89 0.98 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.015 . . . . 0.0 109.588 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -94.84 -50.29 5.2 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.367 -0.833 . . . . 0.0 109.862 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -86.08 9.49 17.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.89 . . . . 0.0 109.826 -179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -76.85 -52.52 9.33 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 26.0 t -58.63 -0.82 0.11 Allowed 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.358 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 20.1 m -83.02 -33.13 26.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.204 -0.935 . . . . 0.0 110.162 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -172.32 -153.76 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.721 -1.237 . . . . 0.0 109.505 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.552 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 25.0 m -113.07 -42.17 3.59 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -104.93 165.68 10.9 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 13.9 tpt -164.06 134.69 4.32 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.855 -1.153 . . . . 0.0 110.37 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.8 122.11 33.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -67.63 -54.36 20.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.164 -0.96 . . . . 0.0 109.747 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -172.64 -160.57 21.47 Favored Glycine 0 N--CA 1.49 2.272 0 C-N-CA 119.495 -1.335 . . . . 0.0 110.006 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.56 167.04 29.32 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.344 -1.092 . . . . 0.0 110.084 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.52 141.65 50.48 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -145.28 165.98 26.84 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.984 -1.072 . . . . 0.0 109.629 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -97.07 142.98 28.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.348 -0.845 . . . . 0.0 109.942 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.443 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 36.6 t60 -117.1 -119.81 0.31 Allowed 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.443 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 71.1 m-20 -73.44 52.22 0.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.18 -0.95 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.03 10.13 85.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -127.74 140.46 52.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.53 -0.982 . . . . 0.0 109.32 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.448 ' CD2' HD13 ' A' ' 77' ' ' LEU . 66.7 m95 -67.36 151.63 47.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.225 -0.922 . . . . 0.0 109.479 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 39.9 tptt -150.3 129.95 13.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 0.0 109.056 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 52.5 t80 -89.58 155.03 19.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.301 -0.874 . . . . 0.0 109.715 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.601 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -157.88 109.52 2.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 0.0 109.298 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.35 154.89 9.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.438 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.4 t -132.63 -40.85 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.432 -0.792 . . . . 0.0 109.5 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 65.69 79.63 0.18 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -146.04 167.89 22.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.548 -0.972 . . . . 0.0 108.568 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.444 ' C ' ' CG ' ' A' ' 158' ' ' TYR . . . -161.99 -172.55 29.54 Favored Glycine 0 N--CA 1.491 2.345 0 C-N-CA 119.4 -1.381 . . . . 0.0 110.281 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.493 ' C ' ' H ' ' A' ' 160' ' ' GLY . 1.1 m-85 -149.93 158.67 44.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.459 -1.024 . . . . 0.0 109.264 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.61 -5.05 0.12 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.558 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.493 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 90.11 91.23 1.25 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -160.08 82.57 0.14 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.647 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.32 -13.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -1.133 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -76.77 -50.45 13.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 168' ' ' GLN . 17.1 m -89.98 -41.6 11.65 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 0.0 109.587 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.531 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 72.7 t -54.63 -21.41 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 0.0 109.955 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.603 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 26.9 p -84.78 -54.06 4.94 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.0 109.788 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.603 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -77.88 -16.12 58.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.936 . . . . 0.0 109.452 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.5 tp-100 -63.19 -28.69 70.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.297 -0.877 . . . . 0.0 109.397 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.531 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 59.9 m-85 -71.66 -13.22 61.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -0.984 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -155.36 40.5 0.61 Allowed Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.469 ' N ' ' O ' ' A' ' 167' ' ' ALA . 15.3 tt -76.39 154.84 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -79.21 124.46 28.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.452 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.55 36.2 0.37 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.0 109.483 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.495 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 2' ' ' MET . 95.8 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.504 ' N ' ' OG ' ' A' ' 1' ' ' SER . 13.2 ptp -160.51 43.85 0.19 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.225 -0.922 . . . . 0.0 109.455 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -51.71 -14.42 0.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.273 -0.892 . . . . 0.0 109.459 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -146.34 127.69 14.91 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 77' ' ' LEU . 54.9 t -111.24 151.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.1 tp -148.64 112.45 5.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.123 -0.986 . . . . 0.0 109.874 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.6 t -85.85 151.1 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.68 116.92 1.13 Allowed Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' A' ' 70' ' ' ASP . 24.1 tp -110.56 133.24 53.48 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.7 151.85 23.89 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.232 -1.461 . . . . 0.0 110.089 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.47 153.68 21.79 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.43 -1.041 . . . . 0.0 109.627 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -82.15 123.58 29.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.463 -0.773 . . . . 0.0 109.682 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -87.92 131.77 34.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.31 -0.869 . . . . 0.0 109.381 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -92.34 106.99 18.88 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.195 -0.941 . . . . 0.0 109.522 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.7 p -93.27 129.59 39.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.243 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.89 -38.6 0.1 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.317 -0.865 . . . . 0.0 109.364 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -158.03 44.58 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -0.842 . . . . 0.0 109.378 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 81.22 -18.18 10.91 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 -78.68 130.4 35.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.427 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -157.17 171.44 20.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.314 -0.866 . . . . 0.0 109.398 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -96.27 146.47 24.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -141.12 99.75 3.66 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.294 -0.879 . . . . 0.0 109.617 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.1 mp -86.22 163.29 17.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.193 -0.942 . . . . 0.0 108.653 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -130.61 127.47 39.05 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.491 -0.756 . . . . 0.0 109.542 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.516 ' N ' ' OE1' ' A' ' 71' ' ' GLU . . . -97.93 146.46 25.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.363 -0.836 . . . . 0.0 109.043 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 t -149.64 167.73 25.58 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.248 -0.907 . . . . 0.0 109.746 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.44 133.38 18.11 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.331 -0.855 . . . . 0.0 109.033 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 13.2 m-85 -114.18 133.29 55.7 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.538 -0.726 . . . . 0.0 109.655 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.764 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.1 mp -83.07 149.27 27.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.362 -0.836 . . . . 0.0 109.008 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 31.9 tp -146.68 129.41 16.16 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.098 -1.001 . . . . 0.0 109.223 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.79 169.74 17.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.192 -0.943 . . . . 0.0 109.679 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.74 -3.41 58.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.259 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -74.95 -7.75 54.49 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.61 -3.64 49.92 Favored Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -144.76 138.41 27.14 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.284 -1.127 . . . . 0.0 109.203 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.8 p -66.58 143.85 15.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.272 -0.893 . . . . 0.0 109.391 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.419 ' CZ ' ' OD2' ' A' ' 83' ' ' ASP . 42.1 mtp180 -69.14 7.55 0.72 Allowed 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.6 97.64 0.16 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 2.6 p-10 -50.13 -36.2 28.9 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -1.168 . . . . 0.0 109.282 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.77 -0.82 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.746 -0.596 . . . . 0.0 109.814 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.685 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.5 t0 -88.03 26.85 1.28 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.1 p90 -88.79 136.72 32.86 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.74 0.781 . . . . 0.0 109.519 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.4 mm -93.36 140.48 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.731 0.777 . . . . 0.0 109.397 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -155.82 -156.0 0.6 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' H ' ' A' ' 47' ' ' ASN . 53.7 p90 -62.34 -38.61 90.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.374 -0.829 . . . . 0.0 109.497 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.415 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 10.9 p30 -66.13 5.23 0.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.249 -0.907 . . . . 0.0 109.383 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 45' ' ' TYR . 16.5 t-20 -154.82 102.7 2.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.333 -0.854 . . . . 0.0 109.146 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.9 tp -57.71 -34.05 69.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.64 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 48.8 pttt -166.19 161.96 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.439 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 11.0 p -83.86 157.47 21.98 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.344 -0.848 . . . . 0.0 109.403 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.89 -46.5 14.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.313 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -116.26 -9.8 11.52 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.663 -0.648 . . . . 0.0 109.43 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.439 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -71.73 -11.87 73.71 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.3 m 58.99 16.6 4.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.584 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.2 t -93.29 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.307 -0.871 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.1 m -148.71 116.45 6.29 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.024 -1.047 . . . . 0.0 110.265 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.43 131.42 37.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.37 -0.831 . . . . 0.0 108.938 179.373 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.537 HG21 ' OG ' ' A' ' 72' ' ' SER . 43.3 p -67.37 -48.48 67.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.055 -1.028 . . . . 0.0 109.51 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.68 140.82 3.0 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 71' ' ' GLU . 23.2 t70 -89.17 110.92 21.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.37 -1.076 . . . . 0.0 109.325 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -59.89 -171.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 109.44 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' O ' HG23 ' A' ' 63' ' ' THR . 95.5 mtt180 -145.12 7.98 1.2 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.255 -0.903 . . . . 0.0 109.537 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 62' ' ' ARG . 31.5 p -155.98 -35.95 0.08 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.238 -0.914 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.1 1.88 26.69 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -58.43 119.36 6.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.217 -1.166 . . . . 0.0 109.305 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 147.73 120.0 1.13 Allowed Glycine 0 N--CA 1.494 2.535 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -81.22 64.28 5.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -1.139 . . . . 0.0 109.463 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 176.59 -164.87 34.79 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.06 105.21 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.219 -1.165 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 9' ' ' LEU . 79.3 m-20 -58.51 -80.32 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.482 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 25' ' ' ALA . 41.4 mt-10 -86.95 155.12 20.32 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.2 -0.938 . . . . 0.0 109.221 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.537 ' OG ' HG21 ' A' ' 58' ' ' THR . 7.1 p -161.52 160.33 28.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.107 -0.995 . . . . 0.0 109.982 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -139.04 118.69 13.05 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.454 -0.779 . . . . 0.0 109.154 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 10.5 ttmm -96.2 109.82 22.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.362 -0.836 . . . . 0.0 109.582 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.4 mm -100.54 106.2 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.808 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -85.48 78.34 9.71 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -63.8 -14.54 53.7 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 -178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.92 -0.44 0.49 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.486 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -143.92 26.04 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.327 -0.858 . . . . 0.0 109.049 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.1 p -60.51 134.84 91.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.402 -0.811 . . . . 0.0 109.299 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.59 -172.67 1.37 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.84 1.694 . . . . 0.0 111.607 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.29 12.18 70.25 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' OD2' ' CZ ' ' A' ' 37' ' ' ARG . 1.1 m-20 -92.29 -60.9 1.72 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.274 -1.133 . . . . 0.0 109.81 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.6 p -85.15 148.97 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.27 -0.894 . . . . 0.0 109.984 -179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -134.65 -33.34 0.96 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.568 -0.708 . . . . 0.0 109.161 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.8 tttp -125.97 140.5 52.57 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.8 mt -129.67 153.85 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.356 -0.84 . . . . 0.0 109.938 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.45 ' CG2' ' OE2' ' A' ' 141' ' ' GLU . 10.8 pt -139.64 157.76 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.426 -0.796 . . . . 0.0 109.302 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 5.2 m-85 -135.1 141.27 45.98 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.472 -0.768 . . . . 0.0 109.306 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.73 157.85 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.365 -0.834 . . . . 0.0 109.86 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 91' ' ' VAL . 11.6 p -123.14 126.43 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.0 p -123.62 141.99 51.48 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.36 -0.837 . . . . 0.0 110.334 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.425 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.2 mm -74.05 133.44 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.472 -0.767 . . . . 0.0 108.983 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.404 ' O ' ' N ' ' A' ' 96' ' ' ALA . 14.5 t-80 -95.93 -56.65 2.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.125 -0.984 . . . . 0.0 109.822 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -48.68 -18.31 0.25 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.631 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.551 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -49.51 -52.92 26.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.295 -0.878 . . . . 0.0 109.61 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -56.25 -25.67 48.68 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.82 -1.175 . . . . 0.0 109.651 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.73 -53.95 4.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.101 -1.0 . . . . 0.0 111.137 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -112.15 -3.67 14.62 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.121 -0.987 . . . . 0.0 110.719 -178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.551 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.0 ttt180 55.19 95.21 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.037 -1.039 . . . . 0.0 109.206 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 105' ' ' GLN . 14.2 pt20 -158.84 152.53 23.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.35 -0.844 . . . . 0.0 109.401 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.5 m -101.59 157.39 16.86 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.333 -0.854 . . . . 0.0 109.43 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.71 -31.53 2.02 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.427 -0.795 . . . . 0.0 109.278 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -55.6 -37.78 69.02 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.42 ' OE1' ' OE1' ' A' ' 101' ' ' GLN . 16.6 tt0 -60.02 -13.07 9.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -1.134 . . . . 0.0 109.346 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 107' ' ' SER . 29.6 t -78.97 166.15 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.521 ' N ' HG12 ' A' ' 106' ' ' VAL . 19.0 m -67.85 -23.79 65.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.187 -0.946 . . . . 0.0 109.759 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 155.07 79.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.81 25.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.163 . . . . 0.0 109.21 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -157.1 137.25 12.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 0.0 110.738 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.38 146.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -141.93 158.27 43.97 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.922 -1.111 . . . . 0.0 110.038 -179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 114' ' ' VAL . 4.1 tt -143.16 117.24 9.47 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -0.835 . . . . 0.0 109.189 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.588 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.4 p -125.29 146.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.505 -0.747 . . . . 0.0 109.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.484 ' C ' ' N ' ' A' ' 117' ' ' ASP . 10.1 m120 -85.75 102.94 14.07 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -53.08 -10.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.943 . . . . 0.0 108.584 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.484 ' N ' ' C ' ' A' ' 115' ' ' ASN . 29.2 t70 -87.46 -50.94 6.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.585 -0.697 . . . . 0.0 109.871 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.474 ' ND2' ' O ' ' A' ' 1' ' ' SER . 2.1 m-20 -86.49 -18.16 32.33 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.202 -0.936 . . . . 0.0 109.885 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 60.35 51.17 5.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.878 . . . . 0.0 109.897 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.33 131.78 13.8 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.251 -0.906 . . . . 0.0 109.325 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -45.14 155.66 0.12 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.394 -0.816 . . . . 0.0 109.876 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 92.7 t -139.9 -33.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.308 -0.87 . . . . 0.0 110.138 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -154.97 158.46 39.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.667 -1.271 . . . . 0.0 110.413 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.574 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -156.79 123.0 4.92 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -104.05 147.84 26.93 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.352 -0.842 . . . . 0.0 109.493 -179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.99 103.32 11.79 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.582 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 58.4 mt -71.76 -26.08 62.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.192 -0.942 . . . . 0.0 109.653 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.0 m -47.39 -34.35 6.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 0.0 109.129 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -95.37 -43.77 7.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.483 -0.761 . . . . 0.0 109.521 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 133' ' ' THR . 17.2 m-20 -84.96 11.88 8.6 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.247 -0.908 . . . . 0.0 110.227 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -82.19 -48.73 10.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.097 -1.002 . . . . 0.0 110.076 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 9.7 t -57.63 3.06 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.481 -0.762 . . . . 0.0 110.718 -179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.629 HG22 ' O ' ' A' ' 130' ' ' ASP . 7.2 t -86.61 -34.52 19.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.769 -1.207 . . . . 0.0 110.659 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -175.27 -144.68 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.985 -1.072 . . . . 0.0 109.84 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.42 0.03 4.03 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -152.77 144.01 23.19 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.3 ptm -164.88 157.93 16.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.102 -0.999 . . . . 0.0 109.788 -179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 tt -85.99 121.14 28.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.363 -0.836 . . . . 0.0 109.205 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.58 -55.38 13.63 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.164 -0.96 . . . . 0.0 109.349 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -159.01 -166.32 17.77 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.17 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.45 ' OE2' ' CG2' ' A' ' 88' ' ' ILE . 22.0 tt0 -150.68 162.91 39.78 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.467 -1.019 . . . . 0.0 109.441 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.466 ' CD1' ' O ' ' A' ' 150' ' ' LYS . 4.9 tp -138.87 143.92 38.96 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.342 -0.849 . . . . 0.0 108.954 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -149.47 166.08 30.21 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.083 -1.011 . . . . 0.0 109.551 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.406 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 14.0 ptm180 -90.96 153.09 20.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.334 -0.854 . . . . 0.0 109.83 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -156.0 118.76 4.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.317 -0.865 . . . . 0.0 109.385 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.0 t30 54.08 31.86 14.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.188 -0.945 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.83 81.05 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -127.79 129.76 47.57 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.595 -0.944 . . . . 0.0 109.334 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -67.23 151.8 46.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.565 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' O ' ' CD1' ' A' ' 142' ' ' LEU . 38.9 mtpt -143.19 176.46 9.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -137.16 138.88 40.72 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.422 -0.799 . . . . 0.0 109.64 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -139.68 115.83 10.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.456 -0.777 . . . . 0.0 108.986 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.96 154.35 38.16 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 109.71 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 12.2 t -146.44 -35.87 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.291 -0.881 . . . . 0.0 109.158 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.05 79.15 0.08 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 38.7 tt0 -106.01 104.44 14.14 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.655 -0.909 . . . . 0.0 109.324 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -83.01 136.7 15.51 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.51 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 1.3 p90 -150.44 147.54 27.66 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -1.14 . . . . 0.0 109.307 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.74 17.45 20.63 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.361 -0.837 . . . . 0.0 109.344 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.85 0.01 OUTLIER Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -160.56 142.61 8.28 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.694 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -47.35 -28.57 2.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -1.157 . . . . 0.0 109.889 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.64 -27.52 25.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.229 -0.92 . . . . 0.0 109.581 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 13.3 t -79.51 -53.53 6.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.47 HG11 ' CE1' ' A' ' 158' ' ' TYR . 27.7 m -53.46 -20.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.182 -0.949 . . . . 0.0 109.735 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.449 ' SG ' ' CD1' ' A' ' 28' ' ' PHE . 49.5 t -80.31 -56.46 4.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.131 -0.981 . . . . 0.0 110.029 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.52 -15.09 55.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.273 -0.892 . . . . 0.0 109.966 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -74.42 -30.05 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.072 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -71.96 -19.82 61.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.964 . . . . 0.0 109.213 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -86.09 -40.93 7.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 88.7 mt -75.55 142.5 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -1.166 . . . . 0.0 109.446 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.475 HD22 ' N ' ' A' ' 172' ' ' ASN . 1.4 m-80 -77.6 107.48 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 15.76 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.485 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 21.4 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.455 179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.305 0.574 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 62.9 mtt -49.5 101.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.222 -0.924 . . . . 0.0 109.495 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.25 -17.71 60.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 0.0 109.496 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.517 HD22 ' CB ' ' A' ' 117' ' ' ASP . 13.5 m-80 -146.17 149.52 34.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.264 -0.897 . . . . 0.0 109.487 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 77' ' ' LEU . 54.5 t -134.7 150.77 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.501 -0.75 . . . . 0.0 109.104 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD11 ' OG ' ' A' ' 72' ' ' SER . 58.0 tp -149.01 116.62 6.21 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.283 -0.886 . . . . 0.0 109.584 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 t -86.3 151.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.354 -0.841 . . . . 0.0 109.025 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -137.14 117.41 1.53 Allowed Glycine 0 N--CA 1.496 2.691 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 tp -125.45 133.14 52.54 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -154.24 153.58 24.92 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.919 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.527 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.2 p90 -159.42 153.67 23.75 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.396 -1.061 . . . . 0.0 109.721 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -80.29 129.88 34.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.502 -0.749 . . . . 0.0 109.823 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.09 156.04 16.48 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.406 -0.809 . . . . 0.0 109.428 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 92.5 mtt180 -132.86 106.81 7.93 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.421 -0.8 . . . . 0.0 109.223 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -95.83 129.9 42.93 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.226 -0.921 . . . . 0.0 109.438 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.5 p -152.82 -81.61 0.09 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.339 -0.851 . . . . 0.0 108.98 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -84.6 25.12 0.93 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.297 -0.877 . . . . 0.0 109.125 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.4 -3.59 86.95 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -82.96 168.71 16.76 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -1.104 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -176.22 157.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -0.908 . . . . 0.0 109.427 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -96.33 141.58 29.48 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -141.14 99.76 3.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.287 -0.883 . . . . 0.0 109.692 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.32 163.35 20.7 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -130.92 119.34 21.99 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.409 -0.807 . . . . 0.0 109.723 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.39 136.83 37.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.388 -0.82 . . . . 0.0 109.105 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.1 t -149.37 167.78 25.2 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.221 -0.925 . . . . 0.0 109.418 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.85 135.78 43.97 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.463 -0.773 . . . . 0.0 109.366 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -113.19 134.33 54.63 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.488 -0.758 . . . . 0.0 109.323 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.693 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.2 mp -81.46 156.07 25.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.451 -0.781 . . . . 0.0 109.548 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.69 131.73 18.24 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.179 -0.95 . . . . 0.0 108.887 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.473 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -85.73 171.42 11.62 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.036 -1.04 . . . . 0.0 109.593 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.8 -4.63 59.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.0 109.291 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.35 -7.91 53.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -0.911 . . . . 0.0 109.4 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.56 -4.55 50.76 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.404 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.7 mttm -144.38 142.54 30.42 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.504 -0.998 . . . . 0.0 108.626 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' C ' ' H ' ' A' ' 38' ' ' GLY . 11.3 p -66.14 143.28 15.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.055 -1.028 . . . . 0.0 109.636 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -63.3 1.47 0.5 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.553 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.9 99.09 0.19 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.489 ' C ' ' H ' ' A' ' 41' ' ' ASP . 23.6 p-10 -48.72 -32.22 8.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.169 -1.195 . . . . 0.0 109.326 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -55.77 -4.37 0.11 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.714 -0.616 . . . . 0.0 109.706 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.556 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.3 m-20 -91.34 26.78 2.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.135 -0.978 . . . . 0.0 108.63 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -90.65 133.4 35.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -0.766 . . . . 0.0 109.553 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.0 tp -77.19 134.23 29.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.649 0.738 . . . . 0.0 109.536 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.488 ' C ' ' H ' ' A' ' 46' ' ' ASN . 10.7 t80 -166.4 -150.5 0.12 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 0.0 OUTLIER -59.61 0.3 0.14 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.382 -0.824 . . . . 0.0 110.204 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' H ' ' C ' ' A' ' 44' ' ' PHE . 30.2 t-20 -86.73 -24.76 25.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.203 -0.935 . . . . 0.0 109.555 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 46' ' ' ASN . 74.3 m-20 -157.15 114.55 3.1 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.226 -0.921 . . . . 0.0 109.546 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.03 -5.41 38.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.203 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.561 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -162.03 136.04 6.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.374 -0.829 . . . . 0.0 109.719 179.868 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.0 t -85.9 139.15 31.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.107 -0.996 . . . . 0.0 109.4 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.87 -39.77 29.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.282 -0.887 . . . . 0.0 109.523 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -116.17 -6.71 11.88 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.542 -0.724 . . . . 0.0 109.659 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.436 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -87.09 -11.12 70.39 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 79' ' ' ALA . 4.2 m 56.78 15.44 2.22 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -1.167 . . . . 0.0 109.352 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.4 t -93.15 148.35 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.293 -0.879 . . . . 0.0 109.089 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -146.3 124.94 12.5 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.082 -1.011 . . . . 0.0 109.849 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.7 t-80 -92.83 128.94 38.87 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.387 -0.821 . . . . 0.0 109.188 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.3 m -60.93 -49.96 75.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.18 137.65 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -83.31 117.71 23.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.248 -1.148 . . . . 0.0 109.451 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.502 ' N ' ' OE2' ' A' ' 71' ' ' GLU . 9.0 m120 -79.43 131.75 36.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.4 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -84.53 -0.96 55.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.411 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.527 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 23.7 p -150.28 -32.95 0.18 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.206 -0.933 . . . . 0.0 109.703 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.28 14.96 36.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -58.25 110.37 0.94 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.398 -1.06 . . . . 0.0 109.379 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 158.74 127.05 0.9 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -80.26 70.85 6.99 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -1.134 . . . . 0.0 109.507 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.54 -173.54 36.31 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -50.0 100.82 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -1.162 . . . . 0.0 109.44 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -65.33 -65.15 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.239 -0.913 . . . . 0.0 109.499 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.502 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 91.3 mt-10 -97.24 169.49 9.74 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.195 -0.94 . . . . 0.0 109.382 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.576 ' OG ' HD11 ' A' ' 6' ' ' LEU . 2.6 t -172.4 170.92 4.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.225 -0.922 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -149.14 120.18 7.71 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.241 -0.912 . . . . 0.0 109.068 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -96.53 133.7 40.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.287 -0.883 . . . . 0.0 109.139 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 75' ' ' ILE . 3.4 mp -135.59 107.15 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 121.481 -0.762 . . . . 0.0 110.11 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -88.76 86.79 7.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 0.0 108.659 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.77 ' H ' HD12 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -59.97 -18.04 42.63 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.277 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -59.9 -3.2 0.5 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.918 . . . . 0.0 109.068 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.483 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -133.31 24.37 4.14 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.436 ' O ' HG13 ' A' ' 80' ' ' VAL . 12.6 p -60.23 135.36 91.02 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.17 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.85 168.86 23.52 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 121.798 1.665 . . . . 0.0 111.883 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 83' ' ' ASP . . . -85.04 44.94 3.44 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 82' ' ' GLY . 79.4 m-20 -138.98 2.41 2.13 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.341 -1.094 . . . . 0.0 109.592 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 t -136.75 148.71 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.288 -0.882 . . . . 0.0 109.253 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.408 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 21.1 m-20 -132.4 -6.66 3.34 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.524 -0.735 . . . . 0.0 109.586 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -152.94 158.8 42.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.125 -0.984 . . . . 0.0 108.98 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.1 mt -142.43 153.82 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.234 -0.916 . . . . 0.0 109.052 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.6 pt -142.04 152.02 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.331 -0.855 . . . . 0.0 109.599 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.08 131.37 45.74 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.67 146.4 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 109.882 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.6 p -105.03 144.43 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.569 -0.901 . . . . 0.0 108.569 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.4 p -138.3 139.78 39.28 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.322 -0.861 . . . . 0.0 109.822 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.459 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.1 mm -74.39 145.68 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.387 -0.821 . . . . 0.0 109.077 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.468 ' O ' ' N ' ' A' ' 96' ' ' ALA . 86.2 t60 -98.69 -66.29 0.91 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.248 -0.907 . . . . 0.0 109.797 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -46.67 -17.87 0.05 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.0 109.558 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' HIS . . . -58.01 -18.17 22.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.434 -0.791 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -70.73 -61.98 1.56 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.937 -1.102 . . . . 0.0 109.659 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.82 -42.34 10.7 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.3 -0.875 . . . . 0.0 111.056 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.6 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -83.28 -19.12 36.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.052 -1.03 . . . . 0.0 110.782 -178.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 99' ' ' ARG . 52.4 ttt180 54.8 98.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.798 -1.189 . . . . 0.0 109.374 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.513 ' NE2' ' OE1' ' A' ' 105' ' ' GLN . 4.3 pt20 -165.93 147.36 6.93 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.253 -0.904 . . . . 0.0 109.483 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.6 m -100.38 158.5 15.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.338 -0.851 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.623 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.34 -30.03 1.2 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.407 -0.808 . . . . 0.0 109.592 -179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.94 -41.01 75.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.513 ' OE1' ' NE2' ' A' ' 101' ' ' GLN . 27.3 tt0 -51.05 -15.53 0.33 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.224 -1.162 . . . . 0.0 109.219 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 107' ' ' SER . 36.1 t -81.76 169.71 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.3 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.8 t -72.21 -21.65 61.38 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.986 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.43 81.37 0.03 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.72 164.82 25.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -1.149 . . . . 0.0 109.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 44.8 p90 -149.71 130.19 13.91 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.05 -1.031 . . . . 0.0 110.561 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.38 145.2 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.492 HH21 ' CD ' ' A' ' 121' ' ' GLU . 57.3 ttt180 -144.49 152.58 40.81 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.024 -1.047 . . . . 0.0 110.056 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 59.4 tp -138.93 135.78 34.77 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.422 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -146.74 152.84 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.112 -0.992 . . . . 0.0 109.563 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.453 ' C ' ' H ' ' A' ' 117' ' ' ASP . 7.0 m120 -89.77 102.62 15.31 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 12.7 p-10 -62.38 -3.62 1.47 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.114 -0.991 . . . . 0.0 108.34 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.517 ' CB ' HD22 ' A' ' 4' ' ' ASN . 15.6 t0 -72.09 -52.31 17.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.305 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -121.96 9.45 9.99 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.687 -0.633 . . . . 0.0 109.296 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 57.71 42.8 23.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.325 -0.86 . . . . 0.0 109.613 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.0 p -101.14 100.82 11.43 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.402 -0.811 . . . . 0.0 109.142 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.492 ' CD ' HH21 ' A' ' 112' ' ' ARG . 43.5 tt0 -46.53 135.36 8.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.204 -0.935 . . . . 0.0 109.754 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 79.1 t -96.63 -62.19 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.321 -0.862 . . . . 0.0 109.539 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.94 174.8 2.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.962 -1.086 . . . . 0.0 110.182 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -145.75 131.08 18.57 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.742 . . . . 0.0 109.023 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -92.07 146.68 23.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.23 -0.919 . . . . 0.0 109.261 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -103.73 104.7 14.76 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.337 -0.852 . . . . 0.0 109.187 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 131' ' ' ALA . 33.1 mt -73.06 -33.35 65.62 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.197 -0.939 . . . . 0.0 109.515 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 128' ' ' THR . 2.3 p -46.09 -31.42 2.34 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.987 -1.07 . . . . 0.0 109.173 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -95.52 -44.7 7.39 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.551 -0.718 . . . . 0.0 109.62 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.442 ' O ' ' OG1' ' A' ' 133' ' ' THR . 2.7 m-20 -89.99 16.37 8.41 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.269 -0.894 . . . . 0.0 110.156 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -85.6 -49.09 8.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.995 -1.065 . . . . 0.0 109.95 -179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.9 t -60.69 3.0 0.09 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.438 -0.789 . . . . 0.0 110.142 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.498 ' H ' ' C ' ' A' ' 131' ' ' ALA . 16.7 p -93.25 -32.49 14.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.006 -1.058 . . . . 0.0 110.662 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.51 ' CD ' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.48 -150.16 0.08 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.633 -1.292 . . . . 0.0 110.427 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.525 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -127.42 -32.06 2.46 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.26 152.11 38.24 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 23.7 ttt -164.39 157.7 17.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.142 -0.974 . . . . 0.0 109.568 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.0 tt -95.13 125.17 39.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.576 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -71.83 -54.4 10.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.905 . . . . 0.0 109.309 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.61 -166.18 26.26 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -151.34 166.68 30.23 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.347 -1.09 . . . . 0.0 110.003 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 mt -135.69 137.02 41.37 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -138.21 162.53 34.04 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.3 mtp180 -89.67 149.17 22.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.368 -0.833 . . . . 0.0 110.107 -179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.403 ' CD2' ' OD1' ' A' ' 146' ' ' ASN . 60.0 t60 -151.82 122.88 7.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.392 -0.817 . . . . 0.0 109.231 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' OD1' ' CD2' ' A' ' 145' ' ' HIS . 9.9 m120 51.62 26.06 3.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.77 16.54 70.14 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -127.93 131.68 49.33 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.48 -1.012 . . . . 0.0 109.328 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -73.0 143.65 47.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -143.75 140.9 30.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.345 -0.847 . . . . 0.0 109.081 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 15.4 t80 -89.8 154.66 19.73 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.448 -0.782 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.526 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 48.7 mtp180 -145.99 130.27 17.6 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -82.47 148.08 28.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.085 -1.009 . . . . 0.0 109.737 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.73 -36.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -0.895 . . . . 0.0 109.127 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 47.51 77.85 0.1 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -100.02 104.17 15.75 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.538 -0.978 . . . . 0.0 109.347 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -90.49 132.82 11.47 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.49 128.3 11.7 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -1.212 . . . . 0.0 109.497 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -89.89 20.83 3.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.261 -0.9 . . . . 0.0 109.341 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.27 -120.05 0.01 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . -158.49 147.32 14.88 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.7 pp -58.21 -13.4 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.583 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -77.8 -60.11 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.218 -0.926 . . . . 0.0 109.649 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 39.2 m -72.28 -42.64 65.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.203 -0.935 . . . . 0.0 109.645 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.526 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 73.8 t -48.16 -20.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -0.899 . . . . 0.0 109.596 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.416 ' SG ' ' OD2' ' A' ' 39' ' ' ASP . 12.9 t -79.63 -59.82 2.59 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.783 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -77.4 -15.32 59.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.349 -0.845 . . . . 0.0 109.568 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -63.83 -22.68 67.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.895 . . . . 0.0 109.387 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.526 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 50.0 m-85 -71.49 -19.68 62.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 109.376 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.77 -42.13 7.38 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 91.0 mt -76.94 112.82 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -1.155 . . . . 0.0 109.438 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.4 107.29 12.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.442 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.52 162.98 24.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.452 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.483 179.999 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.434 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 24.4 mmt -55.17 141.13 36.16 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.25 -0.906 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -128.35 -18.42 4.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.554 -0.716 . . . . 0.0 109.598 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -146.67 128.37 15.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.183 -0.948 . . . . 0.0 109.444 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -110.29 154.5 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.2 tt -148.63 112.29 5.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.287 -0.883 . . . . 0.0 109.591 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.504 ' N ' HD23 ' A' ' 6' ' ' LEU . 5.1 t -86.13 151.44 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.311 -0.868 . . . . 0.0 108.727 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 112' ' ' ARG . . . -136.77 135.89 7.99 Favored Glycine 0 N--CA 1.497 2.753 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.6 tp -139.83 132.46 28.84 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.6 154.16 25.34 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.259 -1.448 . . . . 0.0 110.085 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 40.5 p90 -161.31 154.02 20.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.423 -1.045 . . . . 0.0 109.782 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -81.78 122.64 27.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.495 -0.753 . . . . 0.0 109.76 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -91.84 146.38 23.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.319 -0.863 . . . . 0.0 109.373 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -132.99 106.79 7.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.407 -0.808 . . . . 0.0 109.323 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.9 m -98.04 105.89 18.1 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.279 -0.888 . . . . 0.0 109.451 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.3 p -82.31 -59.83 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.235 -0.915 . . . . 0.0 109.4 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 20.0 p-10 -158.35 18.19 0.22 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.241 -0.912 . . . . 0.0 109.354 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 156.29 -23.85 0.52 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.472 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 4.4 mp0 -81.02 159.41 24.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -1.157 . . . . 0.0 109.531 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -174.7 149.31 1.21 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.316 -0.865 . . . . 0.0 109.397 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' O ' ' O ' ' A' ' 63' ' ' THR . 60.3 m-85 -96.28 134.68 39.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -141.34 116.26 9.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.306 -0.871 . . . . 0.0 109.808 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.548 ' CD2' HD13 ' A' ' 93' ' ' ILE . 50.0 mt -103.55 163.53 12.24 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -131.21 112.05 12.47 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -0.807 . . . . 0.0 109.718 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' N ' ' OH ' ' A' ' 45' ' ' TYR . . . -98.41 136.5 38.47 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.317 -0.865 . . . . 0.0 109.218 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 61.7 m -149.42 167.7 25.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.18 -0.95 . . . . 0.0 109.727 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -128.3 138.56 52.45 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -115.59 128.38 55.91 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.7 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -72.54 156.6 38.84 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.39 -0.819 . . . . 0.0 109.085 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.18 129.09 15.37 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.929 -1.107 . . . . 0.0 109.014 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -85.73 172.62 10.69 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.034 -1.041 . . . . 0.0 109.605 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.98 -9.99 57.49 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.192 -0.942 . . . . 0.0 109.38 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -69.73 -6.17 30.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.169 -0.957 . . . . 0.0 109.353 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.8 -4.71 53.39 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 108.679 -1.768 . . . . 0.0 108.679 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 40.4 mttm -134.54 175.17 9.77 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 29' ' ' LEU . 4.8 t -90.54 137.55 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.0 -1.062 . . . . 0.0 109.182 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.534 HH11 ' CB ' ' A' ' 83' ' ' ASP . 11.2 ptm180 -60.46 -4.85 0.98 Allowed 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.34 84.86 0.06 OUTLIER Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.782 -1.727 . . . . 0.0 108.782 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -46.59 -42.12 15.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.365 -1.079 . . . . 0.0 109.629 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -64.09 6.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.661 -0.649 . . . . 0.0 109.72 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.543 ' O ' HD13 ' A' ' 29' ' ' LEU . 11.5 m-20 -92.62 23.68 3.93 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 109.382 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.8 p90 -91.12 121.22 32.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.511 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.8 mp -82.89 139.59 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.765 . . . . 0.0 109.36 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.629 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 5.6 p90 -169.84 100.44 0.31 Allowed 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.901 0.858 . . . . 0.0 110.369 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.53 ' O ' ' N ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER 59.6 -71.52 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.351 -0.843 . . . . 0.0 110.719 178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.561 ' N ' ' O ' ' A' ' 44' ' ' PHE . 44.3 m-20 -47.35 -12.14 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.273 -0.892 . . . . 0.0 110.053 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.53 ' N ' ' O ' ' A' ' 45' ' ' TYR . 50.5 m-20 -138.12 108.01 6.32 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.353 -0.842 . . . . 0.0 109.167 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.87 -28.52 50.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.27 -0.894 . . . . 0.0 109.32 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.9 pttm -166.39 154.27 10.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.224 -0.922 . . . . 0.0 109.702 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -68.45 157.53 35.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.336 -0.853 . . . . 0.0 109.525 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.2 -48.39 12.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.22 -0.925 . . . . 0.0 109.353 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -116.04 -5.24 11.95 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.692 -0.63 . . . . 0.0 109.365 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.35 -12.78 83.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 m 57.48 18.61 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -1.138 . . . . 0.0 109.576 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.4 t -92.96 151.45 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 108.833 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.1 p -140.09 128.32 22.48 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.319 -0.863 . . . . 0.0 109.65 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -92.91 138.74 31.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.0 109.186 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 m -68.81 -58.13 4.62 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 179.32 177.86 47.98 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -126.27 110.9 13.93 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.606 -0.938 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.31 125.1 29.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.263 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.59 ' CG ' HH11 ' A' ' 62' ' ' ARG . 2.5 mtt-85 -81.88 3.99 24.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -0.92 . . . . 0.0 109.579 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.2 p -153.49 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.227 -0.921 . . . . 0.0 109.455 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 7.36 37.94 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.83 110.4 1.01 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.368 -1.078 . . . . 0.0 109.451 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 158.89 110.97 0.29 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.437 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 5.8 m-20 -69.0 66.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -1.163 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 176.23 -148.45 9.19 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 9.8 t70 -74.59 118.63 17.76 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.239 -1.153 . . . . 0.0 109.469 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -80.53 -40.37 26.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.415 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 77.8 mt-10 -141.82 149.15 39.97 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.4 m -157.28 175.12 14.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 109.4 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -148.99 119.4 7.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.252 -0.905 . . . . 0.0 109.115 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -96.96 143.03 28.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.332 -0.855 . . . . 0.0 109.239 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.83 140.1 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -109.95 100.98 9.85 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.444 HD13 ' CD1' ' A' ' 149' ' ' TRP . 50.7 mt -61.01 -51.1 70.65 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.192 -0.943 . . . . 0.0 109.99 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -50.66 -14.05 0.17 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 0.0 109.751 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.418 ' N ' ' C ' ' A' ' 77' ' ' LEU . . . -99.67 -23.3 15.08 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.261 -0.9 . . . . 0.0 109.913 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -60.78 126.81 86.22 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 0.0 109.123 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 -166.74 0.41 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 121.892 1.728 . . . . 0.0 112.105 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.7 0.04 79.41 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' CB ' HH11 ' A' ' 37' ' ' ARG . 11.3 m-20 -69.37 -60.03 2.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -1.221 . . . . 0.0 109.208 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 50.8 t -76.33 149.02 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.841 . . . . 0.0 109.089 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.0 OUTLIER -133.42 -4.2 2.99 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.448 -0.783 . . . . 0.0 109.521 -179.828 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -158.18 131.03 7.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.049 -1.032 . . . . 0.0 109.013 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.8 mt -120.75 154.09 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.4 pt -141.4 152.01 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.188 -0.945 . . . . 0.0 109.952 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -127.74 130.51 48.9 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.74 157.57 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.232 -0.917 . . . . 0.0 110.125 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 89.4 t -111.88 154.67 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.4 p -145.4 141.16 28.19 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.156 -0.965 . . . . 0.0 109.764 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.719 HD11 ' N ' ' A' ' 103' ' ' PHE . 5.1 mm -74.27 129.35 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.607 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.4 t60 -64.71 -126.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.81 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.607 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.2 m-20 -72.7 -19.29 61.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 109.923 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.615 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -51.68 -19.32 1.53 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.077 -1.014 . . . . 0.0 108.921 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -70.22 -49.33 51.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.268 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.563 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -58.39 -48.14 81.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.563 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.9 mpt_? -73.74 14.23 0.4 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.101 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.453 ' H ' ' C ' ' A' ' 98' ' ' ALA . 8.9 tpm_? 54.57 79.2 0.15 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.827 . . . . 0.0 109.446 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 22.8 mt-30 -154.14 77.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.54 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 104' ' ' GLY . 75.5 p -56.86 164.49 1.53 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.386 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.719 ' N ' HD11 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -46.58 -18.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.245 -0.91 . . . . 0.0 109.495 -179.661 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.474 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -65.07 -45.56 91.58 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 59.3 tp60 -47.65 -18.63 0.15 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.22 -1.165 . . . . 0.0 109.401 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.55 HG12 ' N ' ' A' ' 107' ' ' SER . 22.9 t -75.73 169.46 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.308 -0.87 . . . . 0.0 109.455 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.55 ' N ' HG12 ' A' ' 106' ' ' VAL . 3.0 t -71.6 -21.78 61.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.953 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 153.36 80.96 0.03 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.62 164.53 26.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -1.122 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -152.17 141.18 21.19 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.036 -1.04 . . . . 0.0 110.341 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.4 mt -110.6 144.56 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 8' ' ' GLY . 35.8 ttp180 -149.18 147.06 27.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.056 -1.027 . . . . 0.0 109.459 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.2 tt -137.17 142.92 42.18 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -0.852 . . . . 0.0 108.938 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.536 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -144.5 159.54 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.308 -0.87 . . . . 0.0 109.617 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.536 ' N ' HG22 ' A' ' 114' ' ' VAL . 35.4 m120 -94.23 102.87 14.91 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -57.48 -6.39 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 0.0 108.815 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 22.6 t0 -78.49 -46.51 19.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.502 -0.749 . . . . 0.0 109.696 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -121.61 3.78 10.13 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.579 -0.701 . . . . 0.0 109.509 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' N ' ' O ' ' A' ' 115' ' ' ASN . 43.3 mt-30 53.95 41.49 32.02 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.224 -0.923 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.9 p -99.87 107.69 19.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.389 -0.819 . . . . 0.0 109.301 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.562 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.9 mp0 -46.52 116.05 1.2 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.6 t -78.12 -60.88 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.193 -0.942 . . . . 0.0 109.629 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.47 174.79 2.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.844 -1.16 . . . . 0.0 110.445 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -146.57 129.11 16.01 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.56 -0.713 . . . . 0.0 109.083 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -91.47 146.32 23.9 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.289 -0.882 . . . . 0.0 109.415 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -96.38 112.79 24.41 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.198 -0.939 . . . . 0.0 109.351 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.568 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 47.8 mt -84.36 -41.15 17.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 0.0 109.657 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.2 m -47.82 -29.5 3.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.966 -1.084 . . . . 0.0 109.398 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -95.38 -49.31 5.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.412 -0.805 . . . . 0.0 110.017 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.21 -1.13 43.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.964 . . . . 0.0 110.314 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -64.97 -53.27 48.96 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.101 -0.999 . . . . 0.0 110.328 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 60.0 p -55.93 2.62 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.425 -0.797 . . . . 0.0 110.684 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.536 ' H ' ' C ' ' A' ' 131' ' ' ALA . 27.9 p -91.7 -32.6 15.37 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.73 -1.231 . . . . 0.0 110.46 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.439 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 5.8 tt0 -171.03 -142.94 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.705 -1.247 . . . . 0.0 110.403 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 1.1 p -138.53 -35.38 0.6 Allowed 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.59 145.58 43.28 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.0 ttm -164.71 157.93 17.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.954 -1.091 . . . . 0.0 109.856 -179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -94.56 125.58 39.29 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.376 -0.827 . . . . 0.0 109.548 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -71.66 -54.78 9.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.388 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.89 -165.7 16.49 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.473 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 24.3 tt0 -151.19 165.3 34.35 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.372 -1.075 . . . . 0.0 109.671 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.473 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 10.5 tp -141.07 132.33 26.55 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -139.34 165.84 26.12 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.105 -0.997 . . . . 0.0 109.993 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -96.67 141.92 29.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.341 -0.849 . . . . 0.0 110.479 -179.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.63 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.1 p80 -129.18 -104.64 0.3 Allowed 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.63 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 59.2 t-20 -72.14 58.66 0.37 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.184 -0.947 . . . . 0.0 109.627 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 66.17 8.84 45.7 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.536 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 60.1 mm-40 -128.01 170.87 12.39 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.504 -0.997 . . . . 0.0 108.825 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.444 ' CD1' HD13 ' A' ' 77' ' ' LEU . 96.8 m95 -92.92 151.94 19.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.183 -0.948 . . . . 0.0 110.092 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -142.28 130.83 22.53 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.444 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 18.5 t80 -89.62 148.11 23.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.437 -0.789 . . . . 0.0 109.726 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.409 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -150.16 113.44 4.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.385 -0.822 . . . . 0.0 109.262 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -66.8 154.53 40.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.0 109.653 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.6 -35.53 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.367 -0.833 . . . . 0.0 109.238 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 54.2 80.91 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -111.01 110.36 20.88 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.708 -0.878 . . . . 0.0 109.43 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.79 136.28 13.19 Favored Glycine 0 N--CA 1.496 2.645 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.439 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 5.0 p90 -150.79 118.22 6.05 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.199 -1.177 . . . . 0.0 109.35 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -77.71 23.93 0.23 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -0.897 . . . . 0.0 109.593 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . -60.79 -113.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -178.49 141.16 4.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.645 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.1 pt? -47.36 -13.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.916 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -81.41 -58.8 2.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.173 -0.955 . . . . 0.0 109.472 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.4 ' C ' ' N ' ' A' ' 166' ' ' CYS . 49.6 m -73.86 -40.3 63.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.244 -0.91 . . . . 0.0 109.45 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.497 HG23 ' H ' ' A' ' 161' ' ' GLY . 69.4 t -48.23 -20.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.0 109.587 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.589 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 19.6 t -78.17 -59.58 2.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.853 . . . . 0.0 110.313 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.45 -31.07 26.78 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.269 -0.895 . . . . 0.0 110.159 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -51.51 -35.01 38.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.302 -0.874 . . . . 0.0 109.761 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.13 -19.73 61.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 108.996 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.73 -24.62 41.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.38 141.88 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.164 -1.197 . . . . 0.0 109.355 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.495 ' H ' ' NZ ' ' A' ' 35' ' ' LYS . 41.3 t30 -74.29 116.15 14.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.506 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.46 166.59 21.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.239 -0.913 . . . . 0.0 109.374 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.483 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 p . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -84.73 95.48 8.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.239 -0.913 . . . . 0.0 109.433 179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.426 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 67.9 mttm -84.11 -15.99 45.27 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -0.884 . . . . 0.0 109.275 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.426 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 28.0 m-20 -145.77 128.35 16.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.349 -0.844 . . . . 0.0 109.203 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' CG1' HD11 ' A' ' 113' ' ' LEU . 70.1 t -126.35 155.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.604 -0.685 . . . . 0.0 109.433 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 5' ' ' VAL . 44.8 tp -148.48 117.69 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.424 -0.797 . . . . 0.0 109.087 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.06 151.24 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 108.948 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.99 117.15 2.0 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.6 tp -121.24 127.95 51.93 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.01 157.41 27.3 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.288 -1.434 . . . . 0.0 109.937 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.522 ' NE1' ' O ' ' A' ' 63' ' ' THR . 40.6 p90 -158.99 154.23 25.45 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.489 -1.006 . . . . 0.0 109.59 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.35 124.01 26.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.797 . . . . 0.0 109.682 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -89.7 170.94 10.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.413 -0.804 . . . . 0.0 109.482 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.615 ' NH1' HE21 ' A' ' 19' ' ' GLN . 83.8 mtt180 -131.32 161.18 32.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.457 -0.777 . . . . 0.0 109.141 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.0 m -85.75 166.53 16.03 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.244 -0.91 . . . . 0.0 109.219 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 18' ' ' GLY . 12.8 t -47.68 -26.35 1.5 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.558 -0.714 . . . . 0.0 109.557 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.88 -0.28 0.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 16' ' ' THR . . . -157.51 151.93 23.19 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.615 HE21 ' NH1' ' A' ' 14' ' ' ARG . 5.1 pm0 -46.77 147.03 1.38 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.267 -1.137 . . . . 0.0 109.716 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 3.6 m-20 -93.17 -176.2 4.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.506 ' CD1' ' O ' ' A' ' 20' ' ' ASP . 66.0 m-85 -153.74 134.48 13.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.343 -0.848 . . . . 0.0 109.208 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -141.24 99.6 3.61 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 0.0 110.069 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.43 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.4 mp -86.2 129.83 34.72 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -100.18 131.13 46.3 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.189 -0.945 . . . . 0.0 110.367 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.484 ' O ' ' CE1' ' A' ' 44' ' ' PHE . . . -98.45 148.52 23.63 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.518 ' OG ' ' CE2' ' A' ' 44' ' ' PHE . 3.7 m -149.9 167.84 25.47 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.98 -1.075 . . . . 0.0 110.005 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -147.68 134.19 19.76 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.4 -0.812 . . . . 0.0 108.943 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -118.79 137.14 53.59 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.462 -0.774 . . . . 0.0 110.0 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.708 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -82.95 152.37 25.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 56.1 tp -147.04 130.12 16.4 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.954 -1.091 . . . . 0.0 109.614 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.07 171.54 12.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.121 -0.987 . . . . 0.0 109.673 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.405 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.85 -6.6 59.35 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.269 -0.894 . . . . 0.0 109.294 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -71.27 -7.58 47.91 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 109.214 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.14 -2.23 54.8 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.5 mttp -145.57 140.15 27.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.424 -1.045 . . . . 0.0 108.867 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.556 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.2 p -66.06 144.52 14.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.105 -0.997 . . . . 0.0 109.489 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -65.25 3.83 0.58 Allowed 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 152.63 100.76 0.2 Allowed Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.528 ' C ' ' H ' ' A' ' 41' ' ' ASP . 3.7 p30 -52.87 -36.29 58.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -1.209 . . . . 0.0 109.127 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.09 -1.7 0.05 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.696 -0.628 . . . . 0.0 109.723 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' O ' HD13 ' A' ' 29' ' ' LEU . 14.0 m-20 -91.11 29.95 1.31 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.518 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.2 p90 -88.25 137.96 31.86 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.787 0.804 . . . . 0.0 109.535 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 28.6 mm -91.82 140.94 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.738 0.78 . . . . 0.0 109.866 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.518 ' CE2' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -157.58 -157.43 0.66 Allowed 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' C ' ' H ' ' A' ' 47' ' ' ASN . 50.4 p90 -67.84 -29.77 69.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.337 -0.852 . . . . 0.0 109.5 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -59.37 -3.25 0.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.22 -0.925 . . . . 0.0 109.466 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.465 ' H ' ' C ' ' A' ' 45' ' ' TYR . 44.7 t-20 -153.16 114.31 4.16 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.298 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 26.9 tp -53.08 -38.37 62.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -164.18 154.5 14.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.684 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 m -67.28 163.27 20.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.02 -48.72 8.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.177 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -116.42 -0.39 12.54 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -81.38 -12.74 81.65 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.7 p 58.08 14.46 2.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.202 -1.175 . . . . 0.0 109.467 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.1 t -93.11 146.67 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.295 -0.878 . . . . 0.0 108.938 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -145.05 120.71 10.47 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.08 -1.013 . . . . 0.0 110.187 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.8 OUTLIER -92.58 130.36 38.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.419 -0.8 . . . . 0.0 109.092 179.467 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.4 p -62.93 -51.89 65.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 149.33 5.47 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -91.69 120.14 32.17 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.305 -1.114 . . . . 0.0 109.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.415 ' HB3' ' H ' ' A' ' 64' ' ' GLY . 4.6 m120 -81.06 136.29 35.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 109.426 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -83.64 -11.11 57.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.522 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 17.9 p -140.47 -29.69 0.68 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.318 -0.863 . . . . 0.0 109.835 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.415 ' H ' ' HB3' ' A' ' 61' ' ' ASN . . . 89.08 16.11 58.18 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -58.37 110.24 0.93 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -1.071 . . . . 0.0 109.327 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 155.94 129.35 1.18 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -80.31 79.73 6.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.297 -1.119 . . . . 0.0 109.497 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.92 179.53 33.82 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -49.95 112.28 0.64 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -1.139 . . . . 0.0 109.375 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -71.62 -66.1 0.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.5 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -101.52 160.67 14.24 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.373 -0.829 . . . . 0.0 109.118 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.515 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 33.2 m -162.34 166.99 24.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.147 -0.97 . . . . 0.0 109.709 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -141.42 119.02 11.62 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.312 -0.868 . . . . 0.0 109.103 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.45 ' HZ1' ' CG ' ' A' ' 116' ' ' ASP . 37.7 tttp -96.59 132.12 42.53 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.415 -0.803 . . . . 0.0 109.165 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.11 118.97 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.464 -0.773 . . . . 0.0 109.871 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.49 ' C ' ' H ' ' A' ' 78' ' ' ASP . 57.5 tttm -88.32 82.25 7.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 80' ' ' VAL . 3.4 mt -55.03 -4.88 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.356 -0.84 . . . . 0.0 109.886 -179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 76' ' ' LYS . 15.1 t70 -90.92 -30.16 17.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.41 -2.06 55.08 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.064 -1.022 . . . . 0.0 110.113 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 77' ' ' LEU . 14.3 m -60.72 149.23 80.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.086 -1.009 . . . . 0.0 109.55 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.34 -168.62 0.58 Allowed 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 122.324 2.016 . . . . 0.0 112.002 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.55 57.22 Favored Glycine 0 N--CA 1.496 2.687 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -83.19 -69.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.427 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 22.2 m -58.58 145.77 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 0.0 109.182 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 8.2 m-20 -132.92 -16.67 2.51 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.431 -0.793 . . . . 0.0 110.1 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.4 tttt -145.4 140.7 27.83 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.894 -1.129 . . . . 0.0 109.629 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 76.5 mt -134.67 153.98 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.444 ' C ' ' CD1' ' A' ' 89' ' ' PHE . 10.5 pt -138.28 158.54 32.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 O-C-N 121.282 -0.886 . . . . 0.0 109.89 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -137.93 130.27 29.18 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.14 144.02 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.292 -0.88 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.65 137.46 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 p -132.84 142.71 49.09 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.374 -0.829 . . . . 0.0 110.105 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.528 ' CG2' ' HB2' ' A' ' 96' ' ' ALA . 5.3 mm -73.89 146.04 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.437 ' O ' ' N ' ' A' ' 96' ' ' ALA . 53.6 t-80 -99.55 -70.23 0.74 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.166 -0.959 . . . . 0.0 110.123 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.431 ' OD2' ' OE1' ' A' ' 101' ' ' GLN . 8.3 p-10 -47.57 -17.9 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.317 -0.864 . . . . 0.0 109.714 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.528 ' HB2' ' CG2' ' A' ' 93' ' ' ILE . . . -53.75 -18.36 3.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.847 . . . . 0.0 109.727 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.63 -60.24 2.45 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.925 -1.11 . . . . 0.0 109.833 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.02 -43.17 10.1 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.248 -0.907 . . . . 0.0 111.302 -178.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -85.62 -16.73 38.31 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.927 -1.108 . . . . 0.0 111.112 -178.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.589 ' CG ' HH11 ' A' ' 100' ' ' ARG . 0.2 OUTLIER 55.49 99.33 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.732 -1.23 . . . . 0.0 108.977 -179.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.431 ' OE1' ' OD2' ' A' ' 95' ' ' ASP . 77.2 mt-30 -152.25 140.96 20.9 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.6 p -101.55 165.18 11.37 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.314 -0.866 . . . . 0.0 109.578 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.536 ' CG ' HD22 ' A' ' 127' ' ' LEU . 54.0 m-85 -47.41 -43.44 23.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.289 -0.882 . . . . 0.0 109.848 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.672 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.61 -34.23 80.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -51.01 -22.13 2.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.098 -1.236 . . . . 0.0 109.23 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 107' ' ' SER . 16.7 t -80.04 174.79 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.626 ' H ' HG12 ' A' ' 106' ' ' VAL . 1.2 t -79.83 -8.99 59.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 110.106 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.08 78.82 0.02 OUTLIER Glycine 0 N--CA 1.494 2.5 0 C-N-CA 119.7 -1.238 . . . . 0.0 110.074 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.17 153.32 23.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.211 -1.17 . . . . 0.0 109.349 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 48.2 p90 -154.23 169.75 22.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.9 mt -138.14 151.04 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -149.66 155.14 39.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.897 -1.127 . . . . 0.0 110.173 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.5 HD11 ' CG1' ' A' ' 5' ' ' VAL . 60.0 tp -138.8 136.47 35.7 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.27 150.85 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.219 -0.925 . . . . 0.0 109.674 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.714 HD22 ' H ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -88.8 102.59 15.17 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 74' ' ' LYS . 19.3 t70 -60.61 -3.82 0.79 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.943 . . . . 0.0 108.696 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 115' ' ' ASN . 35.9 t70 -87.45 -52.32 5.43 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.564 -0.71 . . . . 0.0 109.966 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -98.5 -17.61 18.64 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.31 -0.869 . . . . 0.0 109.832 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.714 ' H ' HD22 ' A' ' 115' ' ' ASN . 26.5 tt0 67.99 61.31 0.41 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.381 -0.825 . . . . 0.0 109.506 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.702 ' H ' ' ND2' ' A' ' 115' ' ' ASN . 8.8 p -143.18 120.44 11.54 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.417 -0.802 . . . . 0.0 109.031 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 22.7 mp0 -45.39 122.42 3.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.295 -0.878 . . . . 0.0 109.989 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -82.97 -52.53 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.24 -0.913 . . . . 0.0 109.4 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -169.77 174.57 5.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.955 -1.09 . . . . 0.0 110.146 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 12.0 ptm180 -153.86 127.87 8.95 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -91.32 142.97 27.13 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.198 -0.939 . . . . 0.0 109.398 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -96.62 107.38 19.8 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.234 -0.916 . . . . 0.0 109.315 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.596 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 38.2 mt -77.58 -39.52 45.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.445 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 46.6 p -47.04 -26.59 1.08 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.038 -1.039 . . . . 0.0 109.313 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -95.4 -54.62 3.33 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.425 -0.797 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -81.27 2.61 27.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.225 -0.922 . . . . 0.0 110.301 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.672 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -56.27 -40.94 75.02 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.026 -1.046 . . . . 0.0 110.163 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 82.9 p -78.25 3.04 16.4 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.067 -178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.439 ' OG1' ' OE2' ' A' ' 134' ' ' GLU . 80.6 p -86.38 -33.8 20.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.678 -1.263 . . . . 0.0 110.443 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -171.9 -173.72 1.19 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.144 . . . . 0.0 110.406 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.64 -15.34 13.03 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -138.04 132.84 32.77 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 ptm -153.29 158.01 40.97 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.983 -1.073 . . . . 0.0 110.041 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.0 tt -92.97 127.49 38.5 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.461 -0.774 . . . . 0.0 109.803 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -74.79 -48.56 24.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.296 -0.877 . . . . 0.0 109.537 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.55 -169.34 30.97 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.141 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -151.27 166.71 30.09 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.329 -1.101 . . . . 0.0 110.091 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 mt -133.85 137.72 45.2 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.58 161.8 38.96 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.03 -1.044 . . . . 0.0 109.525 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 -89.89 143.01 27.16 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.291 -0.881 . . . . 0.0 109.735 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 1.2 t60 -118.7 -118.13 0.32 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.627 -0.671 . . . . 0.0 109.203 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.502 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 69.6 m-80 -73.5 52.28 0.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.357 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.88 7.48 88.53 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -127.8 145.0 51.07 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.532 -0.981 . . . . 0.0 109.372 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.507 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 75.5 m95 -67.49 151.83 46.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 0.0 109.429 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -150.23 128.14 11.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.905 . . . . 0.0 109.294 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.467 ' CD1' ' C ' ' A' ' 151' ' ' PHE . 14.2 t80 -90.91 148.9 22.15 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.296 -0.878 . . . . 0.0 109.871 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.0 OUTLIER -146.16 130.32 17.47 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.408 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -79.08 154.54 29.32 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.151 -0.968 . . . . 0.0 109.764 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.3 t -147.92 -36.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.309 -0.869 . . . . 0.0 109.232 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.51 78.19 0.1 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -107.22 106.06 16.33 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.669 -0.9 . . . . 0.0 109.273 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -89.82 133.18 11.66 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.75 138.59 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.278 -1.13 . . . . 0.0 109.295 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -93.19 41.44 1.08 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.206 -0.934 . . . . 0.0 109.258 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -76.81 -93.81 0.21 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.602 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 158.3 134.57 1.74 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.653 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.76 -12.65 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.3 -1.118 . . . . 0.0 109.769 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.653 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -75.67 -55.33 5.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 0.0 110.085 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 168' ' ' GLN . 28.4 p -89.67 -33.65 16.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 109.955 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.602 HG23 ' H ' ' A' ' 161' ' ' GLY . 67.0 t -52.14 -21.28 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.21 -0.931 . . . . 0.0 109.996 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.6 p -85.23 -53.49 5.21 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.055 -1.028 . . . . 0.0 110.119 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.602 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -80.96 -15.08 57.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.971 . . . . 0.0 109.774 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 164' ' ' SER . 8.6 tt0 -67.47 -25.04 65.69 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.263 -0.898 . . . . 0.0 110.004 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.523 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 49.3 m-85 -71.64 -19.78 62.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.024 -1.047 . . . . 0.0 109.6 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.29 -41.81 7.28 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.8 tt -138.35 136.81 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.422 -1.046 . . . . 0.0 109.328 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -80.84 111.36 17.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.532 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 40.05 0.48 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.488 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.582 ' N ' ' SD ' ' A' ' 2' ' ' MET . 1.9 mpt? -79.66 142.66 35.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.359 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' H ' ' CB ' ' A' ' 117' ' ' ASP . 63.9 mttm -134.43 -3.35 2.69 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.461 -0.774 . . . . 0.0 109.585 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -146.63 128.41 15.29 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.162 -0.961 . . . . 0.0 109.358 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 t -113.61 153.09 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.546 -0.721 . . . . 0.0 109.163 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.0 tt -148.7 112.38 5.07 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.07 151.41 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.351 -0.843 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -131.13 132.21 6.73 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.433 HD12 ' O ' ' A' ' 110' ' ' PHE . 13.6 tp -139.34 124.04 18.5 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.76 154.32 25.65 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 119.395 -1.383 . . . . 0.0 109.965 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 31.0 p90 -157.58 152.34 25.37 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.412 -1.052 . . . . 0.0 109.662 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' O ' ' OG ' ' A' ' 107' ' ' SER . 21.2 t70 -87.94 123.33 32.57 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.494 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.42 169.7 17.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.507 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -132.94 107.09 8.07 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.411 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -91.92 129.33 37.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.239 -0.913 . . . . 0.0 109.263 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 m -154.19 -47.77 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.331 -0.856 . . . . 0.0 109.294 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.498 ' OD1' ' NE2' ' A' ' 19' ' ' GLN . 16.9 p-10 -146.1 34.68 1.0 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.303 -0.873 . . . . 0.0 109.058 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 91.63 -6.34 80.05 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.498 ' NE2' ' OD1' ' A' ' 17' ' ' ASP . 32.4 mt-30 -71.59 141.89 50.02 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -1.146 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -160.32 144.79 14.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.2 -0.938 . . . . 0.0 109.522 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -96.29 146.17 24.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -141.17 99.62 3.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.258 -0.901 . . . . 0.0 109.819 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.0 mp -86.28 163.29 17.81 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -135.76 121.11 19.17 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.215 -0.928 . . . . 0.0 109.892 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.3 139.05 34.66 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.406 -0.809 . . . . 0.0 109.043 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.7 m -149.28 149.68 31.33 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.211 -0.93 . . . . 0.0 109.502 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.5 126.24 53.32 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.507 -0.746 . . . . 0.0 109.042 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -104.15 132.83 49.99 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.424 -0.797 . . . . 0.0 109.541 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.762 ' N ' HD12 ' A' ' 29' ' ' LEU . 4.4 mp -85.57 156.99 20.51 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.461 -0.775 . . . . 0.0 109.648 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.28 133.43 20.45 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.038 -1.039 . . . . 0.0 108.649 178.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -88.26 170.31 11.11 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.946 -1.096 . . . . 0.0 109.268 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.86 -3.87 58.86 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.224 -0.922 . . . . 0.0 109.43 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.5 m120 -76.72 -7.19 54.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.945 . . . . 0.0 109.755 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.57 -5.06 51.12 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 76.4 mttt -140.57 150.32 43.49 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.479 -1.012 . . . . 0.0 108.371 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' C ' ' H ' ' A' ' 38' ' ' GLY . 3.0 t -66.31 137.29 25.18 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.207 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 64.5 ttt180 -62.27 -3.53 1.37 Allowed 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 175.8 81.38 0.05 OUTLIER Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.711 -1.755 . . . . 0.0 108.711 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.4 p-10 -45.93 -39.01 8.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -1.008 . . . . 0.0 109.777 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.71 10.54 0.26 Allowed 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.584 -0.697 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.632 ' O ' HD13 ' A' ' 29' ' ' LEU . 40.8 t0 -95.96 26.09 4.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.183 -0.948 . . . . 0.0 109.28 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.1 p90 -91.93 143.39 26.54 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.187 -0.946 . . . . 0.0 109.017 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 25.4 mm -85.34 140.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-O 121.829 0.823 . . . . 0.0 109.881 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.2 OUTLIER -127.95 -166.83 1.67 Allowed 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 46' ' ' ASN . 43.8 p90 -64.0 -53.39 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.208 -0.933 . . . . 0.0 110.358 -179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD2' ' A' ' 45' ' ' TYR . 43.8 t-20 -58.18 -35.26 71.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.022 -1.049 . . . . 0.0 109.755 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.434 ' HB3' ' H ' ' A' ' 44' ' ' PHE . 35.1 t-20 -77.96 83.35 4.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.122 -0.986 . . . . 0.0 109.078 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -54.12 -36.86 63.7 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.339 -0.851 . . . . 0.0 109.807 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -164.39 158.09 18.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.117 -0.989 . . . . 0.0 110.061 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.8 t -79.84 172.94 13.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.38 -0.825 . . . . 0.0 109.148 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.67 -49.4 8.01 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 0.0 108.838 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -117.48 -14.15 10.32 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -55.02 -15.9 7.38 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.5 m 61.81 6.15 1.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.215 -1.168 . . . . 0.0 109.523 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.456 HG12 HG23 ' A' ' 75' ' ' ILE . 16.4 m -92.71 151.83 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 108.821 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.4 p -144.65 128.81 17.68 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.996 -1.065 . . . . 0.0 110.188 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -93.26 133.63 36.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.468 -0.77 . . . . 0.0 109.043 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 72' ' ' SER . 14.3 t -62.43 -42.21 99.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.019 -1.051 . . . . 0.0 109.391 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 58' ' ' THR . . . 156.79 -178.92 32.97 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -125.94 110.85 14.08 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.635 -0.921 . . . . 0.0 109.227 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 61' ' ' ASN . 1.6 m-20 -83.63 132.42 34.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -86.02 11.41 11.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.8 p -154.17 -37.37 0.1 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.213 -0.929 . . . . 0.0 109.331 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.1 16.33 69.89 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.04 110.4 0.92 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.243 -1.151 . . . . 0.0 109.269 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.16 132.67 1.5 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -80.68 81.24 6.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.208 -1.172 . . . . 0.0 109.492 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.46 178.61 35.55 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -55.09 116.19 2.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.234 -1.156 . . . . 0.0 109.456 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -81.09 -56.6 3.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -102.81 159.45 15.47 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.398 -0.814 . . . . 0.0 109.159 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.533 ' H ' HG22 ' A' ' 58' ' ' THR . 66.1 m -166.42 169.91 13.47 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 0.0 109.855 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -145.22 116.86 8.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.387 -0.821 . . . . 0.0 109.01 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -96.32 136.54 36.67 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.274 -0.891 . . . . 0.0 109.108 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.456 HG23 HG12 ' A' ' 55' ' ' VAL . 5.0 mp -134.66 146.7 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -0.767 . . . . 0.0 110.208 -179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -112.1 100.94 9.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.449 HD13 ' CD1' ' A' ' 149' ' ' TRP . 45.5 mt -59.16 -51.47 69.88 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.238 -0.914 . . . . 0.0 109.811 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -50.29 -13.86 0.14 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.511 -0.743 . . . . 0.0 109.626 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -98.34 -22.64 15.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.288 -0.882 . . . . 0.0 109.817 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.95 124.52 80.26 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 0.0 109.279 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -78.47 -163.51 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.923 1.749 . . . . 0.0 112.136 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.73 3.05 70.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -68.18 -59.18 3.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -1.172 . . . . 0.0 109.177 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.8 m -82.74 149.01 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.37 -0.831 . . . . 0.0 109.018 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -123.36 -4.9 8.31 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.515 -0.741 . . . . 0.0 109.536 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 42.9 tttt -157.97 154.52 27.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.028 -1.045 . . . . 0.0 109.425 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 87' ' ' ILE . 13.0 mt -142.49 152.6 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.8 pt -143.11 151.23 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.109 -0.994 . . . . 0.0 110.122 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -119.11 134.25 55.31 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -138.82 157.97 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.29 -0.881 . . . . 0.0 109.943 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.34 125.71 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 p -119.71 142.61 48.36 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.563 -0.711 . . . . 0.0 110.002 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 96' ' ' ALA . 5.1 mm -74.12 147.43 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.332 -0.855 . . . . 0.0 108.877 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 96' ' ' ALA . 0.5 OUTLIER -108.79 -61.47 1.6 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.397 -0.814 . . . . 0.0 109.77 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -47.41 -19.0 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.269 -0.894 . . . . 0.0 109.644 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.443 ' H ' HG22 ' A' ' 93' ' ' ILE . . . -59.11 -18.56 36.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.358 -0.839 . . . . 0.0 109.878 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -62.72 -59.59 4.68 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.773 -1.204 . . . . 0.0 109.172 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.38 -33.82 15.12 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.386 -0.821 . . . . 0.0 111.075 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 64.7 mtt180 -95.29 -19.52 19.92 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.907 -1.12 . . . . 0.0 111.447 -178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 100' ' ' ARG . 13.3 ttm-85 53.63 85.12 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.672 -1.268 . . . . 0.0 109.186 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -142.9 150.88 40.4 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.292 -0.88 . . . . 0.0 109.259 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -105.06 164.51 11.75 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.515 -0.741 . . . . 0.0 109.547 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -46.36 -39.39 10.24 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.261 -0.899 . . . . 0.0 109.811 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.595 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -56.88 -37.17 76.64 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -54.59 -21.79 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.0 -1.294 . . . . 0.0 109.292 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -76.99 164.76 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.338 -0.852 . . . . 0.0 109.377 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.486 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.0 p -64.94 -27.28 68.74 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.534 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.78 78.12 0.02 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.36 164.59 25.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.322 -1.105 . . . . 0.0 109.363 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HD12 ' A' ' 9' ' ' LEU . 32.5 p90 -149.8 169.95 19.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.19 -0.944 . . . . 0.0 110.086 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.36 146.2 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -146.3 160.23 42.28 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.924 -1.11 . . . . 0.0 110.004 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 65.1 tp -143.21 137.65 29.12 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.3 p -145.81 148.09 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.138 -0.976 . . . . 0.0 109.544 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' H ' ' A' ' 117' ' ' ASP . 64.6 m-20 -89.91 102.85 15.55 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -56.47 -9.31 0.68 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.512 ' CB ' ' H ' ' A' ' 3' ' ' LYS . 25.3 t70 -90.26 -52.13 5.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.779 -0.576 . . . . 0.0 109.854 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -82.71 -18.34 41.21 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.399 -0.813 . . . . 0.0 109.851 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 61.28 53.17 3.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.374 -0.829 . . . . 0.0 110.033 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.19 129.95 10.87 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.264 -0.897 . . . . 0.0 109.437 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 24.9 mp0 -47.15 136.8 8.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.52 -0.738 . . . . 0.0 110.046 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.5 t -97.11 -49.9 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.344 -0.848 . . . . 0.0 109.316 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.31 174.66 5.18 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.855 -1.153 . . . . 0.0 110.242 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.32 153.88 40.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.515 -0.741 . . . . 0.0 109.13 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.8 137.98 54.29 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.509 -0.744 . . . . 0.0 109.404 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 1.0 OUTLIER -97.13 110.9 23.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.224 -0.923 . . . . 0.0 109.233 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.5 mt -79.73 -38.34 33.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.713 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 24.5 p -47.02 -28.32 1.63 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.045 -1.034 . . . . 0.0 109.342 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -95.2 -54.49 3.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.417 -0.802 . . . . 0.0 109.728 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.426 ' O ' ' OG1' ' A' ' 133' ' ' THR . 11.6 m-20 -75.38 -1.08 22.16 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.26 -0.9 . . . . 0.0 110.14 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.595 ' HB1' ' H ' ' A' ' 104' ' ' GLY . . . -55.26 -48.55 73.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.113 -0.992 . . . . 0.0 109.147 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 28.7 t -64.77 3.02 0.58 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.637 -0.664 . . . . 0.0 109.706 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -80.11 -34.11 38.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 110.028 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 170.81 -167.11 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.196 -0.94 . . . . 0.0 108.912 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.92 -12.84 14.84 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.13 139.21 33.9 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.451 ' C ' ' SD ' ' A' ' 137' ' ' MET . 0.0 OUTLIER -165.18 157.95 16.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.054 -1.029 . . . . 0.0 109.805 -179.057 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.0 pp -95.17 124.86 39.44 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.285 -0.884 . . . . 0.0 109.632 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -61.68 -44.97 95.93 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.33 -149.94 6.81 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -150.85 166.89 29.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.201 -1.176 . . . . 0.0 109.859 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 150' ' ' LYS . 6.5 tp -135.97 126.26 26.53 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -136.94 166.14 24.34 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.209 -0.932 . . . . 0.0 110.057 -179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 144' ' ' ARG . 13.9 ptm180 -92.24 148.4 22.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.52 -0.738 . . . . 0.0 109.93 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -149.37 122.47 8.87 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.464 -0.773 . . . . 0.0 109.183 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 17.3 m120 51.51 26.22 3.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.898 . . . . 0.0 109.235 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.13 16.62 69.08 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -128.06 131.1 49.12 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.997 . . . . 0.0 109.468 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.449 ' CD1' HD13 ' A' ' 77' ' ' LEU . 74.0 m95 -67.59 152.09 46.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' O ' HD12 ' A' ' 142' ' ' LEU . 80.7 mttt -145.08 173.69 11.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 20.0 t80 -134.69 139.99 45.65 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.464 -0.773 . . . . 0.0 109.392 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 81.2 mtm180 -141.87 107.39 5.06 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.309 -0.87 . . . . 0.0 109.284 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.07 154.71 33.08 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.894 . . . . 0.0 109.443 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 15.8 t -143.1 -34.0 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 68.61 89.11 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -139.14 104.31 4.98 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.462 -1.022 . . . . 0.0 109.259 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -84.05 150.79 26.62 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.464 ' CD1' HG11 ' A' ' 165' ' ' VAL . 1.7 p90 -142.44 136.83 29.88 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.343 -1.093 . . . . 0.0 109.086 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 10.05 41.16 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.295 -0.878 . . . . 0.0 109.429 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.14 -77.17 0.13 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.41 ' H ' HG13 ' A' ' 165' ' ' VAL . . . 157.56 137.59 2.32 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.708 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.7 pt? -46.41 -30.2 2.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -1.131 . . . . 0.0 109.93 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -85.68 -31.0 22.74 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -0.947 . . . . 0.0 109.473 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 58.5 m -81.36 -50.47 9.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.243 -0.91 . . . . 0.0 109.657 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.522 ' O ' ' CD2' ' A' ' 169' ' ' TYR . 17.7 m -49.38 -20.6 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.0 109.459 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.561 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 48.5 t -72.58 -62.58 1.4 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.886 . . . . 0.0 109.643 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.39 62.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.372 -0.83 . . . . 0.0 109.406 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -66.62 -29.17 69.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -0.858 . . . . 0.0 109.78 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 165' ' ' VAL . 53.0 m-85 -71.61 -19.6 62.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 109.321 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -81.31 -26.36 52.11 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.47 120.26 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -1.145 . . . . 0.0 109.421 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.98 129.27 39.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.186 -0.946 . . . . 0.0 109.476 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.47 160.42 25.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.474 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.282 0.563 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.572 ' N ' ' SD ' ' A' ' 2' ' ' MET . 0.0 OUTLIER -73.44 89.78 1.67 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.903 . . . . 0.0 109.456 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 30.1 mmtp -78.33 -23.46 47.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.925 . . . . 0.0 109.451 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -146.11 128.28 15.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.181 -0.949 . . . . 0.0 109.446 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.5 t -123.04 150.06 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.605 -0.685 . . . . 0.0 109.255 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.9 tt -148.76 105.97 3.62 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.353 -0.842 . . . . 0.0 109.08 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.5 p -86.42 150.55 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.081 -1.012 . . . . 0.0 109.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -141.55 118.89 1.4 Allowed Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.136 -1.185 . . . . 0.0 110.136 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' ' N ' ' A' ' 70' ' ' ASP . 31.2 tp -103.09 140.04 37.82 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -151.38 143.14 10.15 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 119.53 -1.319 . . . . 0.0 109.953 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.8 p90 -159.49 155.24 26.13 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.279 -1.13 . . . . 0.0 109.886 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -86.22 132.35 34.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.501 -0.75 . . . . 0.0 109.618 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -79.76 125.09 29.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' NH2' ' OE1' ' A' ' 19' ' ' GLN . 41.0 ttp180 -85.29 106.72 16.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.915 . . . . 0.0 109.604 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.5 p -101.58 132.02 47.46 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.376 -0.828 . . . . 0.0 109.333 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.403 ' CG2' ' CD ' ' A' ' 19' ' ' GLN . 6.1 t -161.36 -34.47 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.306 -0.871 . . . . 0.0 109.34 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 17' ' ' ASP . 17.8 t70 -157.19 42.33 0.33 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.28 -0.887 . . . . 0.0 109.309 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.66 -30.16 4.28 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' OE1' ' NH2' ' A' ' 14' ' ' ARG . 10.8 pt20 -54.66 163.52 0.92 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.265 -1.138 . . . . 0.0 109.446 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -173.15 -162.65 0.17 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -150.95 140.48 21.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.342 -0.849 . . . . 0.0 109.154 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -140.84 101.93 4.17 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.302 -0.874 . . . . 0.0 109.75 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.2 mp -83.37 160.59 21.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 108.571 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -125.71 117.79 24.22 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.52 -0.738 . . . . 0.0 109.357 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.14 132.63 43.5 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.341 -0.85 . . . . 0.0 109.472 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.6 t -149.43 167.78 25.25 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.368 -0.833 . . . . 0.0 109.374 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -132.8 129.1 38.11 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.495 -0.753 . . . . 0.0 109.111 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.524 ' CD1' ' OH ' ' A' ' 169' ' ' TYR . 83.1 m-85 -107.39 138.09 44.24 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.436 -0.79 . . . . 0.0 109.826 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.689 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.0 mp -80.45 156.66 26.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.504 -0.747 . . . . 0.0 109.477 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.99 129.57 15.98 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.098 -1.001 . . . . 0.0 109.125 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -75.01 176.23 7.4 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.229 -0.919 . . . . 0.0 109.67 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.94 -6.15 59.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -78.98 -3.53 45.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.168 -0.957 . . . . 0.0 109.377 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.41 -11.16 69.02 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 35' ' ' LYS . 17.8 mtmm -124.98 138.24 54.23 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.702 -0.881 . . . . 0.0 108.753 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.9 p -73.47 145.45 11.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.03 -1.044 . . . . 0.0 109.345 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.468 ' NH2' ' CG ' ' A' ' 83' ' ' ASP . 9.0 ttm180 -63.67 2.96 0.39 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.583 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 144.25 99.39 0.28 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' OD2' ' N ' ' A' ' 167' ' ' ALA . 18.4 p-10 -46.07 -26.22 0.71 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.297 -1.119 . . . . 0.0 109.571 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.6 -6.19 0.28 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.582 -0.699 . . . . 0.0 109.959 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.555 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.4 m-20 -90.78 26.26 2.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.033 -1.042 . . . . 0.0 108.628 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -90.33 136.08 33.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.52 -0.738 . . . . 0.0 109.893 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 26.7 mm -82.0 140.15 16.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' A' ' 44' ' ' PHE . 0.8 OUTLIER -123.89 -168.81 1.85 Allowed 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.296 0.57 . . . . 0.0 109.474 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -82.87 31.1 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 110.426 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 11.3 t30 -170.46 22.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.014 -1.054 . . . . 0.0 109.844 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 -87.88 36.43 0.76 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 49' ' ' LYS . 47.5 mt 45.55 26.3 0.31 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.53 -0.731 . . . . 0.0 109.826 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER 58.5 129.13 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.447 0.641 . . . . 0.0 109.48 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.409 ' HB3' ' H ' ' A' ' 55' ' ' VAL . 4.9 t -53.88 111.5 0.76 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.833 -1.167 . . . . 0.0 109.272 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.82 -17.95 56.86 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.218 -0.926 . . . . 0.0 109.134 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -116.15 -14.44 11.14 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.685 -0.634 . . . . 0.0 109.577 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.451 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -95.81 -9.05 57.74 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 p 60.45 11.29 2.88 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -1.163 . . . . 0.0 108.979 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG22 HG23 ' A' ' 75' ' ' ILE . 46.1 t -93.2 151.24 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.466 -0.772 . . . . 0.0 109.213 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.2 p -147.5 137.55 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.101 -1.0 . . . . 0.0 109.528 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.435 ' ND1' ' N ' ' A' ' 58' ' ' THR . 10.7 t-80 -93.16 144.11 25.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.321 -0.862 . . . . 0.0 109.421 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.435 ' N ' ' ND1' ' A' ' 57' ' ' HIS . 58.7 m -73.64 -62.45 1.48 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 109.46 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.86 131.35 1.25 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -83.07 116.46 22.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.286 -1.126 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -73.85 -172.19 1.24 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.186 -0.947 . . . . 0.0 109.443 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.1 mtp180 -137.36 1.03 2.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.438 -0.789 . . . . 0.0 109.554 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.2 p -152.52 -32.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.21 -0.931 . . . . 0.0 109.79 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.42 3.45 57.52 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.031 -1.628 . . . . 0.0 109.031 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -58.46 110.22 0.93 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.445 -1.032 . . . . 0.0 109.348 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 144.74 128.55 2.09 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -67.07 -165.35 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -1.174 . . . . 0.0 109.397 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 52.44 -158.64 3.35 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.408 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 13.1 p30 -81.76 135.42 35.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.281 -1.129 . . . . 0.0 109.553 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 9' ' ' LEU . 91.3 m-20 -77.04 -72.29 0.36 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.425 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -94.16 174.37 7.18 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.249 -0.907 . . . . 0.0 109.015 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.467 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.4 t -172.58 162.33 5.13 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.117 -0.989 . . . . 0.0 109.86 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.13 124.54 15.68 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.34 134.22 39.74 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.267 -0.895 . . . . 0.0 109.196 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.532 HG23 HG22 ' A' ' 55' ' ' VAL . 3.1 mp -135.61 146.71 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.468 -0.77 . . . . 0.0 109.679 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 59.2 mttm -125.0 90.02 3.17 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.58 -4.69 3.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.536 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -90.62 4.85 50.17 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.176 -0.952 . . . . 0.0 109.891 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -129.5 9.01 5.49 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.362 -0.836 . . . . 0.0 109.605 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.516 HG21 ' HZ2' ' A' ' 149' ' ' TRP . 13.3 m -64.97 149.55 96.51 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 0.0 109.74 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.1 -161.17 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.279 1.986 . . . . 0.0 111.701 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -102.68 3.1 49.25 Favored Glycine 0 N--CA 1.498 2.772 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' CG ' ' NH2' ' A' ' 37' ' ' ARG . 9.9 t70 -90.4 -72.08 0.59 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.144 -1.21 . . . . 0.0 109.781 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.426 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 10.4 p -57.58 148.66 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.2 -0.938 . . . . 0.0 109.451 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.514 ' CG ' HH11 ' A' ' 144' ' ' ARG . 5.3 m-20 -136.68 -2.63 2.14 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 109.848 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -153.74 150.17 28.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.031 -1.043 . . . . 0.0 109.438 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.94 154.03 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.0 pt -139.97 157.0 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 0.0 109.779 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 24.0 m-85 -133.79 133.79 42.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 0.0 109.139 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -140.68 157.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.34 -0.85 . . . . 0.0 109.831 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.23 113.67 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.5 p -107.05 148.46 28.7 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.6 -0.687 . . . . 0.0 109.901 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.3 mm -74.1 146.5 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.306 -0.871 . . . . 0.0 108.997 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' O ' ' N ' ' A' ' 96' ' ' ALA . 1.6 t60 -96.34 -65.48 0.97 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.147 -0.971 . . . . 0.0 109.906 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -47.45 -18.04 0.11 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.246 -0.909 . . . . 0.0 109.561 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -63.07 -40.96 99.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.346 -0.847 . . . . 0.0 109.635 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.5 -32.44 50.36 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.763 -1.21 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.98 -53.68 4.28 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.214 -0.929 . . . . 0.0 111.273 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' O ' ' A' ' 100' ' ' ARG . 0.1 OUTLIER -111.97 3.05 17.22 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.125 -0.984 . . . . 0.0 111.127 -178.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' ALA . 28.7 ttp180 56.96 104.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.952 -1.092 . . . . 0.0 109.39 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.405 ' H ' ' CB ' ' A' ' 96' ' ' ALA . 80.2 mt-30 -150.15 134.34 17.13 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.26 -0.9 . . . . 0.0 109.485 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.1 p -91.25 149.34 21.8 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 0.0 109.319 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -43.57 -30.89 0.64 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.478 -0.764 . . . . 0.0 109.781 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.59 -38.41 52.06 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -55.81 -16.43 4.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -1.094 . . . . 0.0 109.127 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 107' ' ' SER . 31.1 t -79.81 166.51 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.357 -0.84 . . . . 0.0 109.227 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.529 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.86 -23.63 64.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.847 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.99 80.55 0.03 OUTLIER Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.78 164.8 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.267 -1.137 . . . . 0.0 109.268 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 43.0 p90 -152.05 131.08 12.61 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.059 -1.026 . . . . 0.0 110.553 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.29 145.11 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -140.44 153.33 46.25 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.992 -1.067 . . . . 0.0 110.093 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 tp -135.91 136.34 40.4 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.488 -0.757 . . . . 0.0 108.992 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.7 p -144.06 147.47 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.232 -0.918 . . . . 0.0 109.329 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.481 ' C ' ' H ' ' A' ' 117' ' ' ASP . 73.2 m-20 -88.31 103.2 15.59 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -51.79 -11.54 0.15 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.022 -1.049 . . . . 0.0 108.705 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.481 ' H ' ' C ' ' A' ' 115' ' ' ASN . 44.9 t0 -85.53 -52.1 6.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.609 -0.682 . . . . 0.0 109.725 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -86.51 -17.89 32.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.285 -0.884 . . . . 0.0 109.893 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 59.14 50.16 8.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.879 . . . . 0.0 109.549 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.6 m -142.83 127.49 18.07 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.337 -0.852 . . . . 0.0 109.4 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 26.1 mp0 -49.83 121.88 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.842 . . . . 0.0 109.653 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 66.3 t -84.48 -47.19 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 109.657 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -165.43 174.63 9.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.894 -1.129 . . . . 0.0 110.343 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 18.4 ptt180 -151.07 122.63 7.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.502 -0.749 . . . . 0.0 109.038 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -91.33 134.67 34.4 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.208 -0.932 . . . . 0.0 109.544 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -92.3 114.89 27.56 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 0.0 109.275 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 51.8 mt -82.02 -43.72 17.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.677 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.8 m -47.11 -25.11 0.79 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.946 -1.096 . . . . 0.0 109.474 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -95.27 -54.59 3.36 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.363 -0.836 . . . . 0.0 109.955 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.71 -2.06 41.25 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 0.0 110.15 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.07 -53.13 54.65 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 110.023 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 38.6 m -55.52 -1.27 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 131' ' ' ALA . 12.3 m -83.8 -33.57 24.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.992 -1.068 . . . . 0.0 110.411 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.513 ' OE2' ' N ' ' A' ' 159' ' ' ALA . 5.9 tt0 -173.72 -148.93 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.806 -1.184 . . . . 0.0 109.857 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.546 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 23.8 m -119.9 -44.09 2.53 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.24 154.96 24.8 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.7 ttt -165.32 156.83 14.64 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.873 -1.142 . . . . 0.0 110.114 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 tt -96.69 124.42 40.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.492 -0.755 . . . . 0.0 109.613 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 26.3 t80 -66.94 -57.09 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.239 -0.913 . . . . 0.0 109.243 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.71 -166.04 22.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -151.08 166.65 30.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -1.147 . . . . 0.0 110.004 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.17 135.7 43.27 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -139.04 166.17 25.21 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.292 -0.88 . . . . 0.0 109.618 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.514 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.9 ptm180 -87.09 148.32 25.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.389 -0.819 . . . . 0.0 109.793 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -150.48 120.3 7.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 0.0 109.123 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 61.0 t30 55.74 26.21 9.19 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.903 . . . . 0.0 109.251 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.25 13.69 78.33 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.89 137.07 52.18 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.475 -1.014 . . . . 0.0 109.386 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.516 ' HZ2' HG21 ' A' ' 80' ' ' VAL . 72.2 m95 -67.22 151.58 47.28 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -152.96 141.66 20.98 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.256 -0.903 . . . . 0.0 109.354 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 16.5 t80 -89.86 156.74 18.27 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 0.0 109.796 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.6 ' HE ' ' H ' ' A' ' 153' ' ' ALA . 9.1 tpm_? -149.22 130.55 14.67 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.414 -0.803 . . . . 0.0 108.877 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.6 ' H ' ' HE ' ' A' ' 152' ' ' ARG . . . -83.55 147.02 28.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.15 -0.969 . . . . 0.0 109.716 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.7 t -148.08 -40.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.248 -0.908 . . . . 0.0 109.184 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 46.46 73.34 0.31 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' CE2' ' A' ' 158' ' ' TYR . 6.5 tt0 -103.87 118.8 37.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.653 -0.91 . . . . 0.0 109.41 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -92.21 140.74 15.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.496 ' CE2' ' O ' ' A' ' 156' ' ' GLN . 0.6 OUTLIER -150.13 128.48 12.12 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.513 ' N ' ' OE2' ' A' ' 134' ' ' GLU . . . -102.56 36.93 2.03 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.413 -0.805 . . . . 0.0 109.5 -179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.75 -79.92 0.25 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 165.05 137.4 2.19 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.693 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.6 pt? -45.42 -25.02 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.217 -1.167 . . . . 0.0 110.221 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -86.48 -43.3 12.87 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.193 -0.942 . . . . 0.0 110.281 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.402 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 9.8 t -84.82 -41.08 16.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.141 -0.974 . . . . 0.0 110.581 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.582 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 5.9 p -52.42 -19.49 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.971 -1.081 . . . . 0.0 109.598 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.434 ' SG ' ' O ' ' A' ' 162' ' ' LEU . 71.0 m -75.55 -62.1 1.69 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 110.331 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.456 ' N ' ' OD2' ' A' ' 39' ' ' ASP . . . -88.19 -14.74 37.83 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.219 -0.926 . . . . 0.0 110.819 -178.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.402 ' CB ' ' O ' ' A' ' 164' ' ' SER . 25.7 tt0 -67.85 -54.95 14.93 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.977 -1.077 . . . . 0.0 110.779 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -88.6 6.42 38.29 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.278 -0.889 . . . . 0.0 110.712 -179.062 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -93.01 -35.07 6.48 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 8.9 tt -138.15 140.61 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.432 -1.04 . . . . 0.0 109.137 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -66.55 143.17 57.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 109.539 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.45 -171.94 3.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.254 -0.903 . . . . 0.0 109.471 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.454 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.437 ' SD ' ' CG ' ' A' ' 115' ' ' ASN . 13.1 mmt -79.66 42.35 0.52 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.491 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 60.1 mttm -50.04 -16.61 0.31 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.366 -0.834 . . . . 0.0 109.389 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 7.1 m120 -143.8 128.2 17.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.325 -0.86 . . . . 0.0 109.056 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 113' ' ' LEU . 84.1 t -124.69 155.57 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.574 -0.704 . . . . 0.0 109.465 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -148.72 105.28 3.55 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 p -87.3 150.6 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.223 -0.923 . . . . 0.0 108.571 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -146.0 117.68 0.99 Allowed Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.852 -1.166 . . . . 0.0 110.785 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.408 ' O ' ' N ' ' A' ' 70' ' ' ASP . 25.7 tp -102.33 138.15 39.63 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -144.57 147.41 18.61 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 63' ' ' THR . 33.7 p90 -164.1 152.7 13.27 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.313 -1.11 . . . . 0.0 110.146 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -96.07 96.64 9.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.692 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.44 169.74 11.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.485 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -133.09 111.89 11.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.43 -0.794 . . . . 0.0 109.215 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -75.7 117.33 17.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.24 -0.912 . . . . 0.0 109.516 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 18' ' ' GLY . 4.0 p -148.82 139.35 22.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.367 -0.833 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 49.99 16.67 0.24 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.323 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 16' ' ' THR . . . 87.72 -11.16 67.3 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -77.03 174.77 10.27 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.538 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -175.88 160.68 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -96.32 135.37 38.25 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.232 -0.917 . . . . 0.0 109.438 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -140.95 101.96 4.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.322 -0.861 . . . . 0.0 109.603 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.38 163.02 20.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.0 108.872 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -122.85 154.74 37.87 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.9 123.75 31.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.378 -0.826 . . . . 0.0 109.405 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 p -141.54 167.88 21.11 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.459 -0.776 . . . . 0.0 109.19 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.492 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -144.18 138.61 28.22 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -114.68 140.31 48.95 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.546 -0.721 . . . . 0.0 109.824 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.695 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.3 mp -76.68 151.98 35.93 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.425 -0.797 . . . . 0.0 109.315 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 86' ' ' LYS . 0.6 OUTLIER -147.46 127.5 13.68 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.042 -1.036 . . . . 0.0 109.481 179.325 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -79.88 170.08 17.0 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.161 -0.962 . . . . 0.0 109.469 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.8 -3.05 58.46 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 109.205 179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 33' ' ' ASN . 1.2 m120 -73.72 -8.56 56.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.174 -0.954 . . . . 0.0 109.209 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.54 -3.99 50.43 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 109.083 -1.607 . . . . 0.0 109.083 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -144.62 138.47 27.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.377 -1.072 . . . . 0.0 108.913 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 38' ' ' GLY . 12.9 p -66.46 145.49 13.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -65.13 2.95 0.67 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.559 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.54 99.44 0.2 Allowed Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 41' ' ' ASP . 15.1 p-10 -50.32 -32.65 17.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -1.159 . . . . 0.0 109.288 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.29 -3.88 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.618 -0.676 . . . . 0.0 109.801 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' O ' HD13 ' A' ' 29' ' ' LEU . 15.2 t0 -91.86 26.92 2.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.052 -1.03 . . . . 0.0 108.342 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.627 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 7.7 p90 -94.33 138.53 32.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.596 -0.69 . . . . 0.0 109.449 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mm -89.72 139.57 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.522 -0.736 . . . . 0.0 109.356 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.627 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 12.2 p90 -164.21 -156.19 0.32 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.597 -0.69 . . . . 0.0 109.996 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' ASN . 1.3 m-85 -44.48 -59.5 2.41 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.549 -0.719 . . . . 0.0 110.435 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -48.47 -12.28 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.087 -1.008 . . . . 0.0 109.568 -179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 45' ' ' TYR . 7.8 m120 -145.46 94.45 2.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.71 -30.57 14.17 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.299 -0.876 . . . . 0.0 109.366 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.7 pttp -163.34 162.48 25.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.249 -0.907 . . . . 0.0 109.68 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 54' ' ' SER . 5.6 p -88.6 140.25 29.65 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.329 -0.857 . . . . 0.0 109.553 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.73 -38.35 33.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 0.0 109.087 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 2.7 m-20 -116.22 -11.76 11.27 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' ' 54' ' ' SER . . . -73.2 -20.42 79.92 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 50' ' ' SER . 1.5 p 71.88 0.11 3.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -1.105 . . . . 0.0 109.557 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG22 HG23 ' A' ' 75' ' ' ILE . 5.1 t -92.96 144.13 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.2 -0.937 . . . . 0.0 108.807 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 4.5 p -146.74 147.2 30.7 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.93 -1.106 . . . . 0.0 110.796 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.3 m80 -91.15 127.03 36.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.469 ' CB ' ' OG ' ' A' ' 72' ' ' SER . 32.9 m -66.56 -45.59 78.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.024 -1.048 . . . . 0.0 109.46 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 167.34 126.53 0.84 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -80.34 110.96 16.28 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.251 -1.146 . . . . 0.0 109.449 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -80.49 144.8 32.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.465 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -95.97 0.43 51.78 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.308 -0.87 . . . . 0.0 109.44 -179.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.526 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 35.6 p -155.21 -33.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 0.0 109.431 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.19 8.04 10.84 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -58.09 116.84 3.79 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.376 -1.073 . . . . 0.0 109.685 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 67' ' ' ASP . . . 79.09 172.83 43.01 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 8.3 m-20 58.19 108.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.44 -1.035 . . . . 0.0 109.668 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -66.85 171.54 30.74 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.42 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 2.9 m-20 49.54 50.33 18.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -1.194 . . . . 0.0 109.393 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.41 ' OD1' ' O ' ' A' ' 67' ' ' ASP . 80.4 m-20 -48.32 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.665 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -89.98 152.54 21.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.918 . . . . 0.0 109.424 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.469 ' OG ' ' CB ' ' A' ' 58' ' ' THR . 33.0 p -159.22 156.51 28.99 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.24 -0.913 . . . . 0.0 109.446 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -130.68 137.67 49.67 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.599 -0.688 . . . . 0.0 109.255 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -99.92 123.95 44.73 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.449 HG23 HG22 ' A' ' 55' ' ' VAL . 1.9 mp -129.92 115.72 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.457 -0.777 . . . . 0.0 110.195 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -97.42 84.51 3.46 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mt -50.69 -35.65 32.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.18 -0.95 . . . . 0.0 109.495 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.424 ' OD2' ' O ' ' A' ' 3' ' ' LYS . 2.2 p30 -50.74 -23.73 2.91 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.837 . . . . 0.0 109.854 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.4 -21.08 22.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.212 -0.93 . . . . 0.0 109.913 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.92 124.47 79.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -77.88 -161.5 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.797 1.665 . . . . 0.0 112.101 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -86.47 -0.04 86.68 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -67.46 -58.35 4.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.206 -1.173 . . . . 0.0 109.254 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.9 t -89.27 148.64 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.344 -0.848 . . . . 0.0 109.181 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.545 ' CG ' HH11 ' A' ' 144' ' ' ARG . 4.8 m-20 -135.74 -1.07 2.52 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.347 -0.846 . . . . 0.0 109.541 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.422 ' O ' ' O ' ' A' ' 30' ' ' LEU . 77.3 tttt -158.2 134.34 9.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.0 109.292 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 61.5 mt -128.17 153.92 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.4 pt -129.84 153.24 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.332 -0.855 . . . . 0.0 109.738 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.492 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 46.2 m-85 -133.85 135.37 43.7 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -143.86 158.02 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.256 -0.903 . . . . 0.0 109.566 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.37 127.85 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 p -117.4 149.86 39.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.503 -0.748 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.408 HD11 ' CA ' ' A' ' 103' ' ' PHE . 5.6 mm -73.9 141.64 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.228 -0.92 . . . . 0.0 108.896 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' C ' ' N ' ' A' ' 96' ' ' ALA . 14.1 t-160 -93.13 -63.57 1.2 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.116 -0.99 . . . . 0.0 110.015 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -48.63 -18.15 0.23 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.233 -0.917 . . . . 0.0 109.693 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.546 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -62.19 -41.46 98.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.713 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -52.45 -34.03 47.05 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.592 -1.318 . . . . 0.0 109.268 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -91.2 -53.29 4.42 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.3 -1.39 20.12 Favored 'General case' 0 N--CA 1.506 2.335 0 O-C-N 121.092 -1.005 . . . . 0.0 111.128 -178.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 96' ' ' ALA . 44.8 ttt180 57.27 102.27 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.919 -1.113 . . . . 0.0 109.354 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -150.17 135.22 17.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.331 -0.856 . . . . 0.0 109.36 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.2 p -92.19 150.48 20.89 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.337 -0.852 . . . . 0.0 109.339 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.5 -33.35 1.69 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.398 -0.814 . . . . 0.0 109.701 -179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.469 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.46 -38.56 51.23 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -56.31 -15.51 4.09 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.295 -1.121 . . . . 0.0 109.198 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.562 HG12 ' N ' ' A' ' 107' ' ' SER . 33.2 t -80.72 168.6 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.297 -0.877 . . . . 0.0 109.242 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.562 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.2 t -68.73 -22.94 64.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -0.942 . . . . 0.0 109.752 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 152.91 80.79 0.03 OUTLIER Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.83 164.67 25.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.264 -1.139 . . . . 0.0 109.395 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.08 145.03 19.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.066 -1.021 . . . . 0.0 110.326 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.3 mt -102.87 150.77 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.42 ' NH1' ' OD1' ' A' ' 69' ' ' ASP . 37.2 ttm180 -143.67 148.59 35.98 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 109.399 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.515 HD23 HG11 ' A' ' 122' ' ' VAL . 63.5 tp -140.54 139.35 35.02 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.294 -0.879 . . . . 0.0 109.438 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 p -145.19 151.53 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.45 -0.782 . . . . 0.0 109.162 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.472 ' C ' ' N ' ' A' ' 117' ' ' ASP . 82.0 m-20 -90.93 102.97 15.74 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -55.66 -8.85 0.43 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 108.456 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.472 ' N ' ' C ' ' A' ' 115' ' ' ASN . 22.9 t70 -86.84 -52.21 5.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.747 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -95.71 -6.64 39.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.324 -0.86 . . . . 0.0 109.641 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 52.01 42.31 30.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.374 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.9 m -121.21 128.0 52.01 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.66 -0.65 . . . . 0.0 109.25 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.581 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 30.6 mp0 -52.2 125.15 14.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.84 . . . . 0.0 109.529 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 113' ' ' LEU . 54.6 t -87.06 -54.14 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 0.0 109.643 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -171.67 174.73 4.21 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.781 -1.199 . . . . 0.0 110.44 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -150.13 132.75 15.81 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -103.6 147.91 26.63 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.375 -0.828 . . . . 0.0 109.755 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -106.38 106.52 17.08 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 131' ' ' ALA . 18.4 mt -71.83 -36.66 70.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.191 -0.943 . . . . 0.0 109.716 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.2 m -47.14 -24.35 0.67 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.005 -1.06 . . . . 0.0 109.417 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.17 -54.71 3.32 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.281 -0.887 . . . . 0.0 109.955 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -79.75 -1.83 40.42 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.265 -0.897 . . . . 0.0 110.099 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.541 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -65.27 -53.02 50.43 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.251 -0.906 . . . . 0.0 110.178 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 59.9 p -55.19 -0.3 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.376 -0.827 . . . . 0.0 110.27 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.7 m -83.21 -34.05 25.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.839 -1.163 . . . . 0.0 110.295 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.75 -149.27 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.0 -1.062 . . . . 0.0 109.503 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.545 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 22.4 m -112.17 -39.04 4.57 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -113.83 164.04 14.27 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.447 ' C ' ' SD ' ' A' ' 137' ' ' MET . 2.6 ppp? -164.85 157.5 16.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.997 -1.065 . . . . 0.0 110.164 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.4 tt -102.93 120.31 40.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.502 -0.749 . . . . 0.0 109.03 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -64.38 -50.82 66.16 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.989 -1.07 . . . . 0.0 109.343 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -177.32 -155.81 14.63 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.339 -1.41 . . . . 0.0 110.057 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -151.67 143.28 23.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.257 -1.143 . . . . 0.0 110.451 -179.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 142' ' ' LEU . 8.8 mp -99.63 146.0 26.96 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -151.17 166.49 30.69 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.879 -1.138 . . . . 0.0 109.835 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.545 HH11 ' CG ' ' A' ' 85' ' ' ASP . 14.7 ptm180 -88.6 149.73 23.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.408 -0.808 . . . . 0.0 109.986 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -162.72 137.52 6.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.382 -0.824 . . . . 0.0 109.331 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 13.0 m120 52.98 20.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.315 -0.866 . . . . 0.0 109.853 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.44 5.54 88.5 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -127.8 147.88 50.43 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.455 -1.027 . . . . 0.0 109.305 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -67.55 151.6 47.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.319 -0.863 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -152.01 145.74 25.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.0 109.119 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 28.4 t80 -89.7 156.78 18.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.291 -0.881 . . . . 0.0 109.895 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.549 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 19.2 tpt180 -152.42 122.28 6.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.414 -0.804 . . . . 0.0 108.949 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.24 154.7 27.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 88.5 t -137.09 -35.42 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.425 -0.797 . . . . 0.0 108.856 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 60.56 84.73 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -123.09 163.23 20.92 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.68 134.03 4.95 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.022 -1.231 . . . . 0.0 110.022 -179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -148.92 158.8 44.45 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.503 -0.998 . . . . 0.0 108.603 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -43.0 -49.61 6.0 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.391 -0.818 . . . . 0.0 110.517 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 119.34 118.06 2.71 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.525 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -168.53 85.02 0.09 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 163' ' ' ALA . 0.3 OUTLIER -47.19 -13.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -1.144 . . . . 0.0 109.713 -179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 162' ' ' LEU . . . -85.58 -46.11 11.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.087 -1.008 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 73.2 m -89.63 -40.31 12.66 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.246 -0.909 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 81.2 t -56.29 -23.56 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.0 109.707 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 23.7 p -85.11 -51.74 6.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.111 -0.993 . . . . 0.0 110.363 -179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.599 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -79.56 -37.86 35.44 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.078 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.411 ' CB ' ' O ' ' A' ' 164' ' ' SER . 14.3 tt0 -52.0 -30.54 25.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.97 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -78.58 -19.65 52.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.14 -0.975 . . . . 0.0 109.323 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.21 -55.28 3.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 9.6 pt -76.56 139.73 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -1.135 . . . . 0.0 109.394 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -81.19 114.06 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 0.0 109.469 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.5 -159.5 0.24 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.916 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.489 179.949 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.1 ptt? -175.21 -179.14 1.28 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.236 -0.915 . . . . 0.0 109.469 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.523 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 27.0 pttt -143.83 7.17 1.43 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.299 -0.876 . . . . 0.0 109.461 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 6.6 m120 -146.2 128.24 15.56 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.184 -0.947 . . . . 0.0 109.203 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 t -121.3 150.43 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.6 tt -146.51 113.44 6.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.243 -0.911 . . . . 0.0 109.269 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.53 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.9 t -86.37 151.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.284 -0.885 . . . . 0.0 109.197 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -130.64 127.2 5.16 Favored Glycine 0 N--CA 1.497 2.756 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -133.13 124.21 27.11 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -146.68 150.86 23.17 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 27.1 p90 -161.43 153.19 19.26 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.363 -1.081 . . . . 0.0 109.974 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -101.24 101.67 12.41 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.607 -0.683 . . . . 0.0 109.344 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.81 170.84 10.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.2 OUTLIER -132.5 106.87 8.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.462 -0.774 . . . . 0.0 109.197 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 76.9 p -83.26 105.77 14.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.248 -0.908 . . . . 0.0 109.598 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.35 -57.19 3.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.289 -0.882 . . . . 0.0 109.113 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -155.96 15.74 0.35 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.378 -0.826 . . . . 0.0 109.479 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.42 -16.47 1.29 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.66 168.64 18.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.141 -1.211 . . . . 0.0 109.618 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.421 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 8.9 p30 -176.55 150.87 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.378 -0.826 . . . . 0.0 109.362 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -96.35 142.1 28.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.176 -0.953 . . . . 0.0 109.438 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -141.18 99.82 3.67 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.269 -0.894 . . . . 0.0 109.91 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -84.83 163.43 19.06 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -135.85 118.03 15.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.376 -0.828 . . . . 0.0 109.538 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.28 135.74 39.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.354 -0.841 . . . . 0.0 109.264 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.7 m -149.07 167.61 25.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.0 109.782 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.2 156.41 35.18 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -132.83 131.46 41.06 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.487 -0.758 . . . . 0.0 109.519 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -79.93 141.03 36.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.303 -0.873 . . . . 0.0 109.668 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.87 126.16 13.93 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.106 -0.997 . . . . 0.0 109.374 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.459 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -73.42 163.88 27.45 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.141 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.413 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -83.49 1.63 40.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.15 -0.969 . . . . 0.0 108.972 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -77.3 -8.22 57.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.387 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.8 -7.08 52.69 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -142.09 138.32 31.61 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.477 -1.013 . . . . 0.0 108.816 179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -73.13 147.37 9.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 121.226 -0.921 . . . . 0.0 109.446 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.592 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -68.78 6.61 0.83 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.81 98.0 0.19 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.487 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.2 OUTLIER -55.04 -27.33 43.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.081 -1.246 . . . . 0.0 108.858 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.47 -2.08 0.11 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.392 -0.818 . . . . 0.0 109.709 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 29' ' ' LEU . 9.2 m-20 -89.81 20.32 4.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.98 -1.075 . . . . 0.0 108.985 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.625 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 6.3 p90 -90.73 124.03 34.78 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.373 -0.829 . . . . 0.0 109.155 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 77.7 mt -93.06 136.92 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.333 -0.854 . . . . 0.0 109.709 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -137.86 -163.21 1.41 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -44.97 -15.38 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.178 -0.951 . . . . 0.0 110.602 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' N ' ' O ' ' A' ' 44' ' ' PHE . 27.0 t30 -64.99 -17.69 64.65 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.918 -1.114 . . . . 0.0 109.695 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 49' ' ' LYS . 46.6 t30 -158.84 113.71 2.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.132 -0.98 . . . . 0.0 109.247 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.588 ' N ' HD12 ' A' ' 48' ' ' LEU . 7.5 mp -82.07 4.31 23.49 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.287 -0.883 . . . . 0.0 109.701 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 1.8 tmmm? -152.85 121.69 6.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.078 -1.014 . . . . 0.0 109.469 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 54' ' ' SER . 18.0 p -82.54 149.93 27.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.302 -0.874 . . . . 0.0 109.262 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.21 -48.83 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.187 -0.946 . . . . 0.0 109.494 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -116.44 1.51 13.0 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.648 -0.657 . . . . 0.0 109.43 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.71 -16.47 61.62 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 50' ' ' SER . 2.0 m 60.26 8.54 1.6 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -1.119 . . . . 0.0 109.346 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 77.0 t -93.18 151.74 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.297 -0.877 . . . . 0.0 109.104 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 m -147.19 127.54 13.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.079 -1.013 . . . . 0.0 109.621 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -93.03 130.1 38.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.349 -0.845 . . . . 0.0 109.438 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 55.5 m -56.83 -44.86 82.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.907 . . . . 0.0 109.444 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.14 174.12 27.43 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -126.23 110.84 13.89 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.639 -0.918 . . . . 0.0 109.277 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 16.3 m120 -85.07 142.17 29.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.27 -0.894 . . . . 0.0 109.393 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -86.62 -1.73 57.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.4 p -147.57 -34.74 0.24 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.33 -0.856 . . . . 0.0 109.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' OD1' ' A' ' 70' ' ' ASP . . . 65.96 16.29 63.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -58.03 111.46 1.19 Allowed 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.275 -1.132 . . . . 0.0 109.361 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 68' ' ' GLY . . . 160.82 106.81 0.22 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -52.31 89.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -1.16 . . . . 0.0 109.442 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . 160.08 -149.22 18.56 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 15.5 t70 -78.39 171.19 15.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.162 . . . . 0.0 109.448 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.425 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 14.2 m-20 -152.86 -35.4 0.11 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.217 -0.927 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -142.49 148.02 36.99 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.248 -0.907 . . . . 0.0 109.429 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 30.4 m -157.17 177.63 11.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.305 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -146.14 122.5 10.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.172 -0.955 . . . . 0.0 109.259 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.5 131.51 43.03 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 96.6 mt -135.59 146.71 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.4 -0.813 . . . . 0.0 109.785 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -125.08 108.85 12.23 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' A' ' 79' ' ' ALA . 17.8 mt -71.84 -40.7 68.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.085 -1.009 . . . . 0.0 110.039 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -50.63 -10.33 0.06 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.085 -1.009 . . . . 0.0 109.489 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -113.34 21.23 15.43 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.441 -0.787 . . . . 0.0 109.772 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 81' ' ' PRO . 36.4 t -103.69 105.79 49.31 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.302 -0.874 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 80' ' ' VAL . 74.9 Cg_exo -49.19 -170.47 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.009 1.806 . . . . 0.0 112.439 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -93.19 4.18 73.83 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -66.8 -57.79 6.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -1.188 . . . . 0.0 109.22 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.4 p -89.15 148.84 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.387 -0.82 . . . . 0.0 108.987 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.413 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 91.0 m-20 -128.68 -13.6 4.72 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.489 -0.757 . . . . 0.0 109.668 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -141.94 130.48 22.59 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 67.6 mt -132.31 123.75 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 17.3 pt -104.41 172.73 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.299 -0.875 . . . . 0.0 110.296 -179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -140.86 128.36 21.31 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.7 m -139.02 157.64 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.081 -1.012 . . . . 0.0 110.869 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -116.82 144.71 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 19.5 p -140.68 143.77 35.28 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.054 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 4.9 mm -74.39 138.81 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.403 ' O ' ' N ' ' A' ' 96' ' ' ALA . 18.7 t-80 -94.56 -63.72 1.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.155 -0.966 . . . . 0.0 110.087 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.421 ' OD2' ' O ' ' A' ' 20' ' ' ASP . 81.2 m-20 -48.68 -18.3 0.25 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.278 -0.889 . . . . 0.0 109.683 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 100' ' ' ARG . . . -54.23 -51.28 64.95 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.721 -179.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -54.68 -27.5 40.72 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.684 -1.26 . . . . 0.0 109.713 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.79 -53.56 4.35 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.162 -0.962 . . . . 0.0 111.273 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -111.83 -4.44 14.61 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 121.202 -0.936 . . . . 0.0 110.825 -178.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' A' ' 96' ' ' ALA . 54.3 ttt180 58.96 97.41 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.064 -1.023 . . . . 0.0 109.553 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -153.14 145.46 23.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.378 -0.826 . . . . 0.0 109.2 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.7 p -97.53 154.72 17.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.288 -0.882 . . . . 0.0 109.591 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -46.41 -31.29 2.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.425 -0.797 . . . . 0.0 109.395 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.482 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -52.84 -37.66 52.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.3 mm-40 -59.5 -13.61 9.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.36 -1.082 . . . . 0.0 109.264 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' SER . 29.0 t -80.64 166.19 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.332 -0.855 . . . . 0.0 109.223 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 54.4 m -66.79 -27.27 67.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.661 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 160.14 77.01 0.02 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.56 158.29 31.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -1.139 . . . . 0.0 109.406 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 110' ' ' PHE . 33.9 p90 -148.93 170.04 19.21 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.256 -0.902 . . . . 0.0 109.712 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.0 mt -137.67 150.44 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.4 ttp180 -145.2 153.73 41.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.056 -1.028 . . . . 0.0 109.606 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -142.43 118.94 10.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.909 . . . . 0.0 108.817 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.7 p -127.25 152.71 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.484 -0.76 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 117' ' ' ASP . 5.3 p30 -91.84 103.23 15.8 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.57 -6.09 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 108.926 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 115' ' ' ASN . 20.1 t0 -88.55 -52.35 5.21 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.424 -0.798 . . . . 0.0 109.847 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.47 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.3 m120 -93.29 -12.87 29.07 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 109.738 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 59.22 49.94 8.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.521 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 10.4 p -135.71 106.45 6.57 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -45.2 125.34 5.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.348 -0.845 . . . . 0.0 109.94 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.51 -51.36 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.613 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -178.4 174.94 1.21 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.008 -1.057 . . . . 0.0 110.27 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.83 133.49 23.67 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.34 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.122 -0.986 . . . . 0.0 109.548 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -99.72 114.7 27.99 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.272 -0.892 . . . . 0.0 109.287 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.562 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 96.8 mt -83.98 -39.11 20.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.147 -0.971 . . . . 0.0 109.847 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 18.1 p -46.98 -28.79 1.76 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.091 . . . . 0.0 109.412 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -95.45 -54.2 3.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.418 -0.801 . . . . 0.0 110.065 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -77.29 -3.22 38.79 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.206 -0.934 . . . . 0.0 110.485 -179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -62.29 -51.25 68.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.978 -1.076 . . . . 0.0 109.854 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 20.9 t -58.73 1.43 0.06 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.299 -0.875 . . . . 0.0 109.838 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.522 ' H ' ' C ' ' A' ' 131' ' ' ALA . 8.3 m -87.34 -33.28 19.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 110.347 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -172.95 -144.67 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.777 -1.202 . . . . 0.0 109.966 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.533 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -130.19 -34.27 1.66 Allowed 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -118.37 155.27 30.98 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.454 ' C ' ' SD ' ' A' ' 137' ' ' MET . 10.9 tmm? -164.33 153.87 13.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 0.0 109.525 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -96.57 121.15 38.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.374 -0.828 . . . . 0.0 109.216 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -60.7 -42.64 97.59 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.951 -1.093 . . . . 0.0 109.472 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.73 -149.14 7.01 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.433 -1.365 . . . . 0.0 110.456 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.497 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 23.6 tt0 -151.71 166.75 30.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.522 -0.987 . . . . 0.0 109.53 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.497 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 6.9 tp -144.38 135.37 25.16 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 8.7 p90 -150.57 166.07 31.38 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.802 -1.187 . . . . 0.0 110.333 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 15.0 ptm180 -85.17 148.7 25.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.493 -0.754 . . . . 0.0 109.728 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -154.75 126.09 7.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -0.859 . . . . 0.0 109.266 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 0.8 OUTLIER 55.99 23.24 6.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.357 -179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 82.46 12.09 80.96 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -127.82 139.33 52.71 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.519 -0.989 . . . . 0.0 109.4 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -67.32 149.58 50.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.282 -0.886 . . . . 0.0 109.435 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.487 ' O ' HD12 ' A' ' 142' ' ' LEU . 51.2 tttp -141.12 165.52 27.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.345 -0.847 . . . . 0.0 108.906 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 113' ' ' LEU . 51.9 t80 -133.91 137.62 45.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.443 -0.785 . . . . 0.0 109.679 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -143.33 122.48 12.93 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.353 -0.842 . . . . 0.0 109.162 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -85.54 154.99 21.37 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.213 -0.929 . . . . 0.0 109.75 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 9.3 t -134.55 -32.27 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.452 -0.78 . . . . 0.0 109.206 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.35 87.11 0.02 OUTLIER Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -145.5 116.38 7.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.34 -1.094 . . . . 0.0 109.576 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -85.88 149.49 23.3 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.3 p90 -150.27 133.31 16.14 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.257 -1.143 . . . . 0.0 109.485 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -90.91 48.22 1.5 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.205 -0.934 . . . . 0.0 109.475 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -80.48 -33.94 30.06 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.431 ' O ' HG23 ' A' ' 165' ' ' VAL . . . 91.99 149.81 24.76 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.667 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -65.13 -13.44 58.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -1.162 . . . . 0.0 108.878 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -81.04 -44.18 18.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.885 . . . . 0.0 109.453 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 10.2 m -89.47 -43.36 10.9 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.277 -0.889 . . . . 0.0 109.42 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 161' ' ' GLY . 78.1 t -50.26 -20.74 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.857 . . . . 0.0 109.792 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 52.0 t -74.28 -60.24 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.158 -0.964 . . . . 0.0 110.444 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.85 -19.0 29.59 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.08 -1.013 . . . . 0.0 110.128 -179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -56.69 -45.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.087 -1.008 . . . . 0.0 109.567 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -74.72 9.43 1.83 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -0.826 . . . . 0.0 109.116 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -152.14 27.79 0.9 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.4 tt -75.16 130.76 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.271 -1.134 . . . . 0.0 109.504 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -81.99 109.81 16.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.274 -0.891 . . . . 0.0 109.427 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.37 134.63 36.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.263 -0.898 . . . . 0.0 109.536 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.461 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.5 p . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.3 mtt -74.08 88.9 1.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 0.0 109.405 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' O ' ' OD1' ' A' ' 4' ' ' ASN . 55.5 mtpt -85.6 -19.84 30.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.217 -0.927 . . . . 0.0 109.428 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.412 ' OD1' ' O ' ' A' ' 3' ' ' LYS . 26.2 m-20 -146.32 128.43 15.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.31 -0.869 . . . . 0.0 109.46 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -117.02 152.21 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.562 -0.711 . . . . 0.0 109.16 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' C ' HD23 ' A' ' 6' ' ' LEU . 3.3 tt -149.01 107.43 3.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.308 -0.87 . . . . 0.0 109.302 -179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 p -86.39 150.99 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 108.904 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -128.97 137.07 9.36 Favored Glycine 0 N--CA 1.498 2.833 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 15.6 tp -139.61 125.01 19.08 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -151.55 154.58 25.64 Favored Glycine 0 N--CA 1.494 2.511 0 C-N-CA 119.267 -1.444 . . . . 0.0 110.108 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -160.49 153.9 22.07 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.441 -1.034 . . . . 0.0 109.479 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -82.74 127.17 33.18 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.823 . . . . 0.0 109.574 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.483 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.6 122.21 27.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 109.463 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -87.69 106.77 18.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.181 -0.95 . . . . 0.0 109.379 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.9 m -99.68 133.02 44.62 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.306 -0.872 . . . . 0.0 109.481 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 75.4 m -157.03 -79.2 0.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -92.36 24.15 3.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 108.948 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 89.38 -1.31 81.97 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -84.13 174.46 10.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.283 -1.128 . . . . 0.0 109.547 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -175.85 -163.86 0.12 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.291 -0.881 . . . . 0.0 109.388 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -139.86 146.71 39.66 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.367 -0.833 . . . . 0.0 109.201 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 23' ' ' LEU . 43.2 t0 -141.02 134.65 30.15 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.267 -0.896 . . . . 0.0 109.822 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 ' CD2' HD13 ' A' ' 93' ' ' ILE . 37.4 mt -118.74 163.27 17.11 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -130.48 123.39 29.6 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.394 -0.816 . . . . 0.0 109.808 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.42 133.36 42.91 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.356 -0.84 . . . . 0.0 109.128 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 94.2 p -149.64 167.99 24.85 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.246 -0.909 . . . . 0.0 109.691 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.47 ' HB2' ' CD2' ' A' ' 89' ' ' PHE . . . -134.08 134.7 42.62 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -107.24 134.71 49.93 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.402 -0.811 . . . . 0.0 109.927 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.746 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -84.31 150.89 25.1 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.312 -0.868 . . . . 0.0 109.508 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.95 127.62 13.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.149 -0.97 . . . . 0.0 108.951 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.52 169.43 16.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.087 -1.008 . . . . 0.0 109.584 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.82 -3.83 58.81 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.894 . . . . 0.0 109.239 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -73.29 -8.24 54.97 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.194 -0.941 . . . . 0.0 109.311 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.94 51.52 Favored Glycine 0 N--CA 1.497 2.713 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -144.14 138.36 28.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.45 -1.03 . . . . 0.0 108.847 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.552 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.7 p -66.22 145.22 14.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.181 -0.95 . . . . 0.0 109.563 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.5 ptt180 -68.44 7.23 0.64 Allowed 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.552 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.27 100.7 0.19 Allowed Glycine 0 N--CA 1.495 2.574 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.7 OUTLIER -56.37 -39.91 73.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -1.139 . . . . 0.0 109.196 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.35 -1.17 0.07 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.656 -0.653 . . . . 0.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.628 ' O ' HD13 ' A' ' 29' ' ' LEU . 29.4 t0 -91.05 25.39 2.47 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.032 -1.043 . . . . 0.0 109.022 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -91.11 138.39 31.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.356 -0.84 . . . . 0.0 109.187 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.7 mm -77.84 134.81 27.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.499 -0.751 . . . . 0.0 109.5 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.622 ' CZ ' ' ND2' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -122.51 -165.4 1.28 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.56 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 27.1 p90 -73.72 -46.16 47.74 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.185 -0.947 . . . . 0.0 110.664 -178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.56 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 29.0 t-20 -55.37 -21.38 15.11 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.963 -1.086 . . . . 0.0 109.575 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.622 ' ND2' ' CZ ' ' A' ' 44' ' ' PHE . 74.3 m-20 -87.16 85.35 7.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.192 -0.942 . . . . 0.0 109.032 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.576 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.1 mp -50.12 -34.3 21.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.217 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.4 pttt -170.74 158.13 5.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 0.0 109.53 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.0 t -84.65 153.82 22.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.262 -0.899 . . . . 0.0 109.381 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -48.65 12.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.181 -0.949 . . . . 0.0 109.474 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -116.12 -4.46 11.96 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.654 -0.654 . . . . 0.0 109.362 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -79.85 -7.5 88.45 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 p 56.05 18.2 3.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.186 -1.185 . . . . 0.0 109.339 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 8.9 t -93.08 147.8 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.88 . . . . 0.0 109.413 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -142.58 126.55 17.28 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.245 -0.91 . . . . 0.0 109.171 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -93.07 127.1 38.48 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.5 m -56.44 -45.11 80.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 153.43 137.05 2.42 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -92.11 110.88 22.26 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.257 -1.143 . . . . 0.0 109.337 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 7.5 m120 -74.8 -170.56 1.1 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.0 109.402 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.423 HH11 ' HG3' ' A' ' 62' ' ' ARG . 21.2 ttm-85 -143.19 7.05 1.56 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.219 -0.926 . . . . 0.0 109.222 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 40.8 p -152.77 -35.09 0.12 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.142 -0.974 . . . . 0.0 109.405 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.76 39.53 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -58.92 122.21 13.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.32 -1.106 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 149.33 124.8 1.34 Allowed Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.45 46.8 0.88 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.212 -1.169 . . . . 0.0 109.443 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -171.37 -157.21 12.85 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -61.99 118.36 7.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -1.131 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 2.0 m-20 -82.96 -43.68 16.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.26 -0.9 . . . . 0.0 109.496 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -126.78 158.12 37.39 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.532 -0.73 . . . . 0.0 109.286 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.431 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.9 t -172.43 162.57 5.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.291 -0.88 . . . . 0.0 109.341 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.4 123.89 14.87 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.258 -0.901 . . . . 0.0 109.191 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.1 mttt -96.64 136.69 36.82 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.382 -0.824 . . . . 0.0 108.975 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.5 mp -136.13 136.18 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -109.38 90.28 3.25 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mt -55.84 -37.99 69.45 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.332 -0.855 . . . . 0.0 109.963 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -50.52 -18.73 0.72 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -0.922 . . . . 0.0 109.818 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.37 -21.5 18.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.129 -0.982 . . . . 0.0 109.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.88 125.05 82.43 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.115 -0.99 . . . . 0.0 109.148 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.03 -161.61 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.885 1.723 . . . . 0.0 112.091 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -89.2 1.35 82.5 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -66.69 -57.6 6.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.14 -1.212 . . . . 0.0 109.211 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 t -85.47 148.98 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.372 -0.83 . . . . 0.0 109.14 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.1 m-20 -130.57 -6.76 4.15 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.532 -0.73 . . . . 0.0 109.469 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -154.56 130.63 10.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.097 -1.002 . . . . 0.0 109.344 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.93 154.38 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.6 pt -139.59 170.09 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.083 -1.011 . . . . 0.0 110.615 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.47 ' CD2' ' HB2' ' A' ' 27' ' ' ALA . 87.6 m-85 -139.64 130.52 26.16 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.77 149.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 91' ' ' VAL . 8.4 p -102.63 128.01 55.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.2 p -113.51 141.99 46.47 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.397 -0.815 . . . . 0.0 109.935 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.61 HG23 ' HB3' ' A' ' 96' ' ' ALA . 3.1 mm -74.36 136.59 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.647 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 33.5 t60 -69.07 -141.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.274 -0.891 . . . . 0.0 109.833 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.647 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 43.5 p30 -57.03 -24.28 52.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.884 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.61 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -49.42 -19.27 0.51 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.045 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.411 ' N ' ' C ' ' A' ' 95' ' ' ASP . 14.9 tt0 -69.74 -45.24 68.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.185 -0.947 . . . . 0.0 109.363 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.534 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -62.2 -51.86 66.08 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.873 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.534 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.9 mpt_? -71.52 12.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.483 ' H ' ' C ' ' A' ' 98' ' ' ALA . 16.5 mmm180 56.37 81.85 0.12 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.549 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.595 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 23.5 mt-30 -150.47 75.37 1.22 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.216 -0.928 . . . . 0.0 109.313 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.444 ' O ' ' N ' ' A' ' 104' ' ' GLY . 21.4 p -56.88 157.89 5.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.383 -0.823 . . . . 0.0 109.951 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.88 -21.55 0.06 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.649 -0.657 . . . . 0.0 109.686 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.459 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -59.8 -41.06 97.46 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -179.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 18.5 mm100 -57.63 -16.07 9.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.015 -1.285 . . . . 0.0 109.53 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 107' ' ' SER . 25.4 t -71.43 165.82 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 109.115 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.514 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -70.75 -31.23 67.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.946 . . . . 0.0 109.78 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 166.33 75.51 0.03 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.28 164.55 25.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -1.184 . . . . 0.0 109.227 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -152.82 169.74 22.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.217 -0.927 . . . . 0.0 109.99 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.02 149.19 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -142.94 157.39 44.61 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.038 -1.039 . . . . 0.0 109.852 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.9 tp -141.31 138.69 33.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.369 -0.832 . . . . 0.0 108.959 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -151.36 152.08 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.231 -0.918 . . . . 0.0 109.655 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.477 ' C ' ' H ' ' A' ' 117' ' ' ASP . 3.4 m120 -92.24 103.27 15.75 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -55.36 -7.87 0.28 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.135 -0.978 . . . . 0.0 108.725 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.477 ' H ' ' C ' ' A' ' 115' ' ' ASN . 25.3 t0 -89.81 -52.14 5.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -87.49 -17.71 31.5 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.32 -0.862 . . . . 0.0 109.871 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 59.28 52.3 6.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 109.292 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.6 p -138.17 115.38 11.01 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.527 -0.733 . . . . 0.0 109.174 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -46.11 129.83 10.02 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -0.895 . . . . 0.0 109.912 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.8 t -88.95 -57.73 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.203 -0.936 . . . . 0.0 109.357 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -173.92 174.75 2.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.986 -1.071 . . . . 0.0 110.199 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.571 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.1 OUTLIER -143.63 132.1 22.24 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.476 -0.765 . . . . 0.0 109.13 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -94.13 146.04 24.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.257 -0.902 . . . . 0.0 109.377 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -98.63 114.56 27.08 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.234 -0.916 . . . . 0.0 109.398 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.553 ' O ' ' N ' ' A' ' 131' ' ' ALA . 72.8 mt -81.21 -41.22 22.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.203 -0.935 . . . . 0.0 109.617 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 25.1 p -46.88 -25.9 0.87 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.999 -1.063 . . . . 0.0 109.515 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -95.03 -54.62 3.38 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.826 . . . . 0.0 109.884 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.77 -3.42 41.23 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.271 -0.893 . . . . 0.0 110.141 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -64.5 -55.44 20.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.207 -0.933 . . . . 0.0 109.778 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 22.5 t -53.39 -3.83 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.516 -0.74 . . . . 0.0 109.908 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.53 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.3 m -81.71 -33.57 31.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.029 -1.044 . . . . 0.0 110.299 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -173.63 -146.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.892 -1.13 . . . . 0.0 109.623 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -120.36 -31.15 4.42 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -107.84 164.32 12.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.5 tpt -164.03 146.11 9.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.924 -1.11 . . . . 0.0 109.908 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.7 tt -104.44 125.72 50.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.556 -0.715 . . . . 0.0 109.381 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.73 -47.11 61.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 109.33 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -174.91 -155.79 13.06 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.533 ' O ' ' CD1' ' A' ' 151' ' ' PHE . 7.4 pt-20 -143.77 164.54 30.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.222 -1.163 . . . . 0.0 109.414 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 10.1 tp -128.9 135.38 48.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -150.5 166.1 31.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.905 -1.122 . . . . 0.0 109.88 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -104.93 143.35 33.28 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.543 -0.723 . . . . 0.0 109.977 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 5.2 p80 -127.15 -104.19 0.33 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.617 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 0.1 OUTLIER -70.77 62.79 0.28 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.162 -0.961 . . . . 0.0 109.351 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 145' ' ' HIS . . . 59.24 12.8 18.46 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.538 ' O ' ' CD2' ' A' ' 145' ' ' HIS . 32.6 mt-10 -128.14 159.76 34.12 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.515 -0.991 . . . . 0.0 109.307 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 89.3 m95 -87.2 152.57 22.21 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.261 -0.899 . . . . 0.0 110.31 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -152.11 125.82 8.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.411 -0.805 . . . . 0.0 109.011 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.533 ' CD1' ' O ' ' A' ' 141' ' ' GLU . 30.3 t80 -89.34 150.48 22.55 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.0 109.65 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.3 OUTLIER -147.01 117.3 7.37 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.32 -0.862 . . . . 0.0 109.389 -179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.93 154.83 33.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.225 -0.922 . . . . 0.0 109.442 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.25 -34.12 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.203 -0.936 . . . . 0.0 109.432 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.12 89.01 0.06 OUTLIER Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -139.66 104.53 4.94 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.429 -1.042 . . . . 0.0 109.448 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -87.42 146.06 19.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -150.55 156.89 42.29 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.2 -1.177 . . . . 0.0 109.453 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -110.12 14.91 22.75 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.558 -0.714 . . . . 0.0 109.299 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -48.84 -28.08 6.95 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 87.66 142.91 8.07 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.7 tp -52.71 -21.2 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -1.119 . . . . 0.0 109.351 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -73.24 -52.25 14.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 4.9 m -84.22 -43.36 14.98 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.183 -0.948 . . . . 0.0 109.75 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 79.7 t -49.01 -20.82 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.081 -1.012 . . . . 0.0 109.701 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 45.8 t -81.23 -57.6 3.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 110.517 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.41 -32.45 24.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 110.146 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -50.2 -31.64 14.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.257 -0.902 . . . . 0.0 109.667 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -76.22 -19.67 58.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.128 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -94.67 -50.33 2.17 Favored Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 14.0 mm -81.72 103.25 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -1.128 . . . . 0.0 109.52 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -77.0 132.16 38.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.273 -0.892 . . . . 0.0 109.424 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.38 -56.47 4.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.471 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.474 -179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.4 m . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 12.1 mmt -80.0 98.21 7.11 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.286 -0.884 . . . . 0.0 109.577 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -90.99 -18.24 24.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.284 -0.885 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -146.26 128.4 15.65 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.26 -0.9 . . . . 0.0 109.454 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -119.88 151.96 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 108.831 -0.804 . . . . 0.0 108.831 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.0 tt -148.77 112.91 5.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.236 -0.915 . . . . 0.0 109.745 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 24.5 m -86.0 151.09 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.06 134.25 7.91 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.4 tp -139.01 121.72 16.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -147.92 160.13 28.23 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -163.02 155.76 18.94 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.297 -1.119 . . . . 0.0 110.098 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.29 122.79 28.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.559 -0.713 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -82.07 158.39 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.302 -0.874 . . . . 0.0 109.343 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -132.83 106.72 7.89 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.413 -0.804 . . . . 0.0 109.269 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.2 m -92.84 128.8 38.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 109.448 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 91.8 m -153.28 -78.05 0.11 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.373 -0.829 . . . . 0.0 108.99 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -87.73 22.29 2.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.338 -0.851 . . . . 0.0 109.11 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 85.76 -8.88 70.59 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -84.25 177.97 7.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -1.125 . . . . 0.0 109.504 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -176.21 167.25 2.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.43 ' CZ ' ' O ' ' A' ' 105' ' ' GLN . 26.8 m-85 -96.18 143.21 27.49 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -141.22 100.89 3.9 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.3 -0.875 . . . . 0.0 109.878 -179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 23' ' ' LEU . 9.2 mp -88.0 163.24 16.4 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.213 -0.929 . . . . 0.0 108.504 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -130.53 124.22 31.39 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.384 -0.822 . . . . 0.0 109.9 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.31 137.73 36.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.375 -0.828 . . . . 0.0 109.026 179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 60.6 m -149.67 167.89 25.15 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 109.711 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.52 142.74 45.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.487 -0.758 . . . . 0.0 108.985 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -125.98 137.38 53.67 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.48 -0.762 . . . . 0.0 109.658 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.2 mp -84.96 160.46 20.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.388 -0.82 . . . . 0.0 109.389 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -146.41 133.19 20.03 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.099 -1.0 . . . . 0.0 108.801 178.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 35' ' ' LYS . . . -87.49 175.27 8.03 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.947 -1.096 . . . . 0.0 109.599 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -85.1 -11.65 54.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.3 -0.875 . . . . 0.0 109.57 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -72.32 -3.73 25.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.172 -0.955 . . . . 0.0 109.57 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.11 -8.31 59.11 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 35.5 mttm -127.58 174.67 8.87 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 29' ' ' LEU . 3.9 t -89.86 137.2 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.099 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -60.98 -4.02 0.92 Allowed 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 177.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 172.33 83.41 0.05 OUTLIER Glycine 0 N--CA 1.488 2.139 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.6 p-10 -46.9 -42.04 16.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.413 -1.051 . . . . 0.0 109.558 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.42 3.9 0.11 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.656 -0.652 . . . . 0.0 109.724 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' O ' HD13 ' A' ' 29' ' ' LEU . 39.4 t0 -92.63 25.71 2.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.089 -1.007 . . . . 0.0 109.286 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' SG ' ' A' ' 166' ' ' CYS . 23.9 p90 -89.75 127.51 35.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.268 -0.895 . . . . 0.0 109.095 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.43 ' O ' ' CG2' ' A' ' 43' ' ' ILE . 2.5 tp -76.86 124.68 35.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.405 -0.81 . . . . 0.0 110.101 -178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -103.69 -168.72 1.54 Allowed 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -76.84 -0.45 24.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.172 -0.955 . . . . 0.0 110.092 -179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -80.13 -52.81 7.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.073 -1.017 . . . . 0.0 109.561 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.428 ' OD1' ' O ' ' A' ' 49' ' ' LYS . 45.6 t-20 -81.09 83.63 6.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.155 -0.965 . . . . 0.0 109.28 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.9 mt -54.25 -23.68 15.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.352 -0.843 . . . . 0.0 109.838 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 1.8 tmmm? -151.85 121.64 7.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.04 -1.038 . . . . 0.0 109.532 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 m -70.33 155.04 41.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.9 . . . . 0.0 109.4 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.02 -48.74 11.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.552 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -116.07 -1.01 12.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.604 -0.685 . . . . 0.0 109.355 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.85 -14.98 80.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t 59.49 13.27 3.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.0 109.525 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.436 HG22 HG23 ' A' ' 75' ' ' ILE . 52.2 t -93.3 151.61 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.249 -0.907 . . . . 0.0 109.133 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.5 p -144.79 125.2 13.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.215 -0.928 . . . . 0.0 109.472 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.5 t-80 -92.61 127.34 38.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.319 -0.863 . . . . 0.0 109.101 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.8 m -56.37 -42.09 77.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.169 -0.957 . . . . 0.0 109.362 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 155.33 128.97 1.18 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.5 t0 -89.58 110.79 21.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.272 -1.134 . . . . 0.0 109.217 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 70' ' ' ASP . 70.7 m-20 -80.21 -166.38 1.03 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.217 -0.927 . . . . 0.0 109.503 -179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 79.4 mtm180 -148.0 12.92 0.99 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.287 -0.883 . . . . 0.0 109.363 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 38.1 p -153.85 -34.23 0.11 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.0 109.579 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.57 6.83 37.81 Favored Glycine 0 N--CA 1.497 2.765 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -59.15 110.6 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.343 -1.092 . . . . 0.0 109.45 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 161.44 125.56 0.78 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -78.83 60.9 2.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -1.152 . . . . 0.0 109.535 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 169.14 -147.49 11.19 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -71.62 115.8 11.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.269 -1.136 . . . . 0.0 109.477 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' O ' ' ND2' ' A' ' 61' ' ' ASN . 49.6 m-20 -80.27 -38.13 31.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.411 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -128.31 144.7 51.16 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.561 -0.712 . . . . 0.0 109.105 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.478 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.6 m -164.37 159.44 19.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.926 . . . . 0.0 109.522 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.1 132.29 29.78 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.339 -0.851 . . . . 0.0 109.467 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -110.75 135.47 51.29 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.436 HG23 HG22 ' A' ' 55' ' ' VAL . 5.0 mp -135.99 116.23 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.428 -0.795 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mttm -81.91 91.6 6.59 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 ' C ' ' H ' ' A' ' 79' ' ' ALA . 15.1 mt -57.9 -26.13 61.76 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.332 -0.855 . . . . 0.0 109.746 -178.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 p30 -63.74 4.3 0.29 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.832 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.487 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -124.36 2.57 8.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.439 -0.788 . . . . 0.0 109.302 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.4 t -82.03 125.81 76.42 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.3 -0.875 . . . . 0.0 109.094 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.15 -161.61 0.14 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.867 1.711 . . . . 0.0 112.156 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.6 3.7 78.8 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -63.82 -55.22 24.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -1.222 . . . . 0.0 109.168 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.9 p -88.14 149.0 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.0 109.212 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.527 ' OD2' ' NH1' ' A' ' 144' ' ' ARG . 5.8 t70 -120.08 -12.63 9.08 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.608 -0.683 . . . . 0.0 109.343 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -157.03 131.17 8.4 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.41 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 65.6 mt -111.8 154.1 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.7 pt -141.73 151.41 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.062 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -127.61 127.34 43.66 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 m -136.75 149.25 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.238 -0.914 . . . . 0.0 110.229 -178.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.2 t -104.87 156.2 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.0 p -145.07 143.46 30.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.161 -0.962 . . . . 0.0 110.014 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.646 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.06 123.49 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.615 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 8.9 t-160 -62.0 -130.81 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.876 . . . . 0.0 110.052 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.615 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 60.7 m-20 -68.3 -18.73 64.59 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.869 . . . . 0.0 110.113 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.646 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -51.93 -19.37 1.75 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.066 -1.021 . . . . 0.0 108.864 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -73.2 -38.19 66.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -59.17 -49.34 78.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.26 -0.9 . . . . 0.0 109.25 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.08 10.46 4.33 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.298 -0.876 . . . . 0.0 109.034 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 61.92 88.55 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.388 -0.82 . . . . 0.0 109.43 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.534 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 62.6 mt-30 -154.68 76.02 1.0 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.432 ' HA ' HG22 ' A' ' 135' ' ' THR . 85.5 p -56.88 166.94 0.87 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.872 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.473 ' CG ' HD22 ' A' ' 127' ' ' LEU . 7.1 m-85 -46.3 -19.29 0.07 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.485 -0.759 . . . . 0.0 110.172 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.605 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -64.04 -46.06 92.28 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.614 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.43 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . 50.7 mm-40 -56.4 -9.53 0.72 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.931 -1.335 . . . . 0.0 109.381 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 107' ' ' SER . 25.3 t -72.39 165.13 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 108.892 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.502 ' N ' HG12 ' A' ' 106' ' ' VAL . 42.0 m -78.4 -2.91 40.6 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.084 -1.01 . . . . 0.0 109.601 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 131.13 81.71 0.23 Allowed Glycine 0 N--CA 1.498 2.822 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -78.93 164.87 24.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -1.156 . . . . 0.0 109.841 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' CG ' ' O ' ' A' ' 110' ' ' PHE . 38.6 p90 -148.82 124.03 10.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.25 -0.906 . . . . 0.0 109.942 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 1.8 mt -100.97 144.39 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -143.38 158.5 43.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.039 -1.038 . . . . 0.0 110.23 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' CD2' ' CE1' ' A' ' 151' ' ' PHE . 43.6 tp -136.11 137.17 40.76 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.5 p -146.94 149.67 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.492 ' C ' ' N ' ' A' ' 117' ' ' ASP . 86.8 m-20 -90.05 103.19 15.88 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -52.91 -11.17 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.014 -1.054 . . . . 0.0 108.57 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.492 ' N ' ' C ' ' A' ' 115' ' ' ASN . 23.8 t0 -86.15 -50.8 6.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.651 -0.656 . . . . 0.0 109.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.465 ' N ' ' OD1' ' A' ' 118' ' ' ASN . 1.2 m-20 -89.1 -18.24 27.64 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.217 -0.927 . . . . 0.0 109.986 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 58.81 51.99 7.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.529 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 4.7 m -142.45 127.47 18.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.333 -0.854 . . . . 0.0 109.546 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.599 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.5 mp0 -47.87 132.21 14.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.0 109.671 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.65 -46.53 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.385 -0.822 . . . . 0.0 109.888 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -162.47 174.78 12.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.868 -1.145 . . . . 0.0 110.468 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -150.16 153.62 36.62 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.589 -0.694 . . . . 0.0 109.143 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CZ ' ' CG ' ' A' ' 130' ' ' ASP . 19.5 t80 -133.7 137.59 45.36 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.33 -0.856 . . . . 0.0 109.389 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 126' ' ' ASP . 24.1 p-10 -99.68 124.23 44.71 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.262 -0.899 . . . . 0.0 109.164 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 25.7 mt -89.97 -34.14 16.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.274 -0.891 . . . . 0.0 109.777 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 85.8 m -48.16 -34.31 9.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.811 -1.181 . . . . 0.0 109.067 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 47.8 tt0 -95.4 -44.84 7.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.404 -0.81 . . . . 0.0 109.761 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.475 ' CG ' ' CZ ' ' A' ' 125' ' ' TYR . 35.7 m-20 -79.78 -0.28 33.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.195 -0.941 . . . . 0.0 110.038 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.605 ' HB1' ' N ' ' A' ' 104' ' ' GLY . . . -60.77 -53.73 53.85 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.202 -0.936 . . . . 0.0 109.678 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.3 p -57.24 2.89 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.729 -0.607 . . . . 0.0 110.989 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.502 ' H ' ' C ' ' A' ' 131' ' ' ALA . 44.9 p -86.5 -35.1 19.79 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.572 -1.33 . . . . 0.0 110.263 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.427 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER 178.61 -168.96 0.09 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.931 -1.106 . . . . 0.0 110.052 179.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.432 HG22 ' HA ' ' A' ' 102' ' ' SER . 0.8 OUTLIER -114.15 -1.79 13.59 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 179.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -149.17 135.85 19.55 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 9.1 ptm -161.43 158.17 26.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.743 -1.223 . . . . 0.0 110.427 -178.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tt -87.38 123.91 32.83 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.451 -0.781 . . . . 0.0 109.146 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 139' ' ' PHE . 1.4 t80 -79.15 -40.68 30.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.156 -0.965 . . . . 0.0 109.738 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.67 -175.26 32.5 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.378 -1.392 . . . . 0.0 110.129 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' A' ' 142' ' ' LEU . 28.1 tt0 -150.82 164.11 37.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.374 -1.074 . . . . 0.0 109.55 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.439 ' N ' ' CG ' ' A' ' 141' ' ' GLU . 0.5 OUTLIER -142.45 138.94 31.39 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -143.97 166.08 25.95 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.092 -1.005 . . . . 0.0 110.013 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.603 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -89.46 147.38 24.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.361 -0.837 . . . . 0.0 110.004 -179.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -150.07 123.7 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.423 -0.798 . . . . 0.0 109.153 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 54.03 25.49 5.57 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.381 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.81 76.54 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -127.84 134.82 49.44 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.583 -0.951 . . . . 0.0 109.335 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -67.44 145.5 54.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.922 . . . . 0.0 109.333 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -144.61 135.4 24.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.491 ' CE1' ' CD2' ' A' ' 113' ' ' LEU . 87.6 t80 -89.58 153.86 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 0.0 109.914 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.527 ' NH1' ' O ' ' A' ' 153' ' ' ALA . 1.0 OUTLIER -163.21 106.94 1.04 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . 0.527 ' O ' ' NH1' ' A' ' 152' ' ' ARG . . . -69.0 152.69 44.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.815 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 16.8 t -135.9 -32.24 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.449 -0.782 . . . . 0.0 109.319 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 59.85 86.54 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -120.4 106.73 12.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.695 -0.885 . . . . 0.0 109.276 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -91.51 138.03 14.09 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -150.73 125.32 9.62 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.287 -1.125 . . . . 0.0 109.182 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.95 35.23 0.42 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.441 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -78.97 -119.51 0.26 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -169.7 162.5 35.96 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.637 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.99 -13.54 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.162 -1.199 . . . . 0.0 108.967 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -82.97 -46.63 12.67 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 7.1 m -82.6 -44.99 15.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.934 . . . . 0.0 109.551 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 161' ' ' GLY . 53.8 t -48.77 -20.76 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.13 -0.981 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.579 ' SG ' ' CD1' ' A' ' 42' ' ' PHE . 24.8 t -73.85 -61.47 1.83 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 110.089 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -83.58 -30.11 27.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.264 -0.897 . . . . 0.0 109.939 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -52.78 -33.36 48.33 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -0.874 . . . . 0.0 109.996 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -71.91 -19.78 61.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 108.86 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -74.8 -50.74 8.64 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.15 116.65 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.194 -1.18 . . . . 0.0 109.299 179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -65.92 104.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.928 . . . . 0.0 109.561 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.4 -178.48 6.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.251 -0.905 . . . . 0.0 109.456 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.471 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.413 ' OG ' ' N ' ' A' ' 2' ' ' MET . 10.9 t . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.413 ' N ' ' OG ' ' A' ' 1' ' ' SER . 42.5 mtt -73.45 102.87 3.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.904 . . . . 0.0 109.482 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -88.37 -15.57 35.24 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.245 -0.91 . . . . 0.0 109.576 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -146.38 137.27 24.25 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.149 -0.969 . . . . 0.0 109.651 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -125.3 152.31 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 31.2 tp -148.86 118.82 7.13 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.103 -0.998 . . . . 0.0 109.745 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.1 t -85.99 151.38 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.498 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -138.43 116.93 1.35 Allowed Glycine 0 N--CA 1.496 2.686 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 24.4 tp -120.42 132.07 55.08 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -148.07 148.52 20.11 Favored Glycine 0 N--CA 1.495 2.596 0 C-N-CA 119.585 -1.293 . . . . 0.0 109.936 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 29.8 p90 -162.0 162.35 28.88 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.388 -1.066 . . . . 0.0 109.878 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -81.89 131.59 35.26 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.507 -0.746 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.97 116.3 27.92 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.298 -0.877 . . . . 0.0 109.269 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.7 tpp180 -82.43 106.77 14.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.198 -0.939 . . . . 0.0 109.436 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.4 p -107.25 127.3 53.41 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.45 -0.781 . . . . 0.0 109.259 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 p -145.56 -45.79 0.21 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.241 -0.912 . . . . 0.0 109.28 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -156.64 41.93 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.335 -0.853 . . . . 0.0 109.269 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 99.18 -25.27 28.9 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -72.95 133.12 44.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.249 -1.148 . . . . 0.0 109.293 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -158.17 157.57 32.93 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.203 -0.936 . . . . 0.0 109.574 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -96.24 137.95 34.57 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.285 -0.884 . . . . 0.0 109.378 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -141.14 103.99 4.55 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.332 -0.855 . . . . 0.0 109.867 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.5 mp -83.44 133.31 34.92 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -0.99 . . . . 0.0 108.633 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -96.52 118.16 32.44 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.149 -0.969 . . . . 0.0 109.861 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 133.48 42.59 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.326 -0.859 . . . . 0.0 108.902 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.5 t -149.57 168.1 24.47 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.075 -1.015 . . . . 0.0 109.804 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -140.77 135.67 31.72 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.414 -0.804 . . . . 0.0 109.062 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.56 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 2.6 m-85 -112.55 139.74 47.88 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.528 -0.732 . . . . 0.0 109.781 -179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.783 ' N ' HD23 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -81.47 153.47 26.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.864 . . . . 0.0 109.027 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.79 125.95 12.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.148 -0.97 . . . . 0.0 109.171 179.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -80.51 166.89 20.75 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.11 -0.993 . . . . 0.0 109.495 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.6 -1.92 56.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.225 -0.922 . . . . 0.0 109.192 179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -74.88 -7.74 54.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.299 -0.875 . . . . 0.0 109.296 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.67 -4.05 50.03 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -145.44 138.21 26.05 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.389 -1.065 . . . . 0.0 108.932 179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.5 p -67.44 145.48 13.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.208 -0.932 . . . . 0.0 109.625 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.566 HH11 ' CG ' ' A' ' 37' ' ' ARG . 3.1 mtt-85 -67.36 5.68 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 153.22 100.79 0.19 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 1.1 p30 -55.96 -36.09 67.44 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.319 -1.107 . . . . 0.0 109.203 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.495 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -57.42 -1.49 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.669 -0.644 . . . . 0.0 110.027 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ASP . 4.2 m-20 -92.48 25.73 2.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.01 -1.056 . . . . 0.0 108.947 179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 12.8 p90 -90.46 141.06 29.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.562 HD12 ' N ' ' A' ' 43' ' ' ILE . 1.5 mp -91.95 139.54 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.607 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 13.8 p90 -157.62 -157.73 0.68 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.499 -0.75 . . . . 0.0 109.805 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -67.43 60.42 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.561 -0.712 . . . . 0.0 110.144 -179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.411 ' N ' ' O ' ' A' ' 44' ' ' PHE . 13.5 t-20 -171.81 -41.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.028 . . . . 0.0 108.796 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -97.61 92.04 5.71 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' N ' HD12 ' A' ' 48' ' ' LEU . 10.2 mp -45.98 -23.64 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 0.0 109.466 -179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -172.4 156.11 3.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.324 -0.86 . . . . 0.0 109.943 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.437 ' OG ' ' CA ' ' A' ' 53' ' ' GLY . 4.2 p -72.3 159.58 33.82 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.308 -0.87 . . . . 0.0 109.281 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.79 -48.94 9.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.205 -0.934 . . . . 0.0 109.405 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -116.6 -2.22 12.0 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.67 -0.644 . . . . 0.0 109.448 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.437 ' CA ' ' OG ' ' A' ' 50' ' ' SER . . . -79.72 -9.76 86.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 p 56.81 16.28 2.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -1.167 . . . . 0.0 109.464 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 53' ' ' GLY . 3.9 t -93.12 152.09 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.27 -0.893 . . . . 0.0 109.019 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 3.0 m -140.78 126.74 19.39 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.186 -0.946 . . . . 0.0 109.887 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -93.1 130.65 38.65 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.374 -0.828 . . . . 0.0 109.152 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.0 m -63.85 -52.65 59.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.478 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.44 127.63 0.91 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -85.95 119.02 25.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -1.12 . . . . 0.0 109.423 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.416 ' OD1' ' O ' ' A' ' 70' ' ' ASP . 2.5 m-20 -78.17 158.89 28.88 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' HG23 ' A' ' 63' ' ' THR . 18.7 ttm180 -105.34 8.56 33.78 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.556 -0.715 . . . . 0.0 109.426 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 30.2 p -156.11 -35.42 0.08 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.057 -1.027 . . . . 0.0 109.409 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.63 6.36 30.88 Favored Glycine 0 N--CA 1.498 2.774 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.34 119.14 6.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.218 -1.166 . . . . 0.0 109.267 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 145.72 108.73 0.58 Allowed Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.341 -1.503 . . . . 0.0 109.341 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -81.35 50.52 1.46 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -1.135 . . . . 0.0 109.505 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -176.73 90.71 0.08 OUTLIER Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 68' ' ' GLY . 57.0 m-20 50.7 98.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.341 -1.094 . . . . 0.0 109.734 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' O ' ' OD1' ' A' ' 61' ' ' ASN . 79.9 m-20 -77.02 -36.33 56.31 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.213 -0.929 . . . . 0.0 109.387 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 61' ' ' ASN . 84.3 mt-10 -142.16 157.26 45.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.31 -0.868 . . . . 0.0 109.076 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.4 p -165.43 174.08 10.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 109.704 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -147.51 121.36 9.32 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.393 -0.817 . . . . 0.0 108.832 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -96.61 135.29 38.73 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.361 -0.837 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.3 mp -133.32 108.04 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.442 -0.786 . . . . 0.0 109.639 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 mtmm -87.66 81.16 7.75 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.266 -0.896 . . . . 0.0 108.765 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' C ' ' H ' ' A' ' 79' ' ' ALA . 0.3 OUTLIER -50.08 -29.09 8.2 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.27 -0.894 . . . . 0.0 109.174 -179.098 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -66.25 4.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.274 -0.891 . . . . 0.0 109.63 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -129.61 -3.89 4.75 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.478 -0.764 . . . . 0.0 109.343 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -74.52 125.8 89.38 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -0.921 . . . . 0.0 108.776 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -76.49 -170.34 0.87 Allowed 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 121.8 1.667 . . . . 0.0 112.19 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.01 0.76 89.35 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.518 ' O ' ' NE ' ' A' ' 37' ' ' ARG . 43.6 m-20 -62.47 -54.09 45.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.138 -1.213 . . . . 0.0 109.156 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.9 148.86 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.419 -0.801 . . . . 0.0 109.142 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -129.58 -4.48 4.74 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.447 -0.783 . . . . 0.0 109.504 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -154.02 133.96 13.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 109.306 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 66.0 mt -126.51 154.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.639 -0.663 . . . . 0.0 109.257 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.8 pt -137.87 157.56 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.252 -0.905 . . . . 0.0 110.045 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 12.5 m-85 -137.52 134.69 35.99 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.1 m -142.83 157.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.079 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 91' ' ' VAL . 14.2 p -116.92 130.44 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 18.5 p -123.41 143.52 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.365 -0.834 . . . . 0.0 109.957 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.413 HD11 ' N ' ' A' ' 103' ' ' PHE . 3.6 mm -74.17 152.7 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.631 ' CD2' ' H ' ' A' ' 95' ' ' ASP . 63.3 t60 -79.2 -133.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.934 . . . . 0.0 109.75 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.631 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 45.3 p-10 -71.41 -18.5 62.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.303 -0.873 . . . . 0.0 109.814 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.4 ' HB3' ' CG2' ' A' ' 93' ' ' ILE . . . -51.6 -19.24 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.051 -1.03 . . . . 0.0 108.886 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.63 -36.39 84.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.32 -0.863 . . . . 0.0 109.351 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -77.17 -34.75 56.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.578 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.586 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.57 15.34 2.61 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.238 -0.914 . . . . 0.0 109.236 179.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 53.82 69.27 0.73 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.892 . . . . 0.0 109.49 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -151.27 64.75 0.89 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.901 . . . . 0.0 109.255 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.5 p -56.48 175.24 0.12 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.339 -0.851 . . . . 0.0 109.936 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.23 -32.0 4.15 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.839 . . . . 0.0 109.54 -179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.493 ' H ' ' HB1' ' A' ' 131' ' ' ALA . . . -53.62 -39.8 61.59 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -56.27 -19.38 13.87 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.313 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.5 t -74.33 167.54 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.224 -0.923 . . . . 0.0 109.292 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 6.3 t -70.86 -24.1 62.45 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.909 . . . . 0.0 109.683 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 156.76 79.41 0.03 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.55 164.65 26.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -1.16 . . . . 0.0 108.823 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 110' ' ' PHE . 35.1 p90 -155.6 134.92 12.33 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.875 -1.141 . . . . 0.0 110.758 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 3.3 mt -100.22 146.92 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 8' ' ' GLY . 16.4 ttm180 -144.63 154.1 42.46 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.938 -1.101 . . . . 0.0 110.091 -179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 43.5 tp -139.98 138.15 35.29 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.459 HG22 ' N ' ' A' ' 115' ' ' ASN . 12.6 p -145.77 155.65 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.102 -0.999 . . . . 0.0 109.736 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.459 ' N ' HG22 ' A' ' 114' ' ' VAL . 76.3 m-20 -93.25 102.64 14.92 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -58.31 -7.88 0.99 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.184 -0.947 . . . . 0.0 108.482 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.449 ' H ' ' C ' ' A' ' 115' ' ' ASN . 15.0 t0 -90.19 -52.35 4.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.584 -0.698 . . . . 0.0 109.937 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -90.49 -13.64 34.33 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.366 -0.834 . . . . 0.0 109.904 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 58.39 49.77 10.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.233 -0.917 . . . . 0.0 109.336 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 16.7 p -134.38 113.66 12.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.531 -0.731 . . . . 0.0 109.058 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -45.51 129.05 8.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.251 -0.906 . . . . 0.0 109.97 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.8 t -85.77 -60.55 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -170.79 174.94 4.7 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.03 -1.044 . . . . 0.0 110.186 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -146.86 134.4 20.92 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.518 -0.739 . . . . 0.0 109.066 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -91.33 147.15 23.24 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.234 -0.917 . . . . 0.0 109.31 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.436 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.5 p-10 -100.71 108.09 19.85 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.271 -0.893 . . . . 0.0 109.325 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.572 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 80.5 mt -80.46 -35.65 34.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.65 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 128' ' ' THR . 2.8 p -47.39 -31.96 4.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.971 -1.081 . . . . 0.0 109.263 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -95.39 -48.35 5.91 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.502 -0.749 . . . . 0.0 109.87 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -80.29 1.02 30.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.183 -0.948 . . . . 0.0 110.35 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -68.57 -51.2 45.2 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.99 -1.069 . . . . 0.0 110.313 -179.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 34.0 t -58.84 3.26 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.363 -0.835 . . . . 0.0 110.528 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.506 ' H ' ' C ' ' A' ' 131' ' ' ALA . 33.6 p -89.92 -33.25 16.5 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.854 -1.154 . . . . 0.0 110.906 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 135' ' ' THR . 0.2 OUTLIER -172.78 -146.06 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.495 -1.378 . . . . 0.0 109.982 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.528 ' H ' ' CD ' ' A' ' 134' ' ' GLU . 0.2 OUTLIER -138.49 7.57 2.58 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -156.3 145.44 20.51 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.5 ptp -164.39 156.89 16.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.989 -1.069 . . . . 0.0 109.955 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.5 tt -97.16 127.24 42.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.426 -0.796 . . . . 0.0 109.485 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -70.84 -50.93 30.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.199 -0.938 . . . . 0.0 109.485 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -170.17 -161.94 21.59 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -150.61 166.95 28.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.205 -1.173 . . . . 0.0 109.741 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 45.9 tp -132.07 140.28 48.8 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.3 p90 -151.1 165.74 32.92 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.801 -1.187 . . . . 0.0 110.024 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -96.72 141.55 29.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.824 . . . . 0.0 109.659 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 146' ' ' ASN . 12.0 t-160 -109.25 -122.34 0.26 Allowed 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 145' ' ' HIS . 33.7 m120 -73.83 49.16 0.31 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.125 -0.984 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 87.03 11.2 70.42 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -127.76 140.03 52.3 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.568 -0.96 . . . . 0.0 109.515 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -67.12 151.96 46.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.877 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -153.4 121.68 6.21 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.198 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -90.97 148.11 22.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.321 -0.862 . . . . 0.0 109.668 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -151.73 107.5 3.37 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.334 -0.854 . . . . 0.0 109.176 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -73.82 154.84 39.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.298 -0.876 . . . . 0.0 109.697 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.6 t -138.34 -34.77 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.376 -0.828 . . . . 0.0 109.069 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 67.48 87.76 0.07 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -116.75 167.69 10.87 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.661 -0.905 . . . . 0.0 109.092 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -143.85 135.9 6.56 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.414 ' CE1' HG11 ' A' ' 165' ' ' VAL . 1.3 p90 -150.57 139.15 20.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -1.143 . . . . 0.0 109.302 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.4 11.94 37.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.326 -0.859 . . . . 0.0 109.437 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.11 -71.4 0.61 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.429 ' O ' HG13 ' A' ' 165' ' ' VAL . . . 163.71 172.69 31.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -81.55 -34.58 31.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.188 -1.184 . . . . 0.0 109.175 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.34 -30.21 27.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.267 -0.896 . . . . 0.0 109.651 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 166' ' ' CYS . 16.4 t -70.56 -58.23 3.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.575 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 161' ' ' GLY . 35.0 m -47.58 -20.21 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.164 -0.96 . . . . 0.0 109.514 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.413 ' N ' ' O ' ' A' ' 164' ' ' SER . 17.2 t -73.34 -60.75 2.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.77 -15.38 39.52 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.18 -0.95 . . . . 0.0 110.199 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -69.21 -31.11 69.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.092 -1.005 . . . . 0.0 110.064 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -71.88 -19.42 61.95 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.092 -1.005 . . . . 0.0 109.247 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -77.94 -49.69 6.87 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.4 tt -82.77 134.23 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.207 -1.172 . . . . 0.0 109.488 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -79.91 136.18 36.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.54 -47.02 14.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.199 -0.938 . . . . 0.0 109.458 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 90.9 p . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.459 179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 41.1 t . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 36.2 mtt -74.92 94.47 2.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.267 -0.896 . . . . 0.0 109.498 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.6 mttp -83.57 -25.01 31.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.318 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -146.3 128.5 15.71 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.264 -0.897 . . . . 0.0 109.154 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.651 ' N ' HD22 ' A' ' 4' ' ' ASN . 7.3 p -123.01 158.71 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.565 -0.709 . . . . 0.0 109.295 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' N ' HG22 ' A' ' 5' ' ' VAL . 2.8 tt -148.6 110.37 4.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.267 -0.895 . . . . 0.0 109.318 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.11 151.23 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.341 -0.849 . . . . 0.0 108.879 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -135.22 142.13 13.48 Favored Glycine 0 N--CA 1.498 2.792 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 13.1 tp -139.73 125.12 19.05 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' O ' ' CD2' ' A' ' 110' ' ' PHE . . . -147.74 147.11 17.53 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.574 -1.298 . . . . 0.0 109.915 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.529 ' NE1' ' O ' ' A' ' 63' ' ' THR . 20.2 p90 -156.46 154.12 29.9 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.475 -1.015 . . . . 0.0 109.628 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -89.73 133.59 34.6 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.437 -0.789 . . . . 0.0 109.652 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.99 122.89 28.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 109.319 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -78.09 107.02 10.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 109.604 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.6 p -92.3 129.23 38.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.214 -0.929 . . . . 0.0 109.301 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.5 m -154.55 -46.27 0.09 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.28 -0.888 . . . . 0.0 109.297 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.519 ' OD2' ' NE2' ' A' ' 19' ' ' GLN . 6.2 p30 -148.05 32.76 0.83 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.324 -0.86 . . . . 0.0 109.105 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 92.86 -17.17 58.62 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.519 ' NE2' ' OD2' ' A' ' 17' ' ' ASP . 2.6 pt20 -69.94 150.7 46.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.218 -1.166 . . . . 0.0 109.318 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -158.4 -162.93 1.19 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.191 -0.943 . . . . 0.0 109.521 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -144.32 145.51 32.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.278 -0.888 . . . . 0.0 109.33 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -141.35 103.07 4.35 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 23' ' ' LEU . 11.1 mp -83.91 163.19 20.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.167 -0.958 . . . . 0.0 108.443 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -129.16 120.53 25.98 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.423 -0.798 . . . . 0.0 109.533 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 137.78 36.38 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.395 -0.815 . . . . 0.0 109.211 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 70.9 m -149.52 167.86 25.11 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.47 130.48 38.66 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -108.69 138.38 45.11 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.1 mp -81.72 151.0 27.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.339 -0.851 . . . . 0.0 109.314 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.497 ' H ' ' CG2' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -146.7 121.68 10.03 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.042 -1.036 . . . . 0.0 109.429 179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -71.12 175.82 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.154 -0.966 . . . . 0.0 109.651 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.78 -2.23 57.4 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 109.244 179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -79.49 -5.93 55.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.129 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.74 -12.27 62.72 Favored Glycine 0 N--CA 1.495 2.625 0 N-CA-C 108.938 -1.665 . . . . 0.0 108.938 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.2 mtmt -128.76 138.44 52.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.664 -0.904 . . . . 0.0 108.97 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.4 p -69.76 145.66 12.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -63.68 2.58 0.44 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.574 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 148.91 99.4 0.21 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 41' ' ' ASP . 11.8 p-10 -49.2 -29.14 5.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.191 -1.182 . . . . 0.0 109.352 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.17 -3.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.634 ' O ' HD13 ' A' ' 29' ' ' LEU . 31.9 t0 -95.43 30.17 2.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.069 -1.019 . . . . 0.0 108.383 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.454 ' CE2' ' CD1' ' A' ' 44' ' ' PHE . 15.1 p90 -90.34 136.88 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.549 0.69 . . . . 0.0 109.623 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 tp -82.81 139.6 17.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.596 -0.69 . . . . 0.0 109.391 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 8.9 p90 -166.7 -156.25 0.22 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.424 -0.798 . . . . 0.0 109.933 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 45' ' ' TYR . 0.3 OUTLIER -43.67 -62.8 0.98 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.49 -0.756 . . . . 0.0 110.449 -179.067 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -49.52 -11.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 109.614 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.508 ' N ' ' O ' ' A' ' 45' ' ' TYR . 88.6 m-20 -146.46 94.7 2.49 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.204 -0.935 . . . . 0.0 109.482 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.9 mt -75.01 -14.44 60.61 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.239 -0.913 . . . . 0.0 109.393 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -165.31 149.22 8.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.196 -0.94 . . . . 0.0 109.811 179.899 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.5 t -95.18 139.78 31.02 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.194 -0.941 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.93 -48.63 15.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.547 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -99.54 -11.4 21.06 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.415 -0.803 . . . . 0.0 109.476 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.03 -10.68 82.49 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.0 p 59.72 18.57 7.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -1.138 . . . . 0.0 109.506 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.4 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.287 -0.883 . . . . 0.0 109.002 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.8 m -148.81 115.86 6.07 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.925 -1.109 . . . . 0.0 110.421 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' ND1' ' O ' ' A' ' 72' ' ' SER . 0.9 OUTLIER -93.12 127.24 38.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.437 -0.79 . . . . 0.0 108.88 179.299 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 72' ' ' SER . 14.7 t -59.86 -42.41 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.06 -1.025 . . . . 0.0 109.464 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.499 ' N ' HG23 ' A' ' 58' ' ' THR . . . 153.86 -179.99 29.69 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -126.13 110.89 14.02 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.633 -0.922 . . . . 0.0 109.213 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.732 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -84.93 154.4 22.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -0.927 . . . . 0.0 109.514 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.732 ' H ' HD22 ' A' ' 61' ' ' ASN . 37.9 ttt180 -95.31 4.37 53.52 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.298 -0.876 . . . . 0.0 109.397 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.529 ' O ' ' NE1' ' A' ' 11' ' ' TRP . 39.9 p -153.73 -34.57 0.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 109.51 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 65.14 35.92 92.3 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -79.1 114.09 17.76 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.218 -1.166 . . . . 0.0 108.699 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 157.89 131.31 1.29 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -70.48 85.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.253 -1.145 . . . . 0.0 109.508 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 164.89 161.16 13.27 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -50.96 118.33 3.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -1.149 . . . . 0.0 109.504 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -82.17 -66.59 0.87 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.221 -0.924 . . . . 0.0 109.517 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -97.4 161.34 13.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.303 -0.873 . . . . 0.0 109.135 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.542 ' H ' HG22 ' A' ' 58' ' ' THR . 4.6 m -166.26 169.78 13.87 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.188 -0.945 . . . . 0.0 109.764 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 mt -148.88 118.84 7.13 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.32 -0.863 . . . . 0.0 109.096 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -96.64 131.34 43.4 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.397 -0.814 . . . . 0.0 108.888 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 3.1 mp -135.43 121.48 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.35 -0.844 . . . . 0.0 109.807 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.468 ' C ' ' N ' ' A' ' 78' ' ' ASP . 63.2 mttm -90.28 82.46 5.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.43 -0.794 . . . . 0.0 108.979 179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 8.0 mt -50.82 -10.35 0.07 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.302 -0.874 . . . . 0.0 109.547 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.468 ' N ' ' C ' ' A' ' 76' ' ' LYS . 6.3 t70 -80.82 -40.56 24.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.293 -0.879 . . . . 0.0 109.697 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -86.35 5.91 32.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.161 -0.962 . . . . 0.0 109.67 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 45.4 t -80.6 124.35 82.07 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.128 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -79.44 -161.39 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.917 1.745 . . . . 0.0 111.934 179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.84 4.23 85.48 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -53.53 -39.73 64.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.287 -1.125 . . . . 0.0 109.453 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.497 ' CG2' ' H ' ' A' ' 30' ' ' LEU . 11.5 p -136.27 128.24 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.467 -0.771 . . . . 0.0 109.127 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' CG ' HH11 ' A' ' 144' ' ' ARG . 25.7 m-20 -98.07 -5.77 33.12 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.4 ' H ' HG22 ' A' ' 84' ' ' VAL . 25.2 ttmt -150.27 131.42 14.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 109.104 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 96.2 mt -126.18 153.94 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.443 ' CD1' ' CE1' ' A' ' 169' ' ' TYR . 14.9 pt -136.35 156.62 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.377 -0.827 . . . . 0.0 109.861 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -130.96 126.68 36.67 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.3 m -140.06 152.3 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.345 -0.847 . . . . 0.0 110.17 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.7 p -107.3 144.47 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.2 p -132.23 143.32 49.85 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.402 -0.811 . . . . 0.0 110.053 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.644 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.31 122.29 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 13.6 t60 -61.34 -136.01 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.305 -0.872 . . . . 0.0 110.499 -178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 89.8 m-20 -61.43 -19.34 61.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.424 -0.797 . . . . 0.0 110.414 -179.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.644 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -53.65 -19.26 3.79 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.898 -1.127 . . . . 0.0 108.743 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.421 ' OE1' ' O ' ' A' ' 159' ' ' ALA . 19.7 tt0 -78.58 -21.68 48.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.206 -0.934 . . . . 0.0 109.288 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.47 -52.56 63.04 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.248 -0.908 . . . . 0.0 109.079 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' HD3' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -87.06 10.62 15.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.213 -0.93 . . . . 0.0 108.884 179.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 67.54 95.77 0.06 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.624 -0.673 . . . . 0.0 109.712 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.459 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 66.9 mt-30 -154.16 78.61 1.1 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.334 -0.854 . . . . 0.0 109.237 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.446 ' HA ' HG22 ' A' ' 135' ' ' THR . 42.5 p -56.2 157.62 4.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.594 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -44.96 -22.52 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.553 -0.717 . . . . 0.0 109.848 -179.562 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.479 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -54.87 -39.82 69.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -55.49 -21.26 15.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -1.182 . . . . 0.0 109.249 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.4 t -71.49 168.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.274 -0.892 . . . . 0.0 109.23 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.7 p -76.49 -32.55 58.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -0.933 . . . . 0.0 109.793 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 169.78 74.86 0.04 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.26 164.34 26.15 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.137 . . . . 0.0 109.214 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 10' ' ' GLY . 49.0 p90 -155.87 169.55 24.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.137 -0.977 . . . . 0.0 110.229 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.472 HG21 ' CD2' ' A' ' 139' ' ' PHE . 71.9 mt -131.61 153.11 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -143.09 143.76 31.97 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.137 -0.977 . . . . 0.0 109.723 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD23 ' N ' ' A' ' 114' ' ' VAL . 3.8 tt -134.22 122.73 23.18 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.586 ' N ' HD23 ' A' ' 113' ' ' LEU . 7.2 p -132.22 158.28 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.415 -0.803 . . . . 0.0 109.764 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.523 ' N ' HG22 ' A' ' 114' ' ' VAL . 80.7 m-20 -95.86 102.71 14.54 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -60.42 -8.48 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 115' ' ' ASN . 21.1 t70 -89.89 -52.11 5.14 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.335 0.588 . . . . 0.0 109.691 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -87.73 -14.72 39.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.332 -0.855 . . . . 0.0 109.826 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.81 51.13 6.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 p -143.38 107.06 4.62 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.351 -0.843 . . . . 0.0 109.117 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 68.7 tt0 -45.32 136.96 4.99 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 0.0 109.885 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 89.8 t -91.08 -54.14 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.316 -0.865 . . . . 0.0 109.731 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -176.66 174.92 1.77 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.867 -1.146 . . . . 0.0 110.495 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -142.55 134.65 27.35 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -94.92 147.94 22.84 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.194 -0.941 . . . . 0.0 109.704 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -100.44 113.56 26.43 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 0.0 109.387 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 3.3 mm? -78.93 -41.9 28.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.27 -0.894 . . . . 0.0 109.631 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 8.8 m -46.67 -25.12 0.66 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.995 -1.066 . . . . 0.0 109.524 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -94.79 -51.42 4.71 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.427 -0.796 . . . . 0.0 109.492 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -85.97 13.24 7.85 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -78.4 -50.13 12.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.268 -0.895 . . . . 0.0 109.841 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 69.5 p -59.49 2.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.418 -0.801 . . . . 0.0 109.783 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 131' ' ' ALA . 9.7 m -89.23 -33.05 17.13 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.042 -1.036 . . . . 0.0 110.358 -179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -173.27 -148.95 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.71 -1.244 . . . . 0.0 109.735 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.3 OUTLIER -124.76 -36.48 2.58 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -109.65 155.8 21.03 Favored 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 29.9 ttm -164.99 144.55 6.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.029 -1.044 . . . . 0.0 110.294 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 156' ' ' GLN . 5.0 tt -93.22 136.28 33.64 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.5 -0.75 . . . . 0.0 109.177 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.472 ' CD2' HG21 ' A' ' 111' ' ' ILE . 35.5 t80 -87.91 -46.71 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.035 . . . . 0.0 110.22 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.13 -170.63 24.97 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 119.21 -1.472 . . . . 0.0 110.742 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.41 ' C ' HD22 ' A' ' 142' ' ' LEU . 23.8 tt0 -150.77 131.18 13.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.541 -0.976 . . . . 0.0 109.625 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.495 HD22 ' N ' ' A' ' 142' ' ' LEU . 3.9 mm? -99.4 143.85 29.18 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.297 -0.877 . . . . 0.0 108.697 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -151.76 166.21 32.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.043 -1.036 . . . . 0.0 109.89 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.54 HH11 ' CG ' ' A' ' 85' ' ' ASP . 15.6 ptm180 -94.63 146.95 23.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.355 -0.84 . . . . 0.0 110.018 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -149.24 126.06 11.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.812 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 55.74 23.4 6.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.2 -0.938 . . . . 0.0 109.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.37 12.98 77.56 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -127.86 141.69 51.49 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.494 -1.004 . . . . 0.0 109.242 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.525 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 70.2 m95 -67.18 145.43 55.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 109.586 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 45.0 tptt -146.74 151.47 37.23 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 37.1 t80 -100.31 153.68 19.1 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.32 -0.863 . . . . 0.0 110.401 -179.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.459 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.2 ttt180 -157.55 113.96 2.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -74.07 154.47 39.18 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.136 -0.977 . . . . 0.0 109.86 -179.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.533 ' CG1' HE21 ' A' ' 156' ' ' GLN . 5.4 t -140.0 -35.67 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 58.91 82.75 0.06 OUTLIER Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.533 HE21 ' CG1' ' A' ' 154' ' ' VAL . 60.7 mm-40 -106.93 168.02 9.48 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -147.89 123.12 1.65 Allowed Glycine 0 N--CA 1.496 2.651 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.462 ' C ' ' H ' ' A' ' 160' ' ' GLY . 2.8 m-85 -119.22 155.52 31.55 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.726 -0.867 . . . . 0.0 108.767 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' A' ' 97' ' ' GLN . . . -72.19 11.66 0.54 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.131 -0.98 . . . . 0.0 109.345 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 158' ' ' TYR . . . 81.18 95.55 0.43 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 165' ' ' VAL . . . -148.4 75.33 0.27 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.8 tp -46.89 -21.58 0.22 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.151 -1.205 . . . . 0.0 109.409 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.498 ' O ' ' SG ' ' A' ' 166' ' ' CYS . . . -85.73 -45.31 11.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 109.801 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 168' ' ' GLN . 8.7 t -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.145 -0.972 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.535 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 86.0 t -53.97 -25.17 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 0.0 109.985 -179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.597 ' SG ' ' N ' ' A' ' 167' ' ' ALA . 31.8 p -82.64 -54.82 4.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.086 -1.009 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.597 ' N ' ' SG ' ' A' ' 166' ' ' CYS . . . -75.72 -15.47 60.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.079 -1.013 . . . . 0.0 109.424 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.458 ' N ' ' O ' ' A' ' 164' ' ' SER . 7.4 tp-100 -67.09 -23.68 65.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.209 -0.932 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.535 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.55 -19.57 62.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.14 -0.975 . . . . 0.0 109.101 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -84.56 -40.46 8.32 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 86.6 mt -72.04 148.38 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -1.148 . . . . 0.0 109.475 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -79.78 106.75 12.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.43 -156.91 0.14 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.456 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.514 -179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 64.3 mtt -68.23 100.54 1.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.43 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -87.2 -18.73 29.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 109.429 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.528 HD22 ' CB ' ' A' ' 117' ' ' ASP . 10.5 m-80 -146.13 146.7 30.97 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.225 -0.922 . . . . 0.0 109.444 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -132.8 154.42 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.547 -0.72 . . . . 0.0 109.45 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 6' ' ' LEU . 2.0 tt -148.83 107.83 3.88 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.285 -0.884 . . . . 0.0 109.381 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.421 ' N ' HD23 ' A' ' 6' ' ' LEU . 3.8 t -86.3 151.05 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 0.0 108.935 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -140.56 117.31 1.26 Allowed Glycine 0 N--CA 1.497 2.754 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.89 134.87 53.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -149.25 143.39 10.8 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . 0.414 ' NE1' ' O ' ' A' ' 63' ' ' THR . 23.6 p90 -158.86 153.95 25.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.35 -1.088 . . . . 0.0 109.744 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.0 t0 -94.74 121.28 36.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.502 -0.749 . . . . 0.0 109.688 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.46 158.95 24.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.194 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -132.95 128.24 36.01 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.41 -0.806 . . . . 0.0 109.452 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 4.4 m -81.74 122.45 27.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.35 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.4 m -153.61 133.06 12.84 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.43 13.58 0.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.363 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 79.72 62.54 2.13 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -150.73 170.54 18.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.21 -1.171 . . . . 0.0 109.469 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -157.83 152.83 25.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 109.312 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -96.43 140.42 31.11 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.269 -0.894 . . . . 0.0 109.729 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.44 ' H ' ' CD2' ' A' ' 94' ' ' HIS . 24.8 t0 -141.33 104.58 4.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.357 -0.839 . . . . 0.0 109.595 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.2 mp -83.21 163.12 20.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 108.821 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -128.02 124.72 37.83 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.448 -0.783 . . . . 0.0 109.705 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.22 137.69 36.6 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.363 -0.836 . . . . 0.0 109.136 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.8 t -149.55 167.63 25.78 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 109.922 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.66 133.91 42.49 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -111.03 128.5 55.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.38 -0.825 . . . . 0.0 109.976 -179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.742 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -83.65 146.78 28.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.387 -0.82 . . . . 0.0 109.563 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.7 124.57 11.27 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.159 -0.963 . . . . 0.0 108.818 178.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.498 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -76.77 166.49 23.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.101 -0.999 . . . . 0.0 109.64 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.57 -0.96 55.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -0.866 . . . . 0.0 109.152 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -75.8 -7.96 55.71 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.86 -3.77 49.13 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -145.5 138.29 26.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.4 -1.059 . . . . 0.0 108.888 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.562 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.1 p -68.0 145.68 13.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.244 -0.91 . . . . 0.0 109.594 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -67.42 6.08 0.66 Allowed 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.562 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 150.76 97.98 0.17 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.8 OUTLIER -50.73 -36.41 36.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.203 -1.175 . . . . 0.0 109.035 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.42 -0.91 0.07 Allowed 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.712 -0.617 . . . . 0.0 109.937 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.637 ' O ' HD13 ' A' ' 29' ' ' LEU . 2.6 m-20 -91.06 25.18 2.54 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.977 -1.077 . . . . 0.0 109.188 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -90.76 139.96 30.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.82 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 tp -77.2 139.67 18.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 121.795 0.807 . . . . 0.0 110.04 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -156.41 -171.12 3.58 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.463 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 12.1 p90 -61.65 -29.2 69.91 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.795 -1.191 . . . . 0.0 109.347 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 13.3 p30 -72.05 11.13 0.6 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.302 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.445 ' H ' ' C ' ' A' ' 45' ' ' TYR . 50.6 t-20 -155.13 100.75 2.19 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 0.0 109.273 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.8 mt -62.96 -28.87 70.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 15.9 pttm -167.28 157.96 11.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.602 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' H ' ' A' ' 55' ' ' VAL . 72.6 m -93.2 142.81 26.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.54 -48.56 13.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.897 . . . . 0.0 109.41 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -98.9 -13.06 20.18 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.487 -0.758 . . . . 0.0 109.475 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.67 -13.1 76.41 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t 56.93 20.18 5.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.271 -1.135 . . . . 0.0 109.446 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' H ' ' HB2' ' A' ' 50' ' ' SER . 40.5 t -93.04 151.97 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.355 -0.841 . . . . 0.0 108.993 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.2 m -145.83 116.49 7.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.217 -0.927 . . . . 0.0 109.438 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -92.92 132.5 36.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.218 -0.926 . . . . 0.0 109.099 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 54.4 m -65.79 -55.04 19.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.179 -0.95 . . . . 0.0 109.563 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.49 139.03 2.54 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -87.09 110.89 20.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.264 -1.139 . . . . 0.0 109.507 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -70.59 161.09 31.33 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.412 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.0 OUTLIER -103.48 2.99 34.39 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.421 -0.799 . . . . 0.0 109.551 -179.809 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 62' ' ' ARG . 32.8 p -155.94 -34.59 0.09 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.152 -0.968 . . . . 0.0 109.376 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 72.77 15.31 78.0 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.306 -1.517 . . . . 0.0 109.306 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -58.01 110.12 0.87 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.326 -1.102 . . . . 0.0 109.283 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 152.15 129.55 1.5 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -76.0 93.83 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -1.139 . . . . 0.0 109.504 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.95 166.71 18.5 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -50.04 106.19 0.11 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.187 -1.184 . . . . 0.0 109.446 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -70.46 -69.16 0.38 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.518 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -95.09 171.56 8.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.187 -0.946 . . . . 0.0 109.355 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.409 ' OG ' HD21 ' A' ' 6' ' ' LEU . 1.7 t -159.27 156.71 29.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.75 117.81 10.05 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.26 -0.9 . . . . 0.0 108.676 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mttt -100.68 134.03 44.26 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.373 -0.829 . . . . 0.0 109.665 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.8 mp -136.2 145.94 29.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.347 -0.846 . . . . 0.0 109.479 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -116.03 102.94 10.09 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.2 mt -72.57 -5.48 37.47 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.191 -0.943 . . . . 0.0 109.548 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -83.2 -32.08 26.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.189 -0.944 . . . . 0.0 109.548 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.06 0.57 51.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.243 -0.911 . . . . 0.0 109.739 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 70.9 t -76.91 123.96 87.46 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.219 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.05 -161.57 0.15 Allowed 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 121.764 1.642 . . . . 0.0 112.044 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -84.93 -1.78 88.71 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -70.32 -60.03 2.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.182 -1.187 . . . . 0.0 109.338 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 t -83.63 148.61 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 109.323 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -134.96 -25.05 1.42 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.43 -0.794 . . . . 0.0 110.006 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' A' ' 141' ' ' GLU . 18.5 ttpp -135.92 131.51 35.27 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.05 -1.032 . . . . 0.0 109.547 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 49.6 mt -134.51 119.1 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.456 HG23 ' NZ ' ' A' ' 86' ' ' LYS . 11.1 pt -104.17 167.8 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.347 -0.845 . . . . 0.0 110.071 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -135.64 125.07 24.9 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 m -137.61 154.48 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.249 -0.907 . . . . 0.0 110.38 -178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.75 148.11 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -133.93 143.99 48.56 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.428 -0.795 . . . . 0.0 110.2 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.589 ' CG2' ' HB3' ' A' ' 96' ' ' ALA . 2.4 mm -74.35 150.96 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.585 ' CE1' ' HB2' ' A' ' 96' ' ' ALA . 17.6 p80 -77.73 -154.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.171 -0.956 . . . . 0.0 110.174 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 97' ' ' GLN . 6.0 m-20 -50.92 -17.5 0.59 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.426 -0.796 . . . . 0.0 110.006 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.694 ' HB1' ' HB2' ' A' ' 101' ' ' GLN . . . -47.77 -18.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.054 -1.029 . . . . 0.0 109.303 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 95' ' ' ASP . 21.7 mt-30 -58.14 -48.94 78.71 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.173 -0.954 . . . . 0.0 109.223 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.543 ' HB3' HH11 ' A' ' 99' ' ' ARG . . . -62.07 -52.23 64.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.275 -0.891 . . . . 0.0 109.262 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.543 HH11 ' HB3' ' A' ' 98' ' ' ALA . 11.6 mpt_? -68.89 7.94 0.6 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.113 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' H ' ' C ' ' A' ' 98' ' ' ALA . 29.6 ttm180 51.75 85.78 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.322 -0.861 . . . . 0.0 109.404 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.694 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 40.5 mt-30 -154.92 73.42 0.88 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.387 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 104' ' ' GLY . 13.4 p -56.38 163.23 1.77 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.651 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -47.81 -14.92 0.05 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.885 . . . . 0.0 109.591 -179.849 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -58.97 -41.73 96.49 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -54.53 -19.49 5.95 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.156 -1.202 . . . . 0.0 109.33 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 107' ' ' SER . 21.3 t -71.74 170.39 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 0.0 109.183 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.548 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -79.8 -17.74 52.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 0.0 110.008 -179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 149.96 81.8 0.03 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.82 164.53 26.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.209 -1.171 . . . . 0.0 109.189 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -153.44 138.98 17.74 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.066 -1.021 . . . . 0.0 110.301 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 124' ' ' ARG . 23.5 mt -103.3 151.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 8' ' ' GLY . 43.1 ttp180 -139.64 139.12 36.62 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.15 -0.969 . . . . 0.0 109.491 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 29.1 tp -132.23 132.58 43.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.2 p -149.41 157.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.234 -0.916 . . . . 0.0 109.479 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.501 ' N ' HG22 ' A' ' 114' ' ' VAL . 70.1 m-80 -96.23 102.75 14.59 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 10.2 p-10 -62.6 -5.49 2.68 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.528 ' CB ' HD22 ' A' ' 4' ' ' ASN . 45.9 t0 -73.02 -49.85 26.42 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.2 t30 -121.6 3.85 10.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.653 -0.655 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 115' ' ' ASN . 35.7 tt0 59.92 43.28 15.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -0.855 . . . . 0.0 109.715 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.2 p -99.3 93.75 6.09 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.277 -0.889 . . . . 0.0 109.132 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -48.14 126.96 11.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.376 -0.827 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' A' ' 123' ' ' ALA . 69.5 t -87.1 -67.28 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.152 -0.968 . . . . 0.0 109.584 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 122' ' ' VAL . . . -179.56 175.54 0.88 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.99 -1.069 . . . . 0.0 110.212 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 111' ' ' ILE . 10.4 ptm180 -144.52 134.14 23.48 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -96.52 148.38 22.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.167 -0.958 . . . . 0.0 109.821 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 126' ' ' ASP . 19.8 p30 -96.72 113.59 25.16 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.543 ' O ' ' N ' ' A' ' 131' ' ' ALA . 3.8 mm? -63.57 -44.26 94.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.911 . . . . 0.0 109.618 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 1.3 t -45.48 -17.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.0 109.592 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' A' ' 127' ' ' LEU . 63.9 tt0 -94.95 -54.94 3.27 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.456 -0.777 . . . . 0.0 109.882 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.431 ' O ' ' OE1' ' A' ' 134' ' ' GLU . 18.1 m-20 -92.41 13.24 20.12 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -78.13 -54.17 6.55 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.211 -0.931 . . . . 0.0 110.107 -178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 30.8 p -59.99 2.94 0.07 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.424 -0.798 . . . . 0.0 110.018 -179.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.527 ' H ' ' C ' ' A' ' 131' ' ' ALA . 86.2 m -92.44 -32.59 14.85 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.976 -1.077 . . . . 0.0 110.714 -179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 0.0 OUTLIER -169.55 -150.22 0.08 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.629 -1.295 . . . . 0.0 110.336 -179.79 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.518 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -125.17 -33.51 2.86 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.91 151.45 36.6 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.565 -0.709 . . . . 0.0 109.174 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 ptm -164.38 157.51 17.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.123 -0.986 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.1 tt -99.46 132.06 45.04 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.4 -0.813 . . . . 0.0 109.537 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -79.3 -51.75 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.279 -0.888 . . . . 0.0 109.899 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -155.87 -165.81 14.99 Favored Glycine 0 N--CA 1.494 2.555 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.437 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.828 ' C ' HD12 ' A' ' 142' ' ' LEU . 22.1 tt0 -150.56 159.1 44.73 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.51 -0.994 . . . . 0.0 109.168 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' C ' ' A' ' 141' ' ' GLU . 6.6 mp -140.08 140.15 36.02 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.294 -0.879 . . . . 0.0 108.85 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -150.81 165.88 32.2 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.028 -1.045 . . . . 0.0 109.972 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.524 ' NE ' ' O ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -87.88 146.3 25.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 109.461 179.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 147' ' ' GLY . 70.2 t60 -155.03 137.29 14.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.336 -0.852 . . . . 0.0 109.47 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.2 t30 54.29 10.18 0.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.787 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.407 ' N ' ' C ' ' A' ' 145' ' ' HIS . . . 96.75 5.74 58.55 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.85 152.5 47.74 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.402 -1.058 . . . . 0.0 109.316 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -72.15 150.47 43.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 0.0 109.552 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.09 134.43 19.55 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.255 -0.903 . . . . 0.0 109.48 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.4 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 25.2 t80 -89.88 151.27 21.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.466 -0.771 . . . . 0.0 109.518 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.4 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 65.5 ttt180 -152.96 120.19 5.86 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -77.89 154.49 31.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.279 -0.888 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.4 t -147.97 -36.08 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 109.164 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 56.39 80.36 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -105.9 104.32 14.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.627 -0.926 . . . . 0.0 109.267 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -86.92 134.01 12.19 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -150.31 120.83 7.43 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.228 -1.16 . . . . 0.0 109.279 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -85.64 22.23 1.65 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 109.364 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -61.14 -119.7 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 165' ' ' VAL . . . -159.38 158.0 29.12 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -68.94 -15.16 63.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -1.154 . . . . 0.0 109.048 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -79.75 -48.46 13.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.217 -0.927 . . . . 0.0 109.436 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 23.9 p -81.07 -46.57 14.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.539 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 161' ' ' GLY . 69.7 t -49.66 -20.86 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 109.612 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 14.6 t -83.27 -56.23 3.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -84.63 -35.41 22.69 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.1 -1.0 . . . . 0.0 109.937 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -51.35 -29.12 14.25 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.35 -0.844 . . . . 0.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -72.47 -19.6 61.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.137 -0.977 . . . . 0.0 109.125 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.03 -53.35 3.17 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.0 mm -81.23 99.49 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -75.85 116.85 16.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.205 -0.935 . . . . 0.0 109.454 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.96 7.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.298 -0.876 . . . . 0.0 109.505 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 86.0 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.476 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.468 ' N ' ' OE2' ' A' ' 148' ' ' GLU . 75.8 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 33.1 mtt -82.3 95.79 7.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.19 -0.944 . . . . 0.0 109.56 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -85.76 -25.01 26.65 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.281 -0.887 . . . . 0.0 109.217 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -146.24 145.35 30.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.38 -0.825 . . . . 0.0 108.957 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' HD11 ' A' ' 113' ' ' LEU . 7.2 p -142.09 158.72 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.289 -0.882 . . . . 0.0 109.584 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 7' ' ' VAL . 2.9 tt -146.07 118.49 8.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.382 -0.824 . . . . 0.0 109.197 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' HD23 ' A' ' 6' ' ' LEU . 2.8 t -86.39 151.51 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.135 -0.978 . . . . 0.0 109.15 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -132.48 117.74 2.07 Favored Glycine 0 N--CA 1.498 2.811 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 17.4 tp -123.95 126.62 46.65 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.424 ' O ' ' CD1' ' A' ' 110' ' ' PHE . . . -153.64 156.24 26.66 Favored Glycine 0 N--CA 1.492 2.419 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.103 -179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 34.9 p90 -161.21 153.98 20.78 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.515 -0.991 . . . . 0.0 109.497 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -82.57 125.98 31.77 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.425 -0.797 . . . . 0.0 109.587 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -80.77 119.58 23.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 38.5 ttp180 -88.63 106.6 18.43 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.234 -0.916 . . . . 0.0 109.395 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.3 m -104.12 105.55 15.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.383 -0.823 . . . . 0.0 109.492 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.436 ' OG1' ' N ' ' A' ' 17' ' ' ASP . 14.8 p -95.25 -57.79 2.32 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.241 -0.912 . . . . 0.0 109.109 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.436 ' N ' ' OG1' ' A' ' 16' ' ' THR . 51.1 t0 -156.99 17.07 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.367 -0.833 . . . . 0.0 109.317 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.31 -13.15 1.23 Allowed Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -82.56 169.94 15.75 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.266 -1.137 . . . . 0.0 109.633 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 9.7 p30 -176.45 -164.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.321 -0.862 . . . . 0.0 109.314 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -153.56 142.15 20.85 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.153 -0.967 . . . . 0.0 109.474 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -141.22 144.08 34.53 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.345 -0.847 . . . . 0.0 109.748 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.488 ' CD2' HD13 ' A' ' 93' ' ' ILE . 38.3 mt -124.7 163.4 22.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -129.42 120.15 25.01 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.281 -0.887 . . . . 0.0 109.921 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.44 134.64 41.15 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.359 -0.838 . . . . 0.0 109.081 179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.1 m -149.73 168.09 24.62 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.181 -0.949 . . . . 0.0 109.601 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -138.17 133.32 33.16 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.362 -0.836 . . . . 0.0 109.21 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -107.63 135.13 49.58 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.414 -0.804 . . . . 0.0 109.667 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.744 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.6 mp -82.0 153.17 26.35 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 109.498 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.74 129.07 14.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.229 -0.92 . . . . 0.0 108.959 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.48 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.12 169.07 15.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.09 -1.006 . . . . 0.0 109.582 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.72 -4.13 58.89 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.223 -0.923 . . . . 0.0 109.296 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.42 -7.48 53.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.422 ' O ' ' OD1' ' A' ' 172' ' ' ASN . . . 101.88 -3.33 52.38 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 50.3 mttm -144.15 138.33 28.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.426 -1.043 . . . . 0.0 108.745 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' C ' ' H ' ' A' ' 38' ' ' GLY . 14.2 p -66.12 145.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.139 -0.976 . . . . 0.0 109.496 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.569 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.2 OUTLIER -66.13 4.45 0.68 Allowed 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.66 99.11 0.18 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.509 ' C ' ' H ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -51.77 -39.07 57.94 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -1.152 . . . . 0.0 109.118 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -56.96 -1.61 0.07 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.672 -0.643 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.626 ' O ' HD13 ' A' ' 29' ' ' LEU . 30.1 t0 -91.15 26.2 2.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.045 . . . . 0.0 108.996 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -90.83 135.18 33.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.346 -0.846 . . . . 0.0 109.403 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.559 HD11 ' CG ' ' A' ' 47' ' ' ASN . 3.9 tp -77.31 137.63 22.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.563 -0.71 . . . . 0.0 109.476 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -125.85 -166.86 1.62 Allowed 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.585 ' CD1' ' N ' ' A' ' 46' ' ' ASN . 32.8 p90 -73.4 -45.82 52.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.225 -0.922 . . . . 0.0 110.18 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.585 ' N ' ' CD1' ' A' ' 45' ' ' TYR . 28.4 t30 -51.46 -19.74 1.54 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.991 . . . . 0.0 109.691 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.559 ' CG ' HD11 ' A' ' 43' ' ' ILE . 12.7 t-20 -99.92 90.13 4.31 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.0 109.128 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.9 mm? -49.87 -33.14 16.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 109.191 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -170.2 157.77 6.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.883 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 t -84.1 160.83 20.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.866 . . . . 0.0 109.388 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.79 -48.78 9.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.26 -3.5 11.97 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.579 -0.701 . . . . 0.0 109.547 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 55' ' ' VAL . . . -78.25 -13.34 83.4 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.2 t 59.18 13.81 3.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.231 -1.158 . . . . 0.0 109.391 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 53' ' ' GLY . 5.1 t -93.06 147.9 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -0.855 . . . . 0.0 108.96 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.3 p -145.14 124.58 13.11 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.91 -1.119 . . . . 0.0 109.994 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 72' ' ' SER . 1.0 OUTLIER -93.0 127.85 38.66 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.332 -0.855 . . . . 0.0 108.887 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.8 m -58.97 -46.61 87.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.165 -0.959 . . . . 0.0 109.5 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 154.03 131.36 1.54 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -86.71 110.76 20.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -1.138 . . . . 0.0 109.252 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 62' ' ' ARG . 10.4 t-20 -70.03 -169.39 0.27 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.199 -0.938 . . . . 0.0 109.539 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 61' ' ' ASN . 43.7 mtm180 -143.42 7.76 1.54 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.284 -0.885 . . . . 0.0 109.392 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 13.9 p -150.8 -35.31 0.15 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.314 -0.866 . . . . 0.0 109.317 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.02 8.59 36.11 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -58.68 123.49 16.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -1.096 . . . . 0.0 109.328 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.55 126.65 1.38 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.464 -1.455 . . . . 0.0 109.464 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -79.66 45.6 0.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -1.176 . . . . 0.0 109.498 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -176.95 -144.31 5.22 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -71.99 118.84 15.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.532 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -80.75 -37.25 30.78 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.264 -0.897 . . . . 0.0 109.509 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -132.28 155.66 47.93 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.513 -0.742 . . . . 0.0 109.124 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.458 ' O ' ' ND1' ' A' ' 57' ' ' HIS . 3.1 p -164.32 177.52 8.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.121 -0.987 . . . . 0.0 109.727 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -150.48 121.41 7.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.296 -0.877 . . . . 0.0 109.206 -179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -98.85 131.91 44.6 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.3 mt -136.44 136.87 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 78' ' ' ASP . 84.0 mttt -101.48 82.17 2.28 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.606 ' O ' HG22 ' A' ' 80' ' ' VAL . 8.4 mt -55.1 -4.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.384 -0.823 . . . . 0.0 109.746 -179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 76' ' ' LYS . 27.6 t0 -91.0 -29.29 17.47 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.156 -0.965 . . . . 0.0 109.722 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -90.43 -4.49 56.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.169 -0.957 . . . . 0.0 110.156 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 77' ' ' LEU . 17.4 m -60.7 149.36 79.63 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.107 -0.995 . . . . 0.0 109.472 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -76.17 -170.74 0.91 Allowed 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 122.326 2.017 . . . . 0.0 112.069 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -97.83 0.96 59.46 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.08 -67.09 0.8 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -1.183 . . . . 0.0 109.487 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.411 ' O ' ' OD1' ' A' ' 85' ' ' ASP . 21.8 t -57.88 148.8 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.29 -0.881 . . . . 0.0 109.233 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.42 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 15.9 m-20 -134.36 -5.56 2.62 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.432 -0.793 . . . . 0.0 109.848 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.555 ' HZ1' ' CD ' ' A' ' 141' ' ' GLU . 41.0 tttp -158.09 147.41 19.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.003 -1.061 . . . . 0.0 109.553 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.0 mt -145.61 127.22 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.384 -0.822 . . . . 0.0 108.964 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 9.0 pt -106.72 166.07 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.332 -0.855 . . . . 0.0 110.182 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 1.4 m-85 -140.94 130.77 24.35 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.01 152.92 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.27 -0.894 . . . . 0.0 110.258 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 91' ' ' VAL . 7.6 p -111.2 117.58 55.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.0 p -102.24 145.91 28.75 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.192 -0.943 . . . . 0.0 110.006 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.648 HG23 ' HB3' ' A' ' 96' ' ' ALA . 3.3 mm -74.26 128.63 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.654 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.2 t-80 -60.5 -149.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.29 -0.881 . . . . 0.0 109.737 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.654 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 13.3 p-10 -54.37 -18.23 3.89 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.308 -0.87 . . . . 0.0 110.058 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.648 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -52.0 -19.24 1.73 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.014 -1.053 . . . . 0.0 108.871 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.404 ' NE2' ' N ' ' A' ' 98' ' ' ALA . 5.4 pp0? -74.45 -32.27 62.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.404 ' N ' ' NE2' ' A' ' 97' ' ' GLN . . . -61.67 -51.18 69.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.864 . . . . 0.0 109.358 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 99' ' ' ARG . 0.0 OUTLIER -82.38 12.81 4.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.883 . . . . 0.0 109.038 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 60.94 89.98 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.237 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.545 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 22.8 mt-30 -153.46 81.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.385 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 104' ' ' GLY . 68.0 m -56.72 155.88 7.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.377 -0.827 . . . . 0.0 109.798 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.645 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.45 -16.38 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.553 -0.717 . . . . 0.0 109.462 179.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 102' ' ' SER . . . -65.39 -44.05 93.97 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.026 -1.23 . . . . 0.0 110.026 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -53.03 -15.7 0.88 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.108 -1.231 . . . . 0.0 109.223 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 107' ' ' SER . 21.1 t -73.57 165.72 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 109.366 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 106' ' ' VAL . 14.8 m -67.98 -25.2 65.31 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 158.39 77.96 0.03 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.33 162.2 28.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -1.151 . . . . 0.0 109.246 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 10' ' ' GLY . 52.4 p90 -151.5 169.84 21.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 110.005 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -137.93 148.63 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 8' ' ' GLY . 41.7 ttp180 -146.5 155.13 42.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.917 -1.115 . . . . 0.0 110.214 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.555 HD11 ' CG2' ' A' ' 5' ' ' VAL . 63.0 tp -141.57 137.54 32.02 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.535 HG22 ' N ' ' A' ' 115' ' ' ASN . 7.3 p -141.07 158.38 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.133 -0.979 . . . . 0.0 109.958 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.535 ' N ' HG22 ' A' ' 114' ' ' VAL . 19.7 m120 -94.53 102.58 14.52 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.61 -8.09 5.88 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.048 -1.032 . . . . 0.0 108.289 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -89.94 -52.12 5.13 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.74 -0.6 . . . . 0.0 109.628 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 118' ' ' ASN . 1.0 OUTLIER -90.53 -12.7 36.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.403 -0.811 . . . . 0.0 109.688 -179.697 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 59.59 51.5 6.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 0.0 109.329 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 12.5 p -139.73 118.62 12.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.391 -0.818 . . . . 0.0 109.239 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -46.08 132.12 9.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.0 109.836 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.71 -57.4 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.235 -0.916 . . . . 0.0 109.566 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -172.4 174.7 3.78 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.908 -1.12 . . . . 0.0 110.132 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 29.2 ptt180 -148.03 130.27 15.57 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.471 -0.768 . . . . 0.0 109.363 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.493 ' HH ' ' CG ' ' A' ' 130' ' ' ASP . 9.9 t80 -96.5 140.19 31.5 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.264 -0.897 . . . . 0.0 109.236 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -93.72 115.27 27.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.188 -0.945 . . . . 0.0 109.506 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 131' ' ' ALA . 21.1 mt -81.57 -40.9 22.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.185 -0.947 . . . . 0.0 109.351 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.0 m -47.03 -26.84 1.12 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -95.22 -54.19 3.51 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.397 -0.814 . . . . 0.0 109.985 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.493 ' CG ' ' HH ' ' A' ' 125' ' ' TYR . 9.9 m-20 -77.65 -3.23 39.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.251 -0.906 . . . . 0.0 110.18 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.554 ' HB2' ' O ' ' A' ' 127' ' ' LEU . . . -63.64 -54.67 32.19 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.143 -0.973 . . . . 0.0 109.868 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 39.5 m -53.84 -3.15 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.492 -0.755 . . . . 0.0 109.861 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.541 ' H ' ' C ' ' A' ' 131' ' ' ALA . 7.2 m -83.5 -33.36 25.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.003 -1.06 . . . . 0.0 110.472 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -173.35 -145.47 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.773 -1.204 . . . . 0.0 110.013 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.529 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.2 OUTLIER -128.68 -33.73 2.04 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -116.57 149.87 38.93 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 25.8 ttt -164.42 156.39 16.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.044 -1.035 . . . . 0.0 109.85 -179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.9 tt -98.05 126.17 43.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.403 -0.811 . . . . 0.0 109.644 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -71.36 -49.08 45.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.237 -0.914 . . . . 0.0 109.26 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.1 -164.61 27.09 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' CD ' ' HZ1' ' A' ' 86' ' ' LYS . 14.8 pt-20 -151.24 166.64 30.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -1.113 . . . . 0.0 109.85 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.3 mt -136.94 132.03 33.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -135.02 165.91 24.27 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.336 -0.852 . . . . 0.0 109.704 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -90.85 144.73 25.4 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 0.0 109.982 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -143.33 116.93 9.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 109.051 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 146' ' ' ASN . 37.7 t-20 56.74 27.13 12.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.197 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 83.24 16.02 70.37 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.468 ' OE2' ' N ' ' A' ' 1' ' ' SER . 43.9 tt0 -128.02 133.94 49.17 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.555 -0.968 . . . . 0.0 109.439 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.491 ' CZ2' HG21 ' A' ' 80' ' ' VAL . 72.9 m95 -67.38 149.3 50.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 109.328 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 67.9 tttt -151.07 134.47 16.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.235 -0.916 . . . . 0.0 109.318 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 18.3 t80 -89.84 154.75 19.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.385 -0.822 . . . . 0.0 109.906 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 152' ' ' ARG . 0.4 OUTLIER -152.35 113.49 4.23 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.499 -0.751 . . . . 0.0 109.175 179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -62.2 154.07 28.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.107 -0.996 . . . . 0.0 109.734 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -149.38 -36.2 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.251 -0.906 . . . . 0.0 109.163 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 49.42 79.11 0.08 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -111.11 110.97 21.74 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.737 -0.86 . . . . 0.0 109.627 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -95.27 137.6 13.52 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -150.62 144.18 25.08 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.115 -1.226 . . . . 0.0 109.695 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 160' ' ' GLY . . . -99.52 10.13 41.95 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.359 -0.838 . . . . 0.0 109.339 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 159' ' ' ALA . . . -48.45 -94.97 0.01 OUTLIER Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.547 ' H ' HG23 ' A' ' 165' ' ' VAL . . . 164.19 162.37 15.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 162' ' ' LEU . 0.1 OUTLIER -67.7 -13.47 62.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.205 -1.174 . . . . 0.0 109.04 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.47 -47.66 11.13 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.94 . . . . 0.0 109.623 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 67.5 m -83.18 -44.38 15.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.214 -0.928 . . . . 0.0 109.816 -179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.547 HG23 ' H ' ' A' ' 161' ' ' GLY . 73.0 t -49.46 -20.49 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.132 -0.98 . . . . 0.0 109.627 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 49.9 t -81.08 -57.79 3.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 0.0 110.606 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.65 -30.76 22.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.121 -0.987 . . . . 0.0 110.127 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -50.82 -31.03 15.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.917 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.29 -17.35 58.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.224 -0.923 . . . . 0.0 109.342 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -85.68 -54.16 2.86 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 171' ' ' ILE . 23.0 mt -83.45 90.23 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.254 -1.145 . . . . 0.0 109.472 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' GLY . 15.3 m120 -73.19 140.3 46.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.942 . . . . 0.0 109.478 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 45.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.258 -0.901 . . . . 0.0 109.539 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.516 -179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.8 p . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -175.29 163.08 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.477 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -130.33 -8.65 4.22 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.461 -0.774 . . . . 0.0 109.559 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 -146.54 151.24 37.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.233 -0.917 . . . . 0.0 109.317 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 t -133.22 151.59 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.44 -0.787 . . . . 0.0 108.992 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.1 tp -146.49 111.08 5.19 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.204 -0.935 . . . . 0.0 109.416 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.07 151.31 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' O ' ' N ' ' A' ' 112' ' ' ARG . . . -145.02 117.08 0.98 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 34.0 tp -110.92 138.62 47.1 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.26 149.98 21.75 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 119.244 -1.455 . . . . 0.0 110.139 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 37.9 p90 -161.52 159.28 27.67 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.424 -1.045 . . . . 0.0 109.817 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 14' ' ' ARG . 45.0 t0 -79.67 123.38 27.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.452 -0.78 . . . . 0.0 109.944 -179.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 63' ' ' THR . . . -94.4 137.53 33.43 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.319 -0.863 . . . . 0.0 109.249 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -132.87 106.85 7.96 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.427 -0.795 . . . . 0.0 109.413 -179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.9 m -98.15 105.69 17.88 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 47.4 m -84.81 -64.09 1.22 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.364 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.466 ' N ' ' OD1' ' A' ' 17' ' ' ASP . 20.1 p-10 -157.84 18.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.218 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 157.91 -24.5 0.41 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 91.9 mm-40 -82.54 156.43 24.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -176.13 149.36 0.87 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.296 -0.878 . . . . 0.0 109.43 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -96.17 130.1 43.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -141.28 99.36 3.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.329 -0.857 . . . . 0.0 109.73 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 23' ' ' LEU . 8.6 mp -92.38 137.86 32.01 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -101.3 133.04 46.49 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.196 -0.94 . . . . 0.0 110.185 -179.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.33 144.26 27.92 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.5 p -149.86 167.68 25.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.013 -1.054 . . . . 0.0 110.051 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -152.02 129.7 11.56 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -118.04 145.23 44.95 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.477 -0.764 . . . . 0.0 110.028 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.739 ' N ' HD12 ' A' ' 29' ' ' LEU . 5.7 mp -87.01 150.28 24.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.781 . . . . 0.0 109.107 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.32 131.45 18.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.018 -1.051 . . . . 0.0 109.279 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -81.8 172.42 13.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -0.894 . . . . 0.0 109.626 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.81 -5.03 59.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -72.71 -8.46 55.48 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.22 -0.925 . . . . 0.0 109.198 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.6 -3.67 49.99 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.987 -1.645 . . . . 0.0 108.987 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 49.6 mttp -145.59 140.78 27.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.462 -1.022 . . . . 0.0 108.931 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 38' ' ' GLY . 10.4 p -66.31 142.28 16.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.238 -0.914 . . . . 0.0 109.366 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.92 8.22 0.76 Allowed 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 157.19 99.49 0.16 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 41' ' ' ASP . 1.0 OUTLIER -57.79 -32.77 67.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.281 -1.129 . . . . 0.0 108.953 179.496 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.38 -2.45 0.07 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.77 -0.582 . . . . 0.0 109.802 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.661 ' O ' HD13 ' A' ' 29' ' ' LEU . 3.2 m-20 -92.7 27.39 2.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.039 -1.038 . . . . 0.0 108.748 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -89.28 137.41 32.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.496 -0.753 . . . . 0.0 109.764 -179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 mm -90.17 140.46 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.75 0.786 . . . . 0.0 109.643 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -166.37 -156.09 0.23 Allowed 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.475 ' C ' ' H ' ' A' ' 47' ' ' ASN . 42.7 p90 -62.71 -33.23 74.68 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.356 -0.84 . . . . 0.0 109.478 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 31.0 t30 -59.22 -2.39 0.28 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.492 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.475 ' H ' ' C ' ' A' ' 45' ' ' TYR . 49.5 t-20 -158.88 113.84 2.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.293 -0.879 . . . . 0.0 109.397 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.84 -29.07 54.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.196 -0.94 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' ND2' ' A' ' 47' ' ' ASN . 32.5 pttt -166.39 157.02 12.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.19 -0.944 . . . . 0.0 109.573 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.2 t -72.4 142.93 48.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -78.28 -40.67 36.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.257 -0.902 . . . . 0.0 109.107 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -116.17 -10.37 11.49 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.635 -0.665 . . . . 0.0 109.227 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -14.54 81.94 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 t 59.82 11.39 2.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -1.13 . . . . 0.0 109.665 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 50.9 t -93.12 151.63 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.232 -0.918 . . . . 0.0 108.892 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.7 p -145.35 131.67 19.59 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.0 109.767 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 -93.03 137.97 31.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.322 -0.861 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 53.8 m -71.1 -59.62 2.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 0.0 109.582 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 169.3 136.26 2.04 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -86.95 120.9 28.71 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.27 -1.135 . . . . 0.0 109.503 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -80.74 134.83 35.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.362 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 62' ' ' ARG . 0.1 OUTLIER -89.71 7.74 35.2 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.297 -0.877 . . . . 0.0 109.59 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 13' ' ' ALA . 39.8 p -153.4 -34.85 0.11 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.153 -0.967 . . . . 0.0 109.531 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.19 6.1 39.69 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 28.9 mm-40 -58.47 119.15 6.48 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.325 -1.103 . . . . 0.0 109.284 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 102.37 0.45 Allowed Glycine 0 N--CA 1.495 2.577 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -78.4 62.08 2.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -1.137 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.414 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . 177.69 88.26 0.07 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 71' ' ' GLU . 36.2 t0 47.58 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -1.091 . . . . 0.0 109.826 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -67.41 -68.96 0.34 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.389 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 44.0 mt-10 -106.52 161.88 14.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.459 -0.775 . . . . 0.0 109.324 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.5 p -166.0 174.45 9.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.17 -0.956 . . . . 0.0 109.751 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 mt -147.08 123.21 10.82 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.342 -0.849 . . . . 0.0 108.93 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -96.49 134.49 39.61 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.348 -0.845 . . . . 0.0 109.124 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -133.84 146.65 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.441 -0.787 . . . . 0.0 109.819 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -116.15 101.9 9.13 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.504 ' O ' HG22 ' A' ' 80' ' ' VAL . 59.7 mt -59.44 -50.7 72.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -59.25 -0.25 0.13 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.488 -0.757 . . . . 0.0 110.265 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' A' ' 77' ' ' LEU . . . -113.45 3.58 15.88 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.404 -0.81 . . . . 0.0 110.058 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.504 HG22 ' O ' ' A' ' 77' ' ' LEU . 33.7 m -64.7 147.08 98.19 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.049 -1.032 . . . . 0.0 109.587 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.33 -160.88 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.276 1.984 . . . . 0.0 111.964 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -116.49 42.08 1.96 Allowed Glycine 0 N--CA 1.498 2.823 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 84' ' ' VAL . 0.6 OUTLIER -136.45 -56.58 0.75 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.36 -1.082 . . . . 0.0 109.441 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.514 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 11.1 p -66.35 148.84 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 0.0 109.298 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -132.21 -8.19 3.39 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.458 -0.776 . . . . 0.0 109.785 -179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -151.82 139.96 20.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.001 -1.062 . . . . 0.0 109.847 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 64.5 mt -123.01 154.09 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 pt -140.34 153.34 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.181 -0.95 . . . . 0.0 109.964 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 16.2 m-85 -136.34 133.87 37.29 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.3 m -138.7 157.83 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.373 -0.829 . . . . 0.0 110.137 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 114.02 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 7.0 p -106.43 150.39 26.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.461 -0.774 . . . . 0.0 110.137 -179.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.66 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.5 mm -74.12 126.42 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.635 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 7.4 t-160 -62.0 -138.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.757 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.635 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 87.4 m-20 -63.96 -18.1 63.93 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.297 -0.877 . . . . 0.0 109.772 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.66 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -49.85 -19.3 0.64 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.116 -0.99 . . . . 0.0 109.14 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.4 ' N ' ' C ' ' A' ' 95' ' ' ASP . 17.8 pt20 -72.17 -35.42 69.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.478 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.59 60.97 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.484 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.416 ' HG2' ' H ' ' A' ' 99' ' ' ARG . 3.6 ptp180 -75.98 10.58 1.81 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.234 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 62.46 90.94 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 0.0 109.728 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.55 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 68.9 mt-30 -155.92 67.82 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.344 -0.847 . . . . 0.0 109.175 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.0 p -56.58 170.44 0.38 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.421 -0.799 . . . . 0.0 109.803 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.453 ' CD1' ' HB3' ' A' ' 131' ' ' ALA . 29.8 m-85 -46.88 -40.43 13.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.367 -0.833 . . . . 0.0 109.551 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -51.97 -26.0 18.1 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -68.68 -18.66 64.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -1.182 . . . . 0.0 109.751 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.466 HG12 ' N ' ' A' ' 107' ' ' SER . 15.8 t -80.72 164.88 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.159 -0.963 . . . . 0.0 109.577 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.3 t -73.54 -28.69 62.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.328 -0.857 . . . . 0.0 109.838 -179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 162.21 77.06 0.03 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -76.14 164.77 25.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -1.147 . . . . 0.0 109.287 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -155.21 143.05 19.92 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.051 -1.031 . . . . 0.0 110.5 -179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -99.95 153.01 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' GLY . 35.9 ttp180 -144.4 139.14 28.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.049 -1.032 . . . . 0.0 109.635 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.1 tp -133.35 137.87 46.08 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 115' ' ' ASN . 14.6 p -148.21 157.7 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.197 -0.939 . . . . 0.0 109.703 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.488 ' N ' HG22 ' A' ' 114' ' ' VAL . 10.6 m120 -93.47 102.59 14.81 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.23 -7.36 0.82 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 108.735 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' H ' ' C ' ' A' ' 115' ' ' ASN . 19.1 t70 -89.71 -52.34 5.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.5 -0.75 . . . . 0.0 109.82 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -97.59 -6.06 34.21 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.341 -0.85 . . . . 0.0 109.665 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.441 ' N ' ' O ' ' A' ' 115' ' ' ASN . 58.7 mt-30 53.74 42.3 31.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -0.9 . . . . 0.0 109.439 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.2 p -113.78 110.87 20.84 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.599 -0.688 . . . . 0.0 109.25 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -46.79 125.42 7.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.203 -0.936 . . . . 0.0 109.693 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.2 t -85.72 -60.74 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.182 -0.949 . . . . 0.0 109.671 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -174.24 174.8 2.8 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.836 -1.165 . . . . 0.0 110.296 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -147.71 154.11 40.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.542 -0.724 . . . . 0.0 109.08 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CG ' ' A' ' 130' ' ' ASP . 7.1 t80 -140.6 147.57 39.61 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -104.22 114.96 29.56 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.398 -0.814 . . . . 0.0 109.406 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.11 -37.23 34.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.563 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.43 ' O ' ' OG ' ' A' ' 132' ' ' SER . 28.4 m -54.73 -32.53 59.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.668 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -95.55 -28.95 14.62 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.302 -0.873 . . . . 0.0 110.463 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.484 ' CG ' ' CE2' ' A' ' 125' ' ' TYR . 12.7 m-20 -88.98 -74.37 0.47 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.042 -1.037 . . . . 0.0 110.352 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 133' ' ' THR . . . -73.52 15.41 0.26 Allowed 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.551 0.691 . . . . 0.0 109.63 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 130' ' ' ASP . 0.7 OUTLIER -43.16 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.678 -0.638 . . . . 0.0 110.197 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 131' ' ' ALA . 31.4 m -110.3 -23.99 10.91 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.406 -0.809 . . . . 0.0 109.896 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.422 ' OE1' ' N ' ' A' ' 134' ' ' GLU . 19.0 mp0 -94.08 -176.72 4.08 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.071 -1.018 . . . . 0.0 109.648 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.1 p -135.85 8.11 3.26 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -163.18 138.91 6.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.368 -0.833 . . . . 0.0 109.306 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 39.7 ttp -165.08 155.08 13.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.445 ' O ' HD12 ' A' ' 138' ' ' LEU . 3.1 pp -97.83 125.55 42.75 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.253 -0.905 . . . . 0.0 109.84 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -63.34 -44.91 93.54 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.046 -1.033 . . . . 0.0 108.925 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -179.58 -155.89 16.3 Favored Glycine 0 N--CA 1.492 2.421 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.039 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -150.66 166.82 29.18 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.246 -1.15 . . . . 0.0 109.853 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.2 tp -133.67 121.03 21.4 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -129.61 166.16 20.31 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.337 -0.852 . . . . 0.0 109.903 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.599 HH11 ' CG ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -92.59 138.78 31.21 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.407 -0.808 . . . . 0.0 110.161 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -139.0 124.04 18.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 56.07 20.48 4.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.226 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.03 61.5 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -127.98 137.52 52.27 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.514 -0.992 . . . . 0.0 109.477 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -67.49 151.64 47.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.344 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 41.9 tptt -151.35 124.36 8.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.222 -0.924 . . . . 0.0 109.387 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -89.85 124.57 34.79 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 0.0 109.67 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -122.16 107.55 12.3 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.574 -0.704 . . . . 0.0 109.187 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -72.84 154.73 40.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.907 . . . . 0.0 109.551 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.6 -33.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.35 -0.844 . . . . 0.0 109.297 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 62.68 87.58 0.04 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -139.7 104.38 4.9 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.493 -1.004 . . . . 0.0 109.391 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -82.85 150.53 27.99 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.423 ' CE1' HG11 ' A' ' 165' ' ' VAL . 3.0 p90 -145.79 128.33 16.06 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.299 -1.118 . . . . 0.0 109.065 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.48 25.86 1.36 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.261 -0.899 . . . . 0.0 109.456 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -68.55 -105.08 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -158.7 167.22 34.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.89 -37.36 29.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.264 -1.139 . . . . 0.0 109.549 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -83.98 -23.92 30.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.207 -0.933 . . . . 0.0 109.598 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.402 ' C ' ' N ' ' A' ' 166' ' ' CYS . 82.0 p -75.48 -58.06 3.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.218 -0.926 . . . . 0.0 109.567 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 169' ' ' TYR . 34.4 m -48.54 -20.5 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.173 -0.954 . . . . 0.0 109.517 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . 0.402 ' N ' ' C ' ' A' ' 164' ' ' SER . 45.5 t -71.8 -60.0 2.46 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -0.888 . . . . 0.0 110.001 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -85.51 -31.5 22.71 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 109.83 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -63.47 -23.36 67.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.256 -0.902 . . . . 0.0 110.072 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.519 ' CD1' ' O ' ' A' ' 165' ' ' VAL . 2.9 m-85 -71.86 -19.83 61.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.086 -1.009 . . . . 0.0 109.099 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -88.4 -53.38 2.64 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.0 tt -80.37 150.98 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -1.133 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.48 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.4 p-10 -74.07 127.2 32.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.51 48.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.447 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.48 179.992 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 14.0 ptt? -175.66 43.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.901 . . . . 0.0 109.424 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.492 ' O ' ' ND2' ' A' ' 4' ' ' ASN . 50.2 mttp -149.62 -45.16 0.14 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.295 -0.878 . . . . 0.0 109.198 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 3' ' ' LYS . 3.0 m120 -146.4 127.82 14.97 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.378 -0.826 . . . . 0.0 109.195 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG2' HD11 ' A' ' 113' ' ' LEU . 9.3 p -129.76 151.04 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 tt -148.66 114.3 5.66 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.643 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.4 t -86.41 151.35 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -140.49 117.22 1.25 Allowed Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.5 tp -107.2 135.48 48.66 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 70' ' ' ASP . . . -148.2 148.93 20.86 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.938 -179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 32.9 p90 -160.3 155.36 24.63 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.355 -1.085 . . . . 0.0 109.826 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.88 135.53 35.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.416 -0.802 . . . . 0.0 109.655 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.72 128.37 35.01 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.276 -0.89 . . . . 0.0 109.514 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -132.89 106.9 7.97 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.465 -0.772 . . . . 0.0 109.303 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.46 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 6.6 p -86.59 122.43 30.5 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 109.573 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 18' ' ' GLY . 2.5 p -149.02 135.43 19.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 109.018 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 48.66 12.51 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.365 -0.834 . . . . 0.0 109.631 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 16' ' ' THR . . . 172.94 -156.53 24.95 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -80.43 -171.99 3.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.251 -1.147 . . . . 0.0 109.578 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 15' ' ' SER . 14.7 m-20 -83.78 -170.46 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.0 109.609 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -96.29 147.76 23.45 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.0 109.262 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -141.12 100.34 3.79 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.303 -0.873 . . . . 0.0 109.947 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 23' ' ' LEU . 10.7 mp -83.33 163.26 20.75 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -125.33 121.95 35.44 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.459 -0.776 . . . . 0.0 109.577 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.11 140.75 31.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.422 -0.799 . . . . 0.0 109.022 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.4 t -149.43 167.71 25.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.173 -0.955 . . . . 0.0 109.822 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -136.1 123.25 21.66 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -105.22 127.53 52.97 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 29' ' ' LEU . 6.4 mp -74.9 154.42 38.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.492 -0.755 . . . . 0.0 109.298 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.15 126.96 13.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.974 -1.079 . . . . 0.0 109.074 179.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.463 ' H ' ' HA ' ' A' ' 36' ' ' VAL . . . -82.64 171.43 14.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.14 -0.975 . . . . 0.0 109.685 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.435 ' HB2' ' CB ' ' A' ' 85' ' ' ASP . . . -84.81 -5.14 59.32 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -0.888 . . . . 0.0 109.267 179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -72.36 -8.19 53.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.226 -0.921 . . . . 0.0 109.242 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.22 -3.76 51.4 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 76.5 mttt -144.66 141.02 29.03 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.476 -1.014 . . . . 0.0 108.764 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 13.0 p -66.23 144.75 14.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.113 -0.992 . . . . 0.0 109.574 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.581 HH11 ' CG ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -64.11 2.38 0.56 Allowed 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' VAL . . . 151.79 100.13 0.2 Allowed Glycine 0 N--CA 1.493 2.498 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.504 ' C ' ' H ' ' A' ' 41' ' ' ASP . 21.7 p-10 -51.32 -34.29 32.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.19 -1.183 . . . . 0.0 109.154 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.24 -3.18 0.08 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.677 -0.639 . . . . 0.0 109.702 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HD13 ' A' ' 29' ' ' LEU . 1.6 m-20 -92.05 27.19 2.22 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.091 -1.005 . . . . 0.0 108.707 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -90.36 141.02 29.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 109.452 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 18.5 mm -79.1 140.58 16.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.008 0.909 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -150.22 -171.53 3.94 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.479 ' C ' ' CD1' ' A' ' 45' ' ' TYR . 10.3 p90 -62.97 -31.38 72.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.785 -1.197 . . . . 0.0 109.401 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.422 ' O ' ' OD1' ' A' ' 47' ' ' ASN . 47.2 t30 -63.83 2.33 0.51 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.297 -0.877 . . . . 0.0 109.423 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.472 ' H ' ' C ' ' A' ' 45' ' ' TYR . 94.9 m-20 -146.21 111.86 5.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.267 -0.896 . . . . 0.0 109.252 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 48' ' ' LEU . 3.6 mm? -64.17 -33.93 76.91 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.223 -0.923 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -165.97 156.39 12.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.1 t -72.79 156.6 38.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.498 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.92 -48.71 11.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.14 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -116.41 -5.59 11.76 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.45 -15.29 81.3 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 p 62.16 14.57 6.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -1.148 . . . . 0.0 109.529 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.492 HG22 HG23 ' A' ' 75' ' ' ILE . 53.3 t -93.13 151.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.218 -0.926 . . . . 0.0 109.085 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 1.4 p -144.33 127.69 16.84 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.239 -0.913 . . . . 0.0 109.603 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -92.77 123.66 36.21 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.288 -0.882 . . . . 0.0 109.14 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -59.46 -48.09 82.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.494 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.3 135.87 1.94 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -85.98 111.36 20.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.296 -1.12 . . . . 0.0 109.471 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.727 HD22 ' H ' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -74.06 155.27 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.331 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.727 ' H ' HD22 ' A' ' 61' ' ' ASN . 22.0 mmm180 -110.78 8.15 22.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.498 -0.752 . . . . 0.0 109.591 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.3 p -154.54 -33.45 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.06 -1.025 . . . . 0.0 109.727 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.46 ' H ' ' CG ' ' A' ' 61' ' ' ASN . . . 101.93 6.0 49.66 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -58.45 110.48 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.413 -1.051 . . . . 0.0 109.462 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 160.8 118.28 0.48 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.4 71.82 0.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.165 -1.197 . . . . 0.0 109.476 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 159.05 -175.32 36.02 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.6 m-20 -50.46 107.88 0.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -1.131 . . . . 0.0 109.427 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' H ' ' HA2' ' A' ' 10' ' ' GLY . 73.9 m-20 -63.64 -68.78 0.32 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.424 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -94.19 169.21 10.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.248 -0.908 . . . . 0.0 109.241 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.4 t -171.08 158.82 5.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.201 -0.937 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 mt -143.11 120.89 11.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.284 -0.885 . . . . 0.0 109.172 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 44.1 tttm -96.58 136.72 36.71 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.411 -0.806 . . . . 0.0 109.536 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 HG22 ' A' ' 55' ' ' VAL . 4.7 mp -136.3 114.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.392 -0.818 . . . . 0.0 110.338 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -84.13 91.6 7.72 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' O ' ' NE1' ' A' ' 149' ' ' TRP . 9.7 mt -65.05 -5.21 5.85 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.24 -0.912 . . . . 0.0 109.554 -178.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -84.51 -24.09 29.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.246 -0.908 . . . . 0.0 109.526 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.87 -10.05 25.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.25 -0.906 . . . . 0.0 109.826 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 49.3 t -60.8 125.1 82.31 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.157 -0.964 . . . . 0.0 109.087 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -77.51 -161.53 0.14 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.901 1.734 . . . . 0.0 112.133 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -91.0 3.68 80.92 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -63.69 -55.3 24.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -1.196 . . . . 0.0 109.165 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 31.8 m -98.65 148.68 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.424 -0.797 . . . . 0.0 109.023 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HB2' ' A' ' 32' ' ' ALA . 1.7 m-20 -121.44 -6.9 9.26 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.586 -0.696 . . . . 0.0 109.5 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -156.17 143.49 19.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.12 -0.988 . . . . 0.0 109.288 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 15.4 mt -128.99 153.94 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 4.8 pt -141.1 152.96 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.188 -0.945 . . . . 0.0 109.659 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 89' ' ' PHE . 21.2 m-85 -132.84 127.92 35.54 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.87 153.81 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.368 -0.833 . . . . 0.0 110.033 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -108.84 141.74 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.4 p -129.97 143.67 50.92 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.386 -0.821 . . . . 0.0 109.691 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.651 HG23 ' HB3' ' A' ' 96' ' ' ALA . 4.4 mm -74.35 131.89 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.629 ' CG ' ' H ' ' A' ' 95' ' ' ASP . 6.6 t-80 -73.27 -139.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.266 -0.896 . . . . 0.0 110.36 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.629 ' H ' ' CG ' ' A' ' 94' ' ' HIS . 53.9 m-20 -52.82 -24.91 9.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.398 -0.814 . . . . 0.0 110.126 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.651 ' HB3' HG23 ' A' ' 93' ' ' ILE . . . -52.33 -18.94 1.8 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.06 -1.025 . . . . 0.0 108.727 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -77.7 -38.11 48.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.383 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -57.71 -50.07 74.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 0.0 108.896 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.513 ' NH2' ' OE1' ' A' ' 101' ' ' GLN . 10.8 ptm180 -81.24 3.01 25.4 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 25.0 ttp180 66.42 96.51 0.05 Allowed 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.461 0.648 . . . . 0.0 109.878 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.519 ' HB2' ' HB1' ' A' ' 96' ' ' ALA . 21.4 mt-30 -157.57 80.04 0.88 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.554 -0.716 . . . . 0.0 109.212 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.5 ' HA ' HG22 ' A' ' 135' ' ' THR . 32.2 p -56.11 157.26 4.78 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.323 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.63 ' CD1' ' N ' ' A' ' 103' ' ' PHE . 0.0 OUTLIER -45.83 -25.73 0.56 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.396 -0.815 . . . . 0.0 109.69 -179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HB1' ' A' ' 131' ' ' ALA . . . -51.07 -34.72 31.98 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 37.9 mm-40 -59.25 -24.19 62.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.246 -1.149 . . . . 0.0 109.092 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 107' ' ' SER . 23.1 t -69.07 169.08 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 108.996 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 106' ' ' VAL . 4.1 m -76.65 -24.89 53.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.119 -0.988 . . . . 0.0 110.015 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 157.43 79.53 0.03 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.8 164.64 26.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -1.176 . . . . 0.0 109.183 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -154.89 141.05 18.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.018 -1.051 . . . . 0.0 110.379 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.03 150.75 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -143.11 151.86 41.2 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.038 -1.039 . . . . 0.0 109.571 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.441 HD11 ' CG2' ' A' ' 5' ' ' VAL . 57.3 tp -134.66 145.34 48.48 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 120' ' ' THR . 6.6 p -153.81 144.51 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.366 -0.834 . . . . 0.0 109.534 179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 117' ' ' ASP . 17.9 m120 -82.63 102.6 11.56 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -48.83 -14.48 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.036 -1.04 . . . . 0.0 108.843 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 115' ' ' ASN . 13.6 t70 -79.95 -40.6 27.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.654 -0.654 . . . . 0.0 109.661 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -100.46 -18.34 16.74 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.372 -0.83 . . . . 0.0 110.005 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 58.91 50.72 8.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.242 -0.912 . . . . 0.0 109.567 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.465 ' C ' HG23 ' A' ' 114' ' ' VAL . 19.5 p -146.45 120.7 9.55 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -45.39 148.04 0.72 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.226 -0.921 . . . . 0.0 109.776 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 17.8 m -135.2 -23.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.382 -0.824 . . . . 0.0 110.223 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -159.52 159.04 32.95 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.675 -1.266 . . . . 0.0 110.441 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 124' ' ' ARG . 2.6 ptm180 -160.08 154.01 23.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.551 -0.718 . . . . 0.0 109.299 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -131.76 148.22 52.55 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.348 -0.845 . . . . 0.0 109.232 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -110.67 114.66 28.22 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.363 -0.835 . . . . 0.0 109.472 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.592 ' N ' HD22 ' A' ' 127' ' ' LEU . 3.6 mm? -68.92 -37.77 79.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 109.453 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.41 ' H ' HG22 ' A' ' 128' ' ' THR . 0.1 OUTLIER -45.62 -21.88 0.13 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.039 -1.038 . . . . 0.0 109.496 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 127' ' ' LEU . 58.3 mm-40 -94.83 -51.75 4.56 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.462 -0.774 . . . . 0.0 109.408 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -92.2 17.06 10.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.354 -0.841 . . . . 0.0 109.571 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.57 ' N ' ' O ' ' A' ' 127' ' ' LEU . . . -81.69 -50.15 9.64 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.984 -178.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 4.4 t -60.8 2.93 0.09 Allowed 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.443 -0.786 . . . . 0.0 109.833 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.513 ' H ' ' C ' ' A' ' 131' ' ' ALA . 23.4 m -91.49 -33.07 15.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.091 -1.006 . . . . 0.0 110.745 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.479 ' OE1' ' N ' ' A' ' 158' ' ' TYR . 14.8 pt-20 -171.98 -147.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.903 -1.123 . . . . 0.0 110.032 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.527 ' O ' ' CE2' ' A' ' 103' ' ' PHE . 0.6 OUTLIER -125.33 -30.58 3.13 Favored 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -112.61 157.09 21.63 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.423 -0.798 . . . . 0.0 108.896 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 7.4 ttt -164.28 130.18 2.95 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.753 -1.217 . . . . 0.0 110.426 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.2 tt -82.33 125.47 31.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.235 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -75.11 -56.68 4.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.185 -0.947 . . . . 0.0 109.94 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.58 -166.64 22.77 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.254 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -151.15 166.54 30.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.369 -1.077 . . . . 0.0 110.033 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.5 mt -134.22 138.84 45.37 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 144' ' ' ARG . 9.1 p90 -145.01 166.38 25.49 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.014 -1.054 . . . . 0.0 109.959 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 143' ' ' TYR . 14.7 ptm180 -86.63 150.8 23.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 0.0 109.697 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -154.95 122.87 5.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.329 -0.857 . . . . 0.0 109.256 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 57.8 t30 54.76 25.98 7.14 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.2 -0.938 . . . . 0.0 109.395 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 81.76 11.83 82.3 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -127.87 139.08 52.83 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.532 -0.981 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.484 ' NE1' ' O ' ' A' ' 77' ' ' LEU . 78.2 m95 -67.46 150.94 48.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.311 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -153.68 134.84 14.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.209 -0.932 . . . . 0.0 109.602 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 152' ' ' ARG . 19.3 t80 -89.84 153.85 20.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.369 -0.832 . . . . 0.0 109.47 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.489 ' N ' ' CD1' ' A' ' 151' ' ' PHE . 51.5 ttt180 -151.92 109.09 3.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.307 -0.871 . . . . 0.0 109.406 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ALA . . . . . . . . . . . . . . . -57.25 154.78 9.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -0.905 . . . . 0.0 109.535 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.1 t -139.75 -34.12 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.292 -0.88 . . . . 0.0 109.262 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 52.92 82.19 0.05 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.457 ' CG ' ' N ' ' A' ' 157' ' ' GLY . 42.5 tt0 -145.72 165.88 27.5 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -1.038 . . . . 0.0 108.796 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.457 ' N ' ' CG ' ' A' ' 156' ' ' GLN . . . -164.88 -167.8 26.03 Favored Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.244 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.479 ' N ' ' OE1' ' A' ' 134' ' ' GLU . 1.5 m-85 -150.06 157.01 42.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.489 -1.006 . . . . 0.0 109.049 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' O ' ' OG1' ' A' ' 135' ' ' THR . . . -50.86 -43.04 59.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 109.488 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 147.16 103.72 0.35 Allowed Glycine 0 N--CA 1.494 2.552 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 163' ' ' ALA . . . -159.6 56.48 0.33 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.646 ' N ' HD23 ' A' ' 162' ' ' LEU . 1.2 pt? -45.44 -16.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -1.097 . . . . 0.0 109.821 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 161' ' ' GLY . . . -85.83 -39.49 17.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.404 ' N ' ' O ' ' A' ' 161' ' ' GLY . 58.0 p -89.86 -44.92 9.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.296 -0.878 . . . . 0.0 109.358 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.527 ' O ' ' CE2' ' A' ' 169' ' ' TYR . 69.4 t -48.3 -20.41 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.355 -0.84 . . . . 0.0 109.702 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' CYS . . . . . . . . . . . . . 8.1 t -77.6 -60.96 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.782 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.07 -20.84 59.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 109.391 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -56.88 -24.66 53.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.367 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.527 ' CE2' ' O ' ' A' ' 165' ' ' VAL . 53.2 m-85 -71.45 -15.82 62.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . -82.42 -47.51 6.01 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.2 tt -84.06 146.85 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.185 -1.186 . . . . 0.0 109.477 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.49 ' ND2' ' N ' ' A' ' 172' ' ' ASN . 2.0 m120 -79.93 130.27 35.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.252 -0.905 . . . . 0.0 109.388 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.49 19.56 0.78 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.0 t . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.477 -179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_